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Addiction is a chronic, relapsing disorder associated with health and social 
problems for the individual and great economic costs for society. Despite 
significant progress in the understanding of drug effects on the nervous 
system, major processes involved in the development of addiction are still 
insufficiently understood. At a cellular level, many drugs of abuse induce a 
long term potentiation-like state in the dopamine (DA) neurons of the ventral 
tegmental area (VTA), a process which enhances synaptic transmission and 
potentiates signals for longer within the cell. This is a major cellular 
mechanism underlying normal learning and memory formation, but is also 
important in the formation of drug-related memories and addiction. By 
adopting a correlative approach to further dissect which neuronal mechanisms 
contribute to addiction, the focus of this thesis is placed on two separate 
genes, each of which code for different proteins involved in synaptic plasticity. 
The thesis aims to assess whether these genes contribute to the development 
of drug preference and addiction, and the speed at which these behaviours 
are established. Alpha calcium/calmodulin dependent protein kinase II 
(αCaMKII) and Ras-specific guanine nucleotide releasing factor 2 (Ras-GRF2) 
are calcium/calmodulin dependent kinases which play an important role in the 
plasticity of the glutamatergic and monoaminergic systems by influencing 
long-term potentiation (LTP).  
Transgenic mice were tested through an extensive battery of 
behavioural (spontaneous behaviours, consumption and conditioned place 
preference) and in vivo neurochemical (in vivo microdialysis and HPLC-ED) 
techniques, in order to assess whether αCaMKII and Ras-GRF2 have the 
potential to control the rate at which addiction related behaviours are acquired 
and/or established. The current thesis implicates αCaMKII 
autophosphorylation in the mediation of threat induced activity in response to 
novel situations and stimuli. αCaMKII also appears to play an important role in 
the establishment of drug addiction by altering the differential reinforcing 
effects of alcohol. A deficit in αCaMKII autophosphorylation delayed the rate 
of alcohol drinking establishment. However, repeated periods of withdrawal 
and reinstatement allowed for these drinking behaviours to be established to 
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the same capacity as observed in wild-type mice. Alcohol administration also 
altered dopamine and serotonin levels in the mesocorticolimbic system of 
αCaMKII autophosphorylation deficient mice. Adaptations in this system were 
also found following the development of cocaine preference. Ras-GRF2 has 
an important role at the synapse and Ras-GRF2 deletion appears to result in 
the failure of the monoaminergic system to adapt in a typical way in response 
to alcohol exposure, which may make the animal less vulnerable to the 
rewarding properties of alcohol. One hypothesis is that the Ras-GRF2 deletion 
has the potential to serve as neuro-protective factor against alcoholism. 
Characterisation of the roles of αCaMKII and Ras-GRF2 suggests that the 
proteins encoded by these genes may contribute to aspects of drug addiction 
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1. Addiction and substance abuse disorders 
Addiction is a chronic, relapsing disorder and can be defined as the 
compulsive use of drugs, despite negative consequences (Hyman, 2005), 
progressing from impulsive to compulsive use in stages (Koob and Le Moal, 
2005). Initially, during the intoxication phase drug taking behaviour is 
positively reinforced. As consumption increases, this behaviour progresses 
towards compulsion, any negatively reinforcing effects are offset by drug use, 
and the alleviation of a negative emotional state increases the probability of 
response (Koob and Le Moal, 1997). Substance abuse disorders are 
classified as serious psychiatric disorders by both the Diagnostic and 
Statistical Manual of Mental Disorders IV (DSM IV), and the International 
Classification of Diseases (ICD-10). Drug dependence is a debilitating 
disorder and is associated with huge health and social concerns for the 
individual and great economic costs for society.  
 
 
1.1. Alcohol abuse 
The consumption of fermented beverages, containing alcohol (ethanol), is 
thought to have existed as early as 10,000 BC. Today, alcohol is consumed 
recreationally and legally in western societies, despite its potential for harmful 
use and abuse. Alcohol is consumed for a variety of reasons, although it has 
been suggested that the key component to compulsive drug seeking is the 
alleviation of a negative affective state (Koob, 2011), other factors such as the 
inflation of “self-perceived survival ability and reproductive fitness” (Newlin, 
2002) are likely to play a role in the decision to consume alcohol. Of course, 
not everyone consuming alcohol will become addicted (Zinberg and 
Jacobson, 1976; Zinberg et al., 1978; Glynn et al., 1983; O'Malley and 
Johnston, 2002). The concept of ‘drug instrumentalization’ (Müller and 
Schumann, 2011), suggests that psycho-active drugs are consumed for their 
desirable effects on mental states, for example, in order to enhance everyday 
functioning by influencing mood, by reducing stress, and increasing sociability 
(Chick, 1999; Peele and Brodsky, 2000; Molnar et al., 2009). Approximately 
55% of the global adult population legally consume alcohol. The World Health 
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Organisation (WHO) estimate the number of people who currently use alcohol 
worldwide to be 2 billion, of these people 76.3 million have an alcohol use 
disorder (WHO, 2004). In approximately 10-20% of alcohol consumers, 
chronic use and abuse will lead to serious health problems such as damage to 
organs such as the liver, pancreas and the brain (Spanagel, 2009). The 
Global Information System on Alcohol and Health (GISAH, 2011) cite alcohol 
as having a significant causal role in 60 different types of disease, and can 
account for 9% of deaths in the 15-29 age group (WHO, 2011). Despite 
alcohol being a legally consumed drug of abuse, harmful use results in 2.5 
million deaths each year (WHO, 2011). In addition, it has been shown that 
approximately 10% of an industrialized nation’s gross domestic product is 
spent in connection with alcohol use and abuse (Nutt et al., 2007), and each 
year Europeans alone spend approximately 100 billion Euros on alcoholic 
beverages (Spanagel, 2009).  
 
There are many targets for ethanol within the brain (McBride et al., 2002; 
Harris et al., 2008; Spanagel, 2009). One way in which alcohol is known to 
exert its effects is mediation via the glutamatergic system, in particular the N-
methyl-D-aspartate (NMDA) receptors (Spanagel, 2009). Current flowing 
through the NMDA receptors is known to be reduced during acute ethanol 
exposure (Lovinger, 1997; Narahashi, 2000). NMDA receptors are a major 
constituent of the post-synaptic density, and are highly expressed in neurons 
(Colbran and Brown, 2004; Irvine et al., 2006; Wayman et al., 2008). Calcium 
(Ca2+) entry into the post-synaptic cell, through NMDA receptors, results in 
activation of a number of downstream molecules, such as calcium calmodulin 
dependent protein kinase II (CaMKII), a protein kinase required for induction 
of long term potentiation (LTP). NR1 and NR2 NMDA subunits have been 
identified as the main regulators of channel sensitivity to ethanol (Ronald et 
al., 2001; Ren et al., 2003). Interestingly, the NR2B subunit of the NMDA 
receptor has both binding and phosphorylation sites for CaMKII, indicating 
that NMDA receptor sensitivity may be affected by an interaction with CaMKII 
(Xu et al., 2008). Alterations in channel sensitivity to ethanol have been shown 
to vary across brain regions (Simson et al., 1991; Yang et al., 1996). 
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Importantly, ethanol acts as an NMDA antagonist in certain brain regions 
including the ventral tegmental area (VTA) and the substantia nigra, both 
dopamine (DA) rich areas of the midbrain which have implications for 
motivation, reward and addiction (Yang et al., 1996).  
 There are large numbers of transmitter systems and synaptic 
mechanisms involved in the establishment of alcohol dependence (Nestler 
and Aghajanian, 1997; Heilig and Koob, 2007). The γ-aminobutyric acid 
(GABA) system is the major inhibitory transmitter system in the brain and it 
has been suggested to mediate the rewarding and anxiolytic effects 
associated with ethanol consumption (Koob et al., 1998a; Stephens et al., 
2005). It has been postulated that changes in this circuitry may provide 
motivation for excessive drinking, and the transition from casual alcohol use to 
dependence (Koob et al., 1998a). It is GABAA receptor function that is 
enhanced by ethanol, the extent of which strongly depends on the subunit 
composition of the GABAA receptor (Stephens et al., 2005; Spanagel, 2009). 
Evidence suggests it is the α and β subunits in particular which are involved in 
the actions of ethanol (Mihic et al., 1997). Lending support to the theory that 
GABA activation is an important component of the acute reinforcing effects of 
alcohol, the acute blockade of GABAA receptor function can inhibit the 
motivation for responding for ethanol (Koob, 2004). Acutely, alcohol 
administration is known to enhance DA release from the mesolimbic pathway 
(Di Chiara and Imperato, 1988) with preferential release from the nucleus 
accumbens (NAcc) (Pontieri et al., 1995). It has been postulated that this 
occurs via GABAergic feedback into the VTA, decreasing the activity of the 
GABAergic neurons, leading to a disinhibition of mesolimbic DA neurons 
(Spanagel and Weiss, 1999). GABAA receptor inhibition is mediated by 
several protein kinases (Moss and Smart, 1996; Brandon et al., 2002; Kittler 
and Moss, 2003), one of which is CaMKII. CaMKII can bind to, and 
phosphorylate, different isoforms of GABAA receptors, resulting in alterations 
in GABAA receptor expression and function (Houston et al., 2009). CaMKII is 
capable of either prolonging or increasing the amplitude of inhibitory post-
synaptic currents (IPSC) at GABAA β2 subunit-containing receptors, and has 
been implicated in the trafficking of GABAA receptors (Houston et al., 2009). 
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CaMKII is known to play an important role at excitatory synapses (Sheng and 
Hoogenraad, 2007), associating with a number of different proteins and 
potentially altering synaptic activity (Strack et al., 2000; Robison et al., 2005) 




1.2. Cocaine abuse 
Peruvian Indians originally believed that the coca plant was a gift sent from 
the gods. Cocaine, in its current form, has only been in use for the past 100 
years, but the leaves of the coca plant have been chewed by people for 
thousands of years. Cocaine is the main alkaloid of Erythroxylon coca, a 
shrub which grows abundantly in parts South America, but the main 
constituent wasn’t isolated until the 1850’s (Johanson and Fischman, 1989). 
Sigmund Freud believed cocaine was a cure for a variety of physical and 
psychological illnesses and it was used in medicine as a local anaesthetic and 
vasoconstrictor (Barash, 1977). The consequences of chronic use and the 
potential for abuse were soon discovered and use was limited. Cocaine has 
also been used in consumable products in the past. The Coca-Cola Company 
launched ‘Coca-Cola’ in 1886 and used coca leaves, left over from the 
cocaine extraction process, as part of their recipe leaving only trace amounts 
of cocaine present in the beverage. In 1903 cocaine was removed from the 
recipe. Cocaine was used prolifically up until the early 1900’s when laws were 
introduced to control its use. The drug was banned in 1914, resulting in a 
decrease in consumption up until the 1960’s. Consumption increased again 
during the 70’s and 80’s due to the popularisation of crack cocaine or 
freebase and has since become a substantial public health problem, resulting 
in a large number of medical, psychological and social problems. The United 
Nations office on Drugs and Crime (UNODC) have estimated that the 
prevalence of cocaine use worldwide in 2009 ranged from 0.3% to 0.5% of the 
population aged 15-64, approximately 14.2 to 20.5 million people (UNODC, 
2011). Today, cocaine is the most widely used illicit psycho-stimulant drug in 
the UK, with a prevalence rate of lifetime use of between 3% and 5% 
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(UNODC, 2011). However, the largest cocaine market continues to be the 
United States, accounting for 36% of global consumption (UNODC, 2011).  
 
Cocaine is a psycho-active drug and is classified as a stimulant since it 
enhances activity in the central nervous system (CNS). Cocaine suppresses 
the appetite and increases locomotion and feelings of alertness, pleasure, well 
being and euphoria. Cocaine can also induce feelings of paranoia, anxiety 
and restlessness. Cocaine’s effects are experienced almost immediately after 
administration; this ‘high’ is short lived and typically lasts for between 30 and 
60 minutes.  
Cocaine’s main system effects are on the monoaminergic system. 
Cocaine artificially increases extracellular DA levels by binding to the 
monoamine transporters located pre-synaptically, thus prevents the binding of 
the monoamines themselves and blocking the re-uptake of DA, serotonin (5-
HT) and noradrenaline (NA) (Uhl et al., 2002; Hall et al., 2004; Jones et al., 
2009). This causes the extracellular space to become flooded with the 
transmitter molecules (Pifl et al., 1995; White and Kalivas, 1998) and the 
subsequent over stimulation of the receptors (Nestler, 2005). Cocaine has a 
similar affinity for DA, 5-HT and NA transporters (Chen et al., 2006; Han and 
Gu, 2006) although the most extensively studied mechanism has been the 
dopaminergic transmitter system (Sofuoglu and Sewell, 2009), and is thought 
to be the most clinically relevant (Nestler, 2005). There is a high concentration 
of DA neurons in the limbic system, and this is the site where cocaine 
predominantly produces its psychoactive effects (Koob et al., 1998a; Hyman 
and Malenka, 2001; Nestler, 2001; Kalivas and McFarland, 2003). DA D1 
(DRD1) and DA D2 (DRD2) -like receptors are primary targets for altering 
neurotransmission when challenged with cocaine (Montague et al., 2004; 
Hyman et al., 2006). 
The glutamatergic system has also been identified as a cocaine target 
(Uys and LaLumiere, 2008) and a substantial amount of research is now 
emerging, looking at the role of the glutamatergic system in the mediation of 
addictive behaviours (Kelley et al., 2003; Kauer and Malenka, 2007; Gass and 
Olive, 2008; Uys and LaLumiere, 2008). Cocaine does not act directly on 
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glutamatergic neurons in the same way it does with DA, 5-HT and NA (Ritz et 
al., 1990). Literature indicates that cocaine indirectly influences glutamate 
transmission in the limbic system, including the NAcc, and produces 
persistent changes in neuronal function which alter the behavioural effects of 
cocaine (Gass and Olive, 2008; Thomas et al., 2008; Uys and LaLumiere, 
2008). While an acute cocaine injection does not seem to have a dramatic 
effect on glutamate levels in the NAcc (Pierce et al., 1996), cocaine 
experienced rats increase glutamate levels in the NAcc core in response to 
cocaine administration (Pierce et al., 1996; Cornish and Kalivas, 2000; 
McFarland et al., 2003). Cocaine withdrawal after chronic use has been 
shown to deplete basal levels of glutamate in the NAcc (Pierce et al., 1996; 
Baker et al., 2002). Taken together, this data suggests that cocaine use 
influences neuro-adaptations in glutamatergic signalling in the NAcc by acting 
on monoaminergic transmitters (Schmidt and Pierce, 2010). Both NMDA (Lu 
et al., 2003; Kelley, 2004; Famous et al., 2007) and AMPA (α-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid) (Cornish and Kalivas, 2000; Self 
and Choi, 2004; Suto et al., 2004; Schmidt and Pierce, 2010) glutamate 
receptors contribute to the plasticity at glutamatergic synapses and the 
reinforcing effects of cocaine. NMDA receptor inhibition prevents LTP in 
several brain regions (Malenka and Bear, 2004) and at the same time 
prevents conditioned place preference (CPP), self-administration and 
behavioural sensitisation to drugs of abuse (Kalivas and Alesdatter, 1993; 
Schenk et al., 1993; Harris and Aston-Jones, 2003). After glutamate binds and 
removes the voltage-dependent magnesium (Mg2+) block, the NMDA 
receptors become active and allow Ca2+ ions to flow into the post-synaptic 
cell. This triggers an intracellular signalling cascade which includes a variety 
of protein kinases, most notably CaMKII (Malenka and Nicoll, 1999). Data 
strongly implicates the monoaminergic and glutamatergic systems, in 
conjunction with learning and memory processes, in the development of 






2. Are our genes to blame? 
Addiction is seen to run in families (Cotton, 1979; Guze et al., 1986) and the 
individual risk of developing alcoholism increases with the proximity and 
number of affected individuals (Dawson et al., 1992). The way in which 
addictions are inherited shows no obvious pattern of Mendelian transmission 
(Merikangas and Avenevoli, 2000) but studies on large samples of twins can 
help to tease apart genetic and environmental influences on addictive 
processes (Kendler et al., 2003). Both environmental and genetic factors play 
a role in the development of addictive disorders, and contribute to individual 
differences in vulnerability to the progression from drug use to dependence 
(Goldman et al., 2005; Ripley and Stephens, 2011). Twin studies help to 
assess the relative importance of genetic, shared and non-shared 
environmental influences on complex traits and behaviours. The classical twin 
design compares the similarity of monozygotic (identical) and dizygotic 
(fraternal/non-identical) twins. Monozygotic twins are genetically identical and 
have a high degree of environmental similarity. Dizygotic twins also share 
their environments but only share 50% of their genes. Large scale twin studies 
allow the contribution of genes, shared and unique environments to be 
disentangled. Therefore, if a condition was to be considered heritable it would 
be expected that more co-twins would be affected in monozygotic twin pairs 
when compared with dizygotic twin pairs. This has been reported in the 
majority of twin studies that have investigated the heritability of addictive 
behaviours (Ball and Collier, 2002; Ball et al., 2007). Genetic studies provide 
important information regarding hereditary influences and the risk of addiction 
(Ball, 2008). Addictions are among the most heritable of complex psychiatric 
disorders, with heritability estimates ranging from 0.39 (39%) for 
hallucinogens to 0.72 (72%) for cocaine (see Figure 1.1; taken from (Goldman 
et al., 2005). 
 
Meta-analysis of genetic association studies report specific genetic loci and 
variants which have been associated with drug addiction. However, it can be 
difficult to interpret the results since studies can be inconsistent, sometimes 
analytically biased and under-powered (Li et al., 2011). Meta-analyses of drug 
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addiction studies have been rather limited and the majority of studies have 
focused on candidate genes instead of genome wide analysis. While data 
from human studies can be conflicting, and epidemiological factors can make 
it hard to demonstrate causal relationships, the use of transgenic and knock-
out (KO) animal models has made the investigation of the potentially genetic 
risk factors for addiction easier. Despite this, there are still a large number of 
genes/genetic factors currently being investigated in relation to the 
development of addictive behaviours, several of which mediate normal 
functioning of the mesocorticolimbic system. The metabolising enzyme 
monoamine oxidase A (MAOA) is responsible for breaking down DA, 5-HT 
and NA (Goldman et al., 2005). 5-HT is implicated in impulsivity, anxiety and 
alcoholism. MAOA is responsible for the breakdown of 5-HT and recent 
studies have shown that maltreatment and adversity experienced by young 
boys, combined with low MAOA gene expression levels, can predict conduct 
problems and lead to addiction (Caspi et al., 2002; Foley et al., 2004). This 
suggests that low MAOA expression levels might confer some increased 
susceptibility to alcoholism in certain individuals. Catechol-O-methyl 
transferase (COMT) also has a major role in the metabolism of DA and NA in 
the CNS (Enoch, 2006), and the Val158Met polymorphism of COMT results in 
variation in enzyme activity. The COMT alleles have been implicated in 
alcoholism, but this effect appears to be population dependent. For example, 
the Met158 allele is associated with increased drinking in European 
Caucasian men (Tiihonen et al., 1999; Hallikainen et al., 2000). However, the 
same allele confers a protective effect against alcoholism in Plains American 
Indians (Enoch et al., 2006). The Met158 allele may therefore be considered a 
vulnerability factor for alcohol drinking in certain societies. As mentioned 
earlier in this chapter, both NMDA (Lu et al., 2003; Kelley, 2004) and AMPA 
(Cornish and Kalivas, 2000; Self and Choi, 2004) glutamatergic receptors 
contribute to the plasticity at glutamatergic synapses and the reinforcing 
effects of cocaine and other commonly abused drugs. A large number of 
drugs of abuse are known to induce LTP in DA neurons of the VTA (Saal et 
al., 2003; Thomas and Malenka, 2003; Kauer, 2004) and these changes are 
mediated, at least in part, by AMPA and NMDA receptors. For example, 
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blockade of NMDA receptors in the prefrontal cortex (PFC) inhibits extinction 
learning of amphetamine CPP (Hsu and Packard, 2008), and AMPA infusion 
into the infralimbic cortex blocks cocaine reinstatement of cocaine seeking 
behaviour (Peters et al., 2008). Also acting in the frontal regions of the brain 
are several genetic factors thought to mediate addictive processes, one of 
which is ∆FosB, a transcription factor which accumulates in the NAcc 
following exposure to natural rewards such as sucrose drinking. Levels also 
increase in response to chronic exposure to all drugs of abuse and is thought 
to contribute to a state of sensitisation (Nestler et al., 2001; McClung et al., 
2004; Hyman, 2005). Over expression of ∆FosB in the NAcc increases 
behavioural responses to cocaine, opiates and other natural rewards such as 
sucrose. Accordingly, blockade of ∆FosB function in the NAcc suppresses 
behavioural responses to cocaine (Nestler et al., 2001; McClung and Nestler, 
2003; McClung et al., 2004). Brain-derived neurotrophic factor (BDNF) plays a 
role in the growth and differentiation of developing neurons (Chao, 2003; 
Chao et al., 2006) and is implicated in learning and memory and synaptic 
plasticity (Chiocco et al., 2007; Liu et al., 2008). BDNF can contribute to drug 
taking behaviours including; LTP and long term depression (LTD) in the VTA 
(Thomas et al., 2001; Mameli et al., 2009), drug induced structural plasticity in 
mesocorticolimbic DA areas (Robinson and Kolb, 2004; Russo et al., 2009) 
and drug induced MAPK/ERK (mitogen-activated protein kinase/extracellular 
signal-regulated kinases) signalling in the NAcc and amygdala (Lu et al., 
2006; Girault et al., 2007). Alcohol metabolising genes also have the potential 
to indirectly influence vulnerability to substance abuse disorders. Variations in 
these genes may contribute to the development of alcoholism. Alcohol 
dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) are directly 
involved in the breakdown of alcohol and decreased efficiency of these 
proteins can cause the build up of alcohol’s metabolic products, causing a 
facial flushing reaction. This is predominantly seen in the Southeast Asian 
population, discouraging alcohol intake and thereby conveying an indirect 





Although genetic factors clearly play a role in mediating addiction, the 
environment also plays a substantial role in the development of the complex 
trait of addiction. Further investigation is required into the underlying causes of 
alcohol and cocaine use, abuse and dependence, and to what degree an 







Figure 1.1: The heritability (h²) of ten addictive disorders in a cohort of monozygotic 
and dizygotic twins. An h² value of 0.4 suggests that genetics make a 40% 
contribution to the development of the disorder in question. Cocaine and opiates are 






3. The learning of addictive behaviours 
The process by which addiction is established remains largely unknown, 
however it is thought to involve a number of learning and memory processes. 
Wikler and Pescor (1967) have cited “pathological learning” as a model for 
addiction, although the idea of addiction as a memory was first introduced in 
1972 (Mello, 1972). Since then, numerous researchers have attempted to 
summarise and characterise how the reinforcing effects of drugs may interfere 
with learning and memory pathways. White (1996) proposed three reinforcing 
actions, which can be influenced by psychoactive drugs, affecting learning 
and memory systems: conditioned incentive learning; declarative learning; 
habit/stimulus-response learning. ‘Conditioned incentive learning’ was first 
described by Pavlov (1927) and involves the presentation of a neutral stimulus 
with a reinforcer which elicits an internal state perceived as rewarding, in time 
the originally neutral stimulus can evoke the same response in the absence of 
the reinforcer. The CPP test design is commonly used in the laboratory today 
and is based upon the theory of ‘conditioned incentive learning’, in which a 
neutral environmental cue becomes associated with a motivationally 
significant event such as drug experience (Cunningham et al., 2006), thereby 
eliciting a motivational response. This response is then used to assess the 
significance/preference of the motivationally significant event. The second 
reinforcing action described by White (1996) is ‘declarative learning’.  The 
concept was originally described by Tolman (1948; 1949) and was known as 
‘stimulus-stimulus’ since it involves learning about relationships among cues 
and events and is used to illicit appropriate behaviours when required. The 
neural basis of learning suggests that the hippocampal system can acquire 
information about the relationship between external cues and internal states 
(Hirsh et al., 1978; Hirsh et al., 1979; Davidson and Jarrard, 1993) and rapidly 
store the information relevant to the situation in which a drug is administered 
(for example, in a social setting) and can therefore contribute to addiction. The 
final memory type described by White (1996), and thought to contribute to the 
development of addiction is ‘habit/stimulus-response learning’. Stimulus-
response associations are the “bonds” between the neural representation of a 
stimulus and a response. These associations are strengthened slightly each 
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time the response occurs, resulting in reinforcement and thus the acquisition 
of ‘habit’ strength occurs at a relatively slow pace. In order for these 
associations to affect future behaviour, there must be some process which is 
acting to give them a degree of permanency. This process is thought to be 
mediated by the caudate putamen (CPu) (Divac, 1968; McDonald and White, 
1993). More recently the classification of ‘addiction memories’ has been 
revised, and the different memory types suggested in relation to drug 
consumption include: a memory of drug effect, a memory of drug use and a 
memory of addiction (Heyne et al., 2000; Boening, 2001), although it has been 
suggested that the involvement of Pavlovian incentive learning mechanisms 
and reward are the forces driving consumption (Orford, 2001). In general, 
concepts of drug addiction memory focus on the state of addiction, and tend 
to overlook the immediately preceding processes occurring in the non-
addicted individual, which need to happen before addiction is established. 
This period is critical for the formation of drug-related memories, retrieval of 
these memories and ongoing drug consumption (Müller and Schumann, 
2011).  
 
It is widely believed that addiction and memory formation share a number of 
molecular and anatomical pathways (Nestler, 2002a; Kelley, 2004; Hyman, 
2005; Nestler, 2005). There are several areas of the brain which are affected 
by drugs of abuse including the VTA, the NAcc, the medial PFC, the ventral 
pallidum, the dorsal hippocampus and the central gray and lateral amygdala 
(McBride et al., 1999). These regions are responsible for mediating the 
rewarding potential of drugs (Koob et al., 1998b; Wise, 1998; Swanson, 2000; 
Nestler, 2001; Everitt and Wolf, 2002). Drugs of abuse ‘hijack’ the natural 
reward system in the brain (Nestler, 2002b; Kelley, 2004; Hyman, 2005; 
Novak et al., 2010) which has evolved to evaluate the positive and negative 
reinforcing properties for natural rewards, such as; food, sex, social 
interaction, danger, fighting for territory and incurring injury, for the purpose of 
enhancing survival. In each case, where there has been an adaptation of 




At a cellular level, many drugs of abuse induce a LTP-like state in the DA 
neurons of the VTA (Bonci et al., 2003; Saal et al., 2003; Thomas and 
Malenka, 2003; Borgland et al., 2004; Kauer, 2004), a process which 
enhances synaptic transmission and potentiates signals for longer within the 
cell. This is a major cellular mechanism underlying normal learning and 
memory formation, but is also important for drug memories and addiction as 
well. The present study aims to evaluate whether disruption in two genes, 
αCaMKII and Ras-GRF2, can alter measures of drug preference, and the rate 
at which these preferences are established. Specifically this will be carried out 
by using an in vivo approach to look at the effect of disruption of specific 
proteins which play key roles in synaptic plasticity on the development of 
preference for alcohol and cocaine 
Although involvement of these genes in addition-related behaviours could be 
explained by their role in the learning and memory circuits, this thesis does 





















4. Novel targets in the study of addiction  
There is an established link between addictive processes and learning and 
memory pathways that warrants further investigation. Interruption of this 
circuitry can influence measures of drug preference, and the rate at which 
addiction is established (Hyman and Malenka, 2001; Hyman, 2005). Arguably 
one of the most noteworthy mechanisms worth following-up is the alpha 
Ca2+/calmodulin dependent protein kinase II (αCaMKII). Phosphorylation of 
CaMKII is important for drug addiction (Anderson et al., 2008), but the specific 
involvement of the autophosphorylation mechanism is not yet known. Further 
investigation may provide evidence for a contribution of the 
autophosphorylation mechanism to the development of addiction. Also of 
considerable interest is the Ca2+/calmodulin (CaM) binding exchange factor, 
Ras-specific guanine nucleotide releasing factor 2 (Ras-GRF2). There is 
evidence to suggest that Ras-GRF2 contributes to learning and memory 
formation by influencing the induction of LTP (Thomas and Huganir, 2004; 
Tian et al., 2004; Li et al., 2006; Tian and Feig, 2006). However, Ras-GRF2 
has only recently been associated with drugs of abuse (Stacey et al., 2012). 
Ras-GRF2 is a highly speculative candidate for addictions studies, but further 
studies may provide evidence for a link between this gene and addiction. 
 
 
4.1. alpha Ca2+/Calmodulin Dependent Protein Kinase II (αCaMKII) 
CaMKII is a major post-synaptic density protein. It plays a key role in synaptic 
plasticity in the glutamatergic system and is known to be important for learning 
and memory formation (Fukunaga et al., 1993; Colbran and Brown, 2004; 
Lengyel et al., 2004). There are two main isoforms expressed in the brain, 
αCaMKII and beta CaMKII (βCaMKII) (Colbran and Brown, 2004). The 
expression levels of CaMKII’s α and β isoforms are differentially regulated in 
cultured hippocampal neurons and high levels of synaptic activity have been 
shown to up-regulate the expression of αCaMKII and down-regulate βCaMKII 
expression (Thiagarajan et al., 2002). The αCaMKII isoform is most 
prominently expressed in the forebrain at glutamatergic post-synapses 
(Lisman et al., 2002; Colbran and Brown, 2004; Irvine et al., 2006; Wayman et 
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al., 2008). αCaMKII is part of the Ca2+ signalling cascade in cells and is 
typically inactive under basal cellular conditions. αCaMKII is made up of 3 
domains, a self-association domain, an autoinhibitory domain and a catalytic 
domain. In its inactive state, the enzyme is locked shut by binding of the 
autoinhibitory to the catalytic domain (See Figure 1.2, (Irvine et al., 2006). 
When Ca2+ ions enter the post-synaptic cell they bind calmodulin, forming the 
CaM complex. The CaM complex then activates αCaMKII by displacing the 
autoinhibitory domain from the catalytic site. Once rendered active, the 
catalytic site of αCaMKII is free to phosphorylate downstream substrates 
involved in intracellular signal transduction, but also has the potential to switch 
to an autonomous or independent mode of activity known as 
autophosphorylation (Giese et al., 1998). Upon autophosphorylation, αCaMKII 
is able to phosphorylate neighbouring subunits in the holoenzyme at the 
threonine 286 residue, even after the dissociation of the CaM complex, 
allowing the kinase to remain active for longer. This autophosphorylation 
mechanism prevents αCaMKII from reverting to its resting state even after 
Ca2+ levels drop to baseline levels, the signal ceases and the cell rests. As 
illustrated in Fig 1.2, during Ca2+ independent activation only one CaM 
molecule is required to activate the entire holoenzyme as opposed to during 
Ca2+ dependent activity when six CaM molecules would be needed to achieve 
the same result. It is this switch to a Ca2+ independent state which allows 
signals to be potentiated for longer within the cell, leaving a lasting imprint 










CaMKII is capable of phosphorylating itself and a number of intracellular 
targets including AMPA receptors (Poncer et al., 2002), NMDA receptors 
(Bayer et al., 2001), L-type Ca2+ channels (Dzhura et al., 2000) and tyrosine 
hydroxylase (TH ; Griffith and Schulman, 1988). The potential interaction 
between CaMKII and TH is of particular interest as TH is the rate limiting 
enzyme in DA synthesis, which in turn is a precursor for NA. TH, CaM and 
CaMKII are co-localised in the NAcc. It has been suggested that TH activity 
and DA synthesis are regulated by Ca2+/CaM/CaMKII in the NAcc and other 
areas (Sutoo et al., 2002). There is also a strong link between CaMKII and 
serotonergic function in the brain. Tryptophan hydroxylase (TPH) is the initial 
and rate limiting enzyme in the biosynthesis of 5-HT (Kuhn et al., 2007), and it 
exists in two isoforms, TPH1 and TPH2 (Kuhn et al., 2007). TPH2 is 
exclusively expressed in the CNS and is activated by CaMKII phosphorylation 
(Hamon et al., 1977; 1978; 1981; Kuhn et al., 1980; Kuhn and Lovenberg, 
1982; Yamauchi and Fujisawa, 1981; Ehret et al., 1989). Alterations in the 
activity of CaMKII, and consequently activity of TRP2, could ultimately 
influence the function of serotonergic neurons by altering the amount of 
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transmitter available for release into the extracellular space. Evidence 
therefore implicates CaMKII in the regulation of DA, 5-HT and NA synthesis in 
the CNS, suggesting that CaMKII may act as a mediator of basal activity for 
all three transmitters. 
 
It has been well established that CaMKII signaling is critical for the induction 
of LTP (Pettit et al., 1994; Wang and Kelly, 1995). CaMKII activity and 
autophosphorylation at the threonine 286 residue are essential for normal 
NMDA receptor-dependent forms of LTP in the hippocampal CA1 region 
(Elgersma et al., 2004) and hippocampus-dependent behaviours such as 
spatial learning and memory (Fink and Meyer, 2002; Lisman et al., 2002; 
Matynia et al., 2002). Studies with mouse mutants also demonstrate that 
impairment of αCaMKII signaling severely impairs hippocampus-dependent 
spatial, as well as contextual, memory formation (Silva et al., 1992; Giese et 
al., 1998; Elgersma et al., 2004). Using the Morris Water Maze task, αCaMKII 
autophosphorylation deficient mice take longer to locate a hidden under-water 
platform compared to wild-types, showing that αCaMKII autophosphorylation 
is necessary for hippocampal LTP and hippocampus dependent learning 
(Giese et al., 1998). Subsequent investigation into the specific types of 
learning and memory to be affected by this αCaMKII autophosphorylation 
deficiency found that these mice exhibited reduced ‘freezing’ behaviours and 
were considered to be impaired in cue (amygdala dependent) and contextual 
(hippocampus dependent) fear conditioning after a single shock (Irvine et al., 
2005). Mice were still impaired after three foot shocks in their contextual 
memory, but not cue fear memory. And after 5 foot shocks, both contextual 
and cue memories were formed, indicating that these deficits can be 
overcome by repeated training sessions (Irvine et al., 2005). Data suggest 
that αCaMKII autophosphorylation affects the speed at which memories are 
established but not necessarily the capacity to learn. Irvine et al., (2006) 
conclude that αCaMKII autophosphorylation provides a ‘fast track to memory’ 
and facilitates learning, but is dispensable for memory.  
While there has been a large amount of literature demonstrating the 
importance of αCaMKII autophosphorylation in learning and memory in rodent 
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models, until recently there has been no association confirmed in a human 
sample. Easton and colleagues reported a genetic association between 
polymorphisms in the human CAMK2A gene and performance in a spatial and 
non-spatial working memory task in two independent samples (Easton et al., 
2012). Results suggested that polymorphisms in the human CAMK2A gene 
predict working memory performance without any corresponding changes in 
frontal cortex or hippocampal anatomy. This data supports and expands upon 
findings in animal models which can now be translated to human cognition, 
thereby strengthening the link between αCaMKII and learning and memory 
function in both rodents and humans.  
Albeit to a lesser extent, emotionality and spontaneous behaviours 
have previously been examined in CaMKII transgenic mice. αCaMKII KO mice 
are not as fearful as their heterozygous littermates as they showed reduced 
freezing behaviours in the foot shock test and reduced defensive and 
offensive aggression (Chen et al., 1994). Expression levels of αCaMKII seem 
to play an important role in emotional behaviours (Hasegawa et al., 2009). 
Transgenic mice which over-express αCaMKII in the forebrain displayed 
increased anxiety levels and offensive aggression, whereas heterozygous 
mice showed decreased anxiety and increased defensive aggression 
(Hasegawa et al., 2009). In addition, stress induced increases in glutamate 
signalling subsequently lead to increases in the phosphorylation of CaMKII 
(Suenaga et al., 2004). However, it has yet to be determined whether the 
autophosphorylation mechanism of CaMKII contributes to these behavioural 
differences in anxiety and aggression. The behaviour of αCaMKII 
autophosphorylation deficient mice have not been thoroughly characterised. 
This is surprising, especially given there has been extensive investigation over 
the past 15 years into the learning and memory deficits of these mice. 
Moreover, αCaMKII autophosphorylation deficient mice are noticeably more 
active and more aggressive in response to handling. Mice appear hyperactive, 
more difficult to capture and attempt to avoid handling by biting and jumping 
out of the homecage, and displaying enhanced escape behaviours. Taking all 
evidence into account, there clearly was a need to assess anxiety in αCaMKII 
autophosphorylation deficient mice. Furthermore, differences in anxiety could 
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impact upon the more complex test paradigms used to assess drug 
preference in the current thesis. 
Long-term plasticity in the brain requires relatively stable changes in 
gene expression; these changes may alter neurotransmission and the 
structure of target neurons (Nestler, 1997; Robinson and Kolb, 2004; McClung 
and Nestler, 2008). Modifications in αCaMKII expression in the brain have 
previously been linked to drugs of abuse, lending support to the involvement 
of CaMKII in pathways of addiction. Alcohol treatment has been shown to 
induce increases in αCaMKII in prenatal and postnatal rat cerebral cortex 
(Mahadev et al., 2001), an effect which can be attributed to Ca2+ influx during 
chronic alcohol exposure. However, chronic ethanol treatment has also been 
shown to have no effect on αCaMKII expression levels in human embryonic 
kidney (HEK) 293 cells (Xu et al., 2008). It has been previously reported that 
acute morphine treatment does not affect αCaMKII gene expression (Lou et 
al., 1999). However, chronic morphine administration was found to induce a 
specific increase in αCaMKII mRNA levels in the hippocampus and frontal 
cortex, but not in the amygdala and piriform cortex of the rat brain (Chen et 
al., 2008). Data illustrate a regional specific regulation of αCaMKII gene 
expression in response to chronic morphine treatment. 
 
Evidently, αCaMKII autophosphorylation plays a specific role in synaptic 
plasticity, and particularly in rodent hippocampal and amygdala dependent 
learning and memory via LTP (Silva et al., 1992; Giese et al., 1998; Elgersma 
et al., 2004; Irvine et al., 2005). CAMK2A also plays a role in working memory 
performance in a human sample (Easton et al., 2012). Deficiency of αCaMKII 
autophosphorylation can also potentially alter baseline behaviour and 
emotionality in mice which needs to be formally assessed. CaMKII expression 
and consequently long term plasticity have been shown to be mediated by 
drug administration but the involvement of this autophosphorylation 
mechanism in the motivational and rewarding effects of drugs of abuse 
remains unclear. Given the differences in learning and memory tasks and the 
potential interaction with drugs of abuse, one may speculate as to whether 
this autophosphorylation mechanism plays an important role in the 
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motivational and rewarding effects leading to addiction. Since the presence of 
αCaMKII autophosphorylation can accelerate learning (Irvine et al., 2006), we 
hypothesised that αCaMKII is more relevant during early drug exposure and 
the establishment of addiction related behaviours and less so after 
consumption has been increased. We asked whether the αCaMKII 
autophosphorylation mechanism may mediate the speed at which addiction 
related behaviours are established. 
 
 
4.2. Ras-specific guanine nucleotide releasing factor 2 (Ras-GRF2) 
The Ras superfamily of proteins includes over 150 GTPases and is made up 
of six subfamilies, one of which is the Ras subfamily.  The Ras subfamily 
contains 13 members which are split into five subgroups (Ehrhardt et al., 
2002). The first group (p21 Ras proteins) consists of the classic Ras proteins 
(H-Ras, K-Ras and N-Ras) which show considerable homology of 85%. The 
other four subgroups share approximately 40%–50% homology with the p21 
Ras proteins (Ehrhardt et al., 2002). The Ras family of proteins are generally 
responsible for regulating trafficking and localization in membranes. The 
proteins play a part in development, growth, differentiation, cell adhesion, 
proliferation and transport. 
 
Ras-GRF2 belongs to a family of CaM associated guanine nucleotide 
exchange factors and acts as an ‘on-off switch’ in cells. Ras-GRF2 activates 
the RAS protein which is known to be involved in the MAPK/ERK signal 
transduction pathway (Fig. 1.3). The RAS protein activates the MAPK/ERK 
pathway, by allowing the exchange of Guanosine diphosphate (GDP) for 
Guanosine-5'-triphosphate (GTP), thereby regulating signalling pathways in 
cells. NMDA receptor activation of the Ras-MAPK signalling cascade is also 
critically involved in the induction of LTD and LTP (Thomas and Huganir, 
2004; Li et al., 2006). Ras-GRF2 KO mice were impaired in LTP induction, but 
LTD remained unaffected, demonstrating a specific role in synaptic plasticity 
(Thomas and Huganir, 2004; Tian et al., 2004; Li et al., 2006; Tian and Feig, 
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2006). Interestingly, Ras-GRF1 was shown to contribute predominantly to 
LTD (Li et al., 2006).  
 
 
Figure 1.3: The MAPK/ERK signal transduction pathway. The MAPK/ERK signaling 
cascade has a crucial role in mediating intracellular signal transduction. RAS is 
activated in the cytosol and then, via this protein kinase cascade, translocates to the 
nucleus where MAPK regulates the activity of several transcription factors. The 
cascade begins extracellularly, Epidermal growth factor (EGF) binds to EGF receptor 
and activates tyrosine kinases (TK) in the cytoplasmic domain of the receptor. 
Subsequently, intracellular TK’s bind docking proteins e.g. GRB2 (Growth factor 
receptor-bound protein 2) which contain SH2 (Src Homology 2) domains, this in turn 
binds SOS (son-of-sevenless) which then becomes active, promoting the removal of 
GDP from RAS. RAS then binds GTP and becomes active itself and activates RAF 
enzyme. RAF then phosphorylates and activates MEK (MAP kinase kinase) which 
phosphorylates and activates MAPK. Taken from Kim and Bar-Sagi, 2004. 
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In many cell types RAS-MAPK/ERK pathway activation promotes cell division. 
This may explain why mutations in the RAS family of proteins can account for 
approximately 30% of all human cancers (Bos, 1989). Ras mutations are 
common in human pancreatic cancer, colorectal cancer, lung 
adenocarcinoma, gall bladder cancer, bile duct cancer and thyroid cancer 
(Rowinsky et al., 1999) but not in breast cancer, where Ras mutations have a 
frequency of less than 5% (Clark and Der, 1995; Rowinsky et al., 1999). For 
these reasons the RAS-ERK pathway has been a target for a number of anti-
cancer drugs and works by inhibiting RAS and other proteins (Hilger et al., 
2002). Although deletion of Ras-GRF2 has the potential to have a major 
impact on neuronal signalling pathways, knockout of Ras-GRF2 does not 
interfere with basal developmental conditions in mice. Fernandez-Medarde 
and colleagues (2002) report that Ras-GRF2 is not essential for embryonic 
and adult mouse development, knockouts have a similar weight and size as 
their wild-type (WT) littermates, and show similar fertility levels, reaching 
sexual maturity at the same as WT controls. In addition, no specific pathology 
was observed following histological analysis. This study demonstrates that 
Ras-GRF2 is dispensable for mouse growth and development. 
 
Evidence suggests that Ras-GRF2 acts on pathways which are also 
implicated in alcoholism, including the dopaminergic reward system. The 
RAS-MAPK/ERK pathway has been linked to DRD1 (Tian et al., 2004; Girault 
et al., 2007), and has also been isolated as a binding partner of the dopamine 
transporter (DAT) (Maiya et al., 2007). These studies report a role for Ras-
GRF2 both pre- and post-synaptically. Bloch-Shilderman and colleagues 
(2001) report a direct role for the MAPK/ERK pathway in neurotransmitter 
release. Ras-GRF2, as a MAPK/ERK activating protein, may therefore be 
linked to neurotransmitter release. Under basal conditions, alcohol will 
stimulate neuronal firing in the reward circuitry of the brain. This is mediated in 
large part by an interaction of alcohol with GABAergic and DA neurons in the 
ventral tegmental area (McBride et al., 1999). In terminal areas of the DA 
projections, this typically involves the pre-synaptic neuron becoming 
depolarized following a large Ca²⁺ influx into the cell. This then sets into 
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motion a series of events which ultimately result in the release of a given 
neurotransmitter into the synaptic cleft. Agell and colleagues (2002) report the 
activation of all Ras-GRF’s depend upon Ca²⁺ and Calmodulin. Ras-GRF’s 
contain an ilimaquinone (IQ) motif which dictates Ca²⁺ sensitivity to Ras-GRF. 
When a cell receives an intracellular signal, the Ca²⁺ channel becomes active, 
allowing a large Ca²⁺ influx, resulting in depolarization of the cell. Following 
influx, Ca²⁺ binds to calmodulin forming a (CaM) complex which can in turn 
bind Ras-GRF2. The Ca²⁺/CaM/Ras-GRF2 complex then activates the RAS 
protein which induces GDP-GTP exchange, activating the MAPK/ERK 
pathway and neurotransmitter release. For example, the RAS dependent 
MAPK/ERK pathway has previously been reported to be involved in DA 
release in neurons (Bloch-Shilderman et al., 2001). Figure 1.4 represents a 




Figure 1.4: The Ca²⁺/CaM/Ras-GRF2 complex is responsible for binding to, and 
activating, the RAS protein. This switches RAS ‘on’ and subsequently allows RAS to 
exchange GDP for GTP, resulting in the continuation of the MAPK/ERK pathway and 





The potential involvement of Ras-GRF2 in intracellular signalling and 
neurotransmitter release has considerable implications for the development of 
drug addiction. Drugs of abuse ‘hijack’ the natural reward system in the brain 
(Nestler, 2002b; Kelley, 2004; Hyman, 2005) resulting in the alteration of 
extracellular transmitter levels in areas such as the NAcc and PFC (Pontieri et 
al., 1995), thereby mediating the rewarding potential of these drugs (Koob et 
al., 1998b; Wise, 1998; Swanson, 2000; Nestler, 2001; Everitt and Wolf, 
2002). Ras-GRF2 has recently been implicated as a novel candidate in the 
regulation of alcohol consumption (Stacey et al., 2012). Polymorphisms in the 
human RASGRF2 gene were significantly associated with alcohol 
consumption, and Ras-GRF2 KO mice also consumed significantly less 
alcohol and had a reduced alcohol preference compared to controls (Stacey 
et al., 2012). Altogether, evidence from human and animal studies suggests 
an important contribution of Ras-GRF2 to addiction establishment, in 
particular for alcohol. Although Ras-GRF2 is a highly speculative candidate for 



















5. The importance of genetically manipulated animals in 
behavioural pharmacology research  
Humans possess around 30,000 protein coding genes, approximately a third 
of which have a known function. Trying to discern the function of each gene 
can be difficult especially since one gene may have several functions, or one 
function may involve several genes. The use of genetically manipulated 
animals is becoming increasingly useful when trying to determine single gene 
function and can be performed in a number of different ways. Targeted 
insertions work by introducing DNA into embryonic stem (ES) cells, and then 
cells in which the insert has undergone homologous recombination are 
selected (Stephens et al., 2002). This is comparable to a congenic strain (i.e. 
where a small region around, and including, a gene is altered) and can result 
in the elimination (‘knock-outs’) or alteration (‘knock-ins’) of gene function. 
Non-targetted transgenic organisms have had DNA artificially introduced 
randomly into the genome, resulting in the alteration of normal function of the 
targeted gene or genetic region. Other types of genetic manipulation include 
N-ethyl-N-nitrosourea (ENU) mutagenesis which involves the utilisation of a 
highly potent mutagen (ENU), capable of inducing point mutations within a 
genome (Russell et al., 1979; Noveroske et al., 2000; Gondo et al., 2010). 
RNA interference leads to the knockdown or silencing of gene activity by 
creating double-stranded messenger RNA which is recognised as foreign and 
destroyed within cells (Lu et al., 2005). This process essentially renders the 
gene inactive. Genetic manipulations have been performed in a variety of 
organisms including bacteria, yeast, flies, fish, frogs, rodents and even 
monkeys. These highly sophisticated techniques provide neuroscientists with 
powerful and, in some cases, specific tools for understanding gene function 
(Stephens et al., 2002).  
There are a number of benefits and difficulties when using genetically 
manipulated animals. The use of such manipulations is highly specific and a 
major advantage in behavioural pharmacology. By disrupting small selected 
parts of the genetic sequence distinct behavioural phenotypes may result. 
Drugs can be used to achieve the same effect as genetic manipulation, 
however this can have unknown consequences on downstream targets and 
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may interfere with the hypothesis being tested. Furthermore, the role 
pharmacokinetics also needs to be considered when assessing 
pharmacodynamics of the drug under study. Since behavioural pharmacology 
research routinely involves the use of drugs, the use of genetically modified 
animals is of considerable benefit. In addition, these techniques provide a way 
to study certain targets when there are no drugs available to achieve the 
desired effects. The dopamine D2 receptor (DRD2) is a good example of how 
genetic techniques can be exploited based on the advantages they possess in 
terms of specificity. DRD2 naturally occurs in two isoforms, long and short. 
Deletion of exon 6 of the DRD2 gene results in the expression of the DRD2 
short form (Missale et al., 1998). This approach allows for the investigation of 
the two isoforms separately, an effect which cannot be achieved using 
pharmacological intervention (Glickstein and Schmauss, 2001). Distinct 
functions of the two isoforms were revealed using a genetic manipulation 
approach. The DRD2 long form is expressed postsynaptically and is targeted 
by neuroleptic drugs (Wang et al., 2000). The DRD2 short form is expressed 
presynaptically as an autoreceptor (Usiello et al., 2000). The autoreceptor 
function of the DRD2 short form can control DA release when synaptic 
concentrations are high i.e. the concentrations achieved during cocaine or 
morphine treatment (Rouge-Pont et al., 2002). The short isoform of DRD2 
may therefore be involved in vulnerability to drug abuse. 
Genetic manipulation also brings with it some distinct limitations. 
Insertion of foreign DNA sequences can disrupt function of other genes. This 
may cause problems with the interpretation of data generated and 
understanding whether any changes in phenotype are due to the inserted 
DNA sequence (the congenic footprint effect). It is not uncommon that by 
introducing mutations at such an early stage (i.e. at the single cell/blastocyst 
stage), it is not possible to distinguish whether the phenotypic effect observed 
in the adult is due to an effect of the mutation during development or on the 
adult. However, the engineering of conditional knockouts deals with both of 
these issues as the activation of the knockout can be developmental and/or 
tissue-specific. Genetic background also needs to be given careful 
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consideration as the effects of mutations can differ according to the strain 
used (genetic background effect; Gerlai, 1996). 
Initially seen as a way to understand behaviour, we can now look at 
integrating genetic approaches and behavioural pharmacology and 
investigate how genes influence the mechanisms by which drugs alter 
behaviour. They help reveal novel systems underlying drug action, which in 





























6. Main research questions, aims and hypotheses 
At a cellular level, many drugs of abuse induce a LTP-like state in the DA 
neurons of the VTA (Bonci et al., 2003; Saal et al., 2003; Thomas and 
Malenka, 2003; Borgland et al., 2004; Kauer, 2004), LTP is a process which 
enhances synaptic transmission and potentiates signals for longer within the 
cell. This is a major cellular mechanism underlying normal learning and 
memory formation, but is also important for establishing cellular memories of 
drug exposure and addiction following repeated exposure. The present thesis 
evaluates whether disruption in key genes of the learning and memory 
circuitry can affect or alter measures of drug preference, and the rate at which 
these preferences are established. Specifically, this will be carried out by 
using an in vivo approach to look at the effect of disruption of specific target 
molecules (αCaMKII and Ras-GRF2) involved in synaptic plasticity on the 
development of drug preference behaviours.  The experiments contained in 
this thesis assess whether deficits in αCaMKII and Ras-GRF2 can have an 
impact on the development of drug preference and addiction, and the speed 
at which these behaviours are established. 
 
 
Hypotheses tested in the thesis: 
 
Hypothesis 1:  
There is a growing body of research supporting a role for αCaMKII in the 
behavioural responses to threat or fearful stimuli (Chen et al., 1994; 
Hasegawa et al., 2009; Suenaga et al., 2004). However, the specific 
contribution of the autophosphorylation mechanism to these behavioural 
differences remains unknown. From observation alone, it is clear that lack of 
αCaMKII autophosphorylation alters the behavioural response in novel, 
potentially threatening, test situations. This is especially important since the 
internal emotional state has the potential to influence behavioural outcomes 




 αCaMKII autophosphorylation will alter behavioural responses in 
potentially threatening situations. 
 
The exploratory activity of αCaMKII mutants was tested across a range of 
novel and familiar test environments. Little is known about the behavioural 
response of these mice to novel situations and altered anxiety can be a 
serious confound in the assessment of other behaviours in a novel test 
situation. This was therefore deemed an important control experiment. 
 
Hypothesis 2: 
Memory formation and addiction are thought to share a number of molecular 
and anatomical pathways (Nestler, 2002a; Kelley, 2004; Hyman, 2005; Müller 
and Schumann, 2011). αCaMKII is important for memory formation (Elgersma 
et al., 2004) and also for drug addiction (Anderson et al., 2008). αCaMKII 
autophosphorylation deficiency causes learning impairments (Irvine et al., 
2005), but does not alter the capacity to learn, long term memory storage or 
memory retrieval (Irvine et al., 2006). This suggests that autophosphorylation 
may affect the speed of normal learning (Lengyel et al., 2004; Lee et al., 
2009). Based on this evidence, the following hypotheses were tested in 
Chapters 3 and 4: 
 The lack of autophosphorylation should lead to a delay in the 
establishment of addiction related behaviours. 
 This should not limit the capacity to establish these behaviours after 
prolonged drug exposure, or play a role in the maintenance of an 
addictive state once established. 
 The initial delay should coincide with changes in the monoaminergic 
system 
 
Alcohol increases αCaMKII expression levels in rat cerebral cortex which can 
be attributed to Ca2+ influx during chronic alcohol exposure (Mahadev et al., 
2001). Chapter 3 therefore tests the above hypotheses in relation to alcohol 
use. Also, cocaine reinstatement is associated with CaMKII activation and 
phosphorylation of CaMKII at the Thr286 site (Anderson et al., 2008). Chapter 
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Ras-GRF2 is a novel candidate in the regulation of alcohol consumption 
(Stacey et al., 2012). Polymorphisms in the human RASGRF2 gene are 
significantly associated with alcohol consumption, and Ras-GRF2 KO mice 
consume and show a reducd preference for alcohol compared to controls 
(Stacey et al., 2012). Ras-GRF2 KO mice are impaired in LTP induction, 
demonstrating a specific role for this gene in synaptic plasticity (Thomas and 
Huganir, 2004; Tian et al., 2004; Li et al., 2006; Tian and Feig, 2006). The 
RAS-MAPK/ERK pathway has been linked to the dopaminergic system (Tian 
et al., 2004; Girault et al., 2007; Maiya et al., 2007) and neurotransmitter 
release (Bloch-Shilderman et al., 2001). This has potential implications for the 
development of drug addiction. Chapter 5 aims to further examine the reason 
for diminished alcohol drinking behaviours in Ras-GRF2 KO mice. The 
following hypotheses were tested: 
 Ras-GRF2 KO mice do not experience the motivationally rewarding 
properties of alcohol to the same extent as wild-type mice. 
 This may be accounted for by dysfunction of neurochemistry in the 
reward system. 
 
Evidence from human and animal studies suggests an important contribution 
of Ras-GRF2 to addiction establishment, for alcohol in particular. However, 
functional mechanisms are currently unknown and warrant investigation. Ras-
GRF2 is a highly speculative candidate for addiction studies. However, further 
examination may provide evidence for a potential link between this gene and 
addiction. 
It is important to note that any consequences of the manipulation of either 
gene on behaviours related to addiction are not necessarily attributable to 
their roles in learning. Experiments performed in the thesis do not explicitly 
test learning and memory in these mice. Further experimentation would be 
required in order to definitively determine whether it is the learning deficit in 
  
 46
these animals causing any alterations seen in addictive behaviours. Data from 
this thesis merely suggests an association between αCaMKII and Ras-GRF2 
and addiction related behaviours, whether this is mediated by altered 
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Autophosphorylation of αCaMKII is regarded as a ‘molecular memory’ for Ca2+ 
transients and a crucial mechanism in aversely, but less so in appetitively, 
motivated learning and memory. While there is a growing body of research 
implicating αCaMKII in general in behavioural responses to threat or fearful 
stimuli, little is known about the contribution of the autophosphorylation. The 
present study asked how αCaMKII autophosphorylation controls anxiety-like 
behavioural responses toward novel, potentially threatening stimuli. 
Homozygous and heterozygous T286A αCaMKII autophosphorylation 
deficient mice and wild types were tested in a systematic series of behavioural 
tests. Homozygous mutants were more active in the open field test and 
showed reduced anxiety-related behaviour in the light/dark test, but these 
findings were confounded by a hyperlocomotor phenotype. The analysis of 
elevated plus maze showed significantly reduced anxiety-related behaviour in 
the αCaMKII autophosphorylation-deficient mice which appeared to mediate a 
hyperlocomotor response. An analysis of home cage behaviour, where neither 
novel nor threatening stimuli were present, showed no differences in 
locomotor activity between genotypes. Increased locomotion was not 
observed in the novel object exploration test in the αCaMKII 
autophosphorylation-deficient mice, implying that hyperactivity does not occur 
in response to discrete novel stimuli. The present data suggest that the 
behaviour of αCaMKII autophosphorylation-deficient mice cannot simply be 
described as a low anxiety phenotype. Instead it is suggested that αCaMKII 
autophosphorylation influences locomotor reactivity to novel environments 











There is a growing body of research supporting a role for αCaMKII in 
behavioural responses to threat or fearful stimuli. Chen and colleagues (1994) 
show that αCaMKII knockout mice exhibit reduced freezing behaviour in the 
foot shock test and, therefore, do not appear to be as fearful as their 
heterozygous littermates. Homozygous (KO) mice also displayed reduced 
defensive and offensive aggression. This is interpreted as a sign of reduced 
fear in the KO mouse (Chen et al., 1994). A recent study generated transgenic 
mice over-expressing αCaMKII in the forebrain and reports increased 
offensive aggression and increased anxiety levels in these mice (Hasegawa et 
al., 2009). Suenaga and colleagues (2004) demonstrate that stress increases 
glutamate signalling, which in turn increases the phosphorylation of CaMKII. 
Also, expression levels of αCaMKII play an important role in emotional 
behaviours (Hasegawa et al., 2009). However, it remains unclear how 
important the specific role of the autophosphorylation mechanism contributes 
to these behavioural differences.  
 
Prior to commencing the present study, mice were seen to react with 
unusually high levels of aggression or fear towards the experimenter, 
exhibiting behaviours such as biting and responding in a very hyperactive way 
in an attempt to escape. This raised the question of differential threat reactivity 
and anxiety-like responses present in the αCaMKII autophosphorylation 
deficient mice. The behaviour of these mice has never been thoroughly 
characterised. This is surprising, especially since there has been extensive 
investigation into the learning and memory deficits of these mice. Any 
differences in basal behavioural responses have the potential to interfere with 
further behavioural paradigms. αCaMKII autophosphorylation deficient mice 
show learning deficits in tasks associated with aversive stimuli or a stressful or 
emotional component (Giese et al., 1998; Need and Giese, 2003; Irvine et al., 
2005), but not in appetitively motivated tasks (Carvalho et al., 2001). 
Spontaneous behaviour tests assess anxiety-like traits in response to 
anxiolytic drugs, such as benzodiazepines. More recently, these tests have 
been used to assess basal behavioural differences between mice, for 
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example, between mice of different strains or genotypes. Tests such as the 
open field, light/dark box, elevated plus maze, homecage, and novel object 
have a high sensitivity to anti-anxiety pharmacological agents. Moreover, 
these tests are based on the monitoring of spontaneous behaviours, which is 
a major strength of the test battery in the present study. This provides a high 
degree of ethological validity, relying upon unconditional reactions to 
potentially threatening novel situations.  
 
In their book ‘The Neuropsychology of Anxiety’ (2000), Gray and McNaughton 
analyse the cognitive and behavioural functions of anxiety in the septo-
hippocampal system and the roles of these functions in memory and fear. 
There is a distinct difference between fear and anxiety. Fear implies 
immediate threat, whereas anxiety suggests threat is possible although not 
yet present. The theory suggests that this is mainly controlled by the septo-
hippocampal system and its connections to other brain regions such as the 
amygdala (Gray and McNaughton, 2000). The system is designed to detect 
conflict between competing goals (such as food, threat, escape, etc.). Anxiety 
manifests when there is competition between two goals which are controlled 
by the septo-hippocampus. This conflict creates uncertainty, and the 
hippocampus tries to resolve this through behavioural inhibition i.e. approach 
or avoidance. The hippocampus has been studied extensively as part of the 
brain system responsible for spatial memory (O’Keefe and Nadel, 1978; Silva 
et al., 1992; Giese et al., 1998; Fink and Meyer, 2002; Lisman et al., 2002; 
Matynia et al., 2002; Elgersma et al., 2004). Lesions of the hippocampus 
impairs spatial memory as measured in the Morris Water Maze task (Morris et 
al., 1982). Gray and McNaughton (2000) argue that such a lesion would also 
remove the inhibitory system which attempts to resolved goal conflict. 
Therefore, does destruction of the hippocampus cause spatial deficits or 
simply an inability of the system to resolve goal conflict i.e. trying to escape 
versus interpretation of sensory cues. This is described as a hierarchical 
defense system theory that relates anxiety, fear and memory. 
Differences in cognitive processing have the potential to alter resulting 
emotional responses (McNaughton, 1997). Furthermore, cognitive systems 
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have been described as a filter for environmental information in order to 
produce an appropriate emotional response (McNaughton, 1997). The limbic 
system, and the hippocampus in particular, has been identified as crucial for 
both memory (O’Keefe and Nadel, 1978) and emotion (Gray, 1992). It 
therefore follows that there is potential for overlap between the two processes, 
where cognitive dysfunction and increased negative associations of stimuli 
can result in increases in anxiety (McNaughton, 1997).  
 
Given the differences in emotion-related behaviours observed in these mice 
and the potential interaction between anxiety-like behaviours and cognition 
(Gray and McNaughton, 2000), the aim of the current study is to investigate 
how αCaMKII autophosphorylation controls behavioural responses towards 























2. Material and Methods 
All housing and experimental procedures were performed in accordance with 




Male and female αCaMKIIT286A mice (Giese et al., 1998) were studied. These 
mutants were generated using a gene-targeting strategy which utilizes a 
replacement vector containing the point mutation and a neo gene flanked by 
loxP sites (Fig 2.1); after homologous recombination the neo gene was 
removed by Cre recombination (Giese et al., 1998). R1 ES cells (F1 between 
129/Sv and 129/Sv-CP) were used. An initial PCR was used to detect the loxP 
site which determining the genotype. A second PCR was used to identify the 
point mutations. The mice were subsequently backcrossed for at least eight 
generations into C57BL/6J and then crossed once with 129S2/SvHsd mice 
and kept in this mixed background by interbreeding for reasons of fecundity. 
(Mice had gone through more than four rounds of interbreeding before 
testing). Mice were obtained from interbreeding of heterozygotes and 
genotypes were determined by PCR with tail biopsies as described (Irvine et 
al., 2005). In the homozygous mutants the autophosphorylation of αCaMKII is 
prevented due to the insertion of a missense mutation (threonine-286 
changed to alanine; T286A) within the autoinhibitory domain (Giese et al., 
1998). This mutation does block the autophosphorylation of CAMKII but does 
not affect the Ca2+ dependent activity (Giese et al., 1998). Animals were 
provided with food and water ad libitum, and kept on a 12:12 h light: dark 
cycle (lights on at 7.00 am). Behavioural tests were performed during the light 
cycle between 09:00 and 16:00 h. Room temperature was maintained 
between 19 °C and 22 °C at a humidity of 55% (±10%) . Animals were singly 
housed when adult to avoid any potential confounds from social hierarchies 
and aggressive behaviour 1 week prior to behavioural testing. Mice were 
housed in Tecniplast cages (32 cm x16 cm x 14 cm), using Litaspen sawdust 






Figure 2.1: Generation of the αCaMKIIT286A mutants with the Pointlox procedure. (A) 
The targeting construct (B), a partial map of the αCaMKII gene (C), the resulting 
targeted allele (D), and the targeted allele after Cre recombination (E) are illustrated. 
B, Bam HI; G, Bgl II; H, Hind III; V, Pvu II; X, Xba I. Taken from Giese et al., 1998. 
 
 
2.2. Experimental procedures  
Male and female wild type (WT), homozygous (Mt) and heterozygous (Ht) 
αCaMKIIT286A mice were tested through a battery of behavioural tests in the 
following order: open field, light-dark box, elevated plus maze, home-cage 
activity and novel object exploration. Group sizes were the same for open 
field, light-dark box, elevated plus maze and novel object exploration, (WT 
n=5 (M=3, F=2); Ht n=7 (M=5, F=2); Mt n=7 (M=3, F=4)). For the home-cage 
test a different batch of mice was used which had not previously been 
exposed to potentially threatening situations and stimuli (WT n=8; Ht n=8; Mt 
n=8; M:F ratio was 50:50 in each group). Mice were excluded from the test if 
they either escaped from the apparatus or were completely inactive (open 
field = 1 WT female; Light-dark box = 1 Ht female; elevated plus maze = 2 Mt 








behavioural suite adjacent to the housing room immediately before testing. 
Apart from the homecage test, each test apparatus was wiped clean with 1% 
Trigene® between subjects to avoid any olfactory cues influencing 
behaviours. Mice were returned to their home cage at the end of each test 
and allowed to recover for at least five days before further testing. Behaviours 
for all tests were recorded on videotape for subsequent scoring by an 
experimenter blind to the genotype of the mice.  
 
2.2.1. Experiment 1: Open Field 
Each mouse was placed in a square white acrylic arena (72×72×33 cm), 
facing an outer wall, for 10 min and allowed to freely explore the arena (Fig. 
2.2). White light of 25 lx was evenly distributed across the arena during testing 
(Hall, 1921). Video recordings were taken using EthoVision and analyzed 
using the automated tracking software (Noldus et al., 2001; Spink et al., 
2001); Fig. 2.2B). A virtual square of equal distance from the periphery (36×36 
cm) was defined as the ‘central zone’ in order to determine the number of 
entries, and time (s) spent in the central zone (Fig. 2.2A). Locomotor activity in 
the outer and inner zones, distance moved (cm) and mean speed (cm/s) were 
measured.  
 
A.           B.    
   
  
Figure 2.2: Open Field experimental set-up. 
 
Centre zone Outer zone 
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2.2.2. Experiment 2: Light/Dark Test  
For the light-dark test (Crawley and Goodwin, 1980), a box of white acrylic 
was used (44×21×21cm) (Fig. 2.3). The box was partitioned with a white 
acrylic wall, so that approximately one-third (15×21×21 cm) of the total area 
was dimly lit (15-20 lx) and therefore represented the ‘dark chamber’. The 
remaining two thirds were brightly lit (80-110 lx) with white light, which served 
as the ‘light chamber’. A small entry door within the partition (5×7 cm), allowed 
mice to move freely between chambers. Each mouse was taken from its home 
cage and placed into the dark chamber facing the end wall parallel to the 
partition. Activity was recorded for the following 5 minutes using EthoVision. 
Locomotor activity (distance moved in cm, mean speed in cm/s), transitions 
between, and the time spent in both the dark and light chambers were 




A.           B.    
         
   




Light zone Dark zone 
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2.2.3. Experiment 3: Elevated Plus Maze 
The elevated plus maze (Lister, 1987) was constructed from black opaque 
acrylic, each arm measuring 30×5 cm and the central platform 5×5 cm (Fig. 
2.4). One set of arms, opposing one another, were enclosed completely by a 
wall of opaque acrylic, 15 cm high, while the other set was open with a ledge 
of 0.5 cm either side of the arms. The maze was elevated 40 cm from the 
ground on a transparent acrylic stand. The mouse was placed on the central 
platform, facing towards a closed arm, and allowed to freely explore the maze 
for 5 min. EthoVision tracking software was used to record locomotor activity 
during the test (mean speed in cm/s and distance moved on the open and 
closed arms), and the number of entries into, and time spent on, closed and 
open arms. An arm entry was counted when two paws had entered an arm, 













2.2.4. Experiment 4: Homecage 
This task was run in the homecage (32x16x14 cm) in order to observe 
spontaneous behaviours in a familiar environment (Mill et al., 2002); Fig. 2.5). 
The test room light intensity and light cycle matched that of the housing room. 
All nesting materials were removed from the cages. Cage tops were replaced 
with a Plexiglas lid (42×25.5 cm) to prevent escape. Activity was recorded for 
two hours. Video recordings were analyzed using the automated EthoVision 
tracking software (Noldus et al., 2001; Spink et al., 2001), from which total 


















2.2.5. Experiment 5: Novel Object Exploration 
The novel object exploration paradigm (Dere et al., 2007) was used to detect 
differences in exploratory behaviour between groups in a familiar arena, in the 
presence of novel, potentially non threatening stimuli (Fig. 2.6). The test room 
was evenly lit with low white light, at approximately 25 lx.  Each mouse was 
taken from its home cage and briefly placed into a clean, temporary cage. 
Two identical glass (8x8x5.5 cm; Fig 2.6A.) or plastic (10x5x7 cm; Fig 2.6B.) 
objects were introduced into the homecage, counter-balanced across 
genotype to avoid any object preference confound. Two identical objects were 
used to attempt to maximize exploration but avoid any preference between 
these objects (Dere et al., 2007). The animal was quickly reintroduced in the 
homecage, facing an outer wall. Cage tops were replaced with a Plexiglas lid 
(42×25.5 cm) to prevent escape. The mouse was allowed to explore the 
objects freely for 10 minutes whilst activity was tracked using EthoVision 
software. The time (s) spent in object exploration was scored manually to 
specifically measure directed exploration towards the objects. Total Distance 
moved (cm), mean velocity (cm/s) and time spent exploring each object (s) 
were measured. 
 
       A.    B.   B).                          
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2.3. Statistical Analysis: 
All graphical output data is expressed as a mean ± SEM. Data were initially 
compared using a two-way analysis of variance (ANOVA) using factors 
genotype (3) and sex (2) to assess potentially confounding sex differences. 
Data were subsequently compared using one-way ANOVA to assess group 
differences. Tukey’s HSD test was used post-hoc to determine the differences 
between individual group means. Analysis of Co-Variance (ANCOVA) was 
used to determine whether there was an interaction effect between 
confounding measures of locomotor activity and anxiety. Planned pair-wise 
comparisons (independent by variable t-tests) were performed between 
certain trials for each genotype group. A significance level of p<0.05 was used 
to test for statistical significance. The software used was Statistica version 
7.1. 
 
When designing animal experiments, the sample size is typically selected 
based on previous literature. However, this can often result in an 
overestimation of the animal numbers needed, which can mean a waste of 
resources and unnecessary animal suffering. On the other hand, an 
underestimate of group size means that the sample size may be too small to 
achieve the scientific objectives of the study (Festing et al., 2002). Sample 
size can be estimated using either a power analysis or application of the 
resource equation method. As a general rule, the power analysis method is 
the most appropriate for relatively simple but extensive experiments which are 
likely to be repeated several times with slightly different treatments. The 
resource equation method is more suitable for complex biological experiments 
involving several treatment groups, quantitative data, and where the standard 
deviation cannot be estimated (Festing et al., 2002).  
 
The present study retrospectively used the ‘Resource Equation’ (Mead, 1988) 
method to quantify the probability that experiments detected biologically 





E = (total number of experimental units) – (number of treatment combinations*) 
 
*Treatment combinations = 2 (sexes) x 3 (genotypes) x 1 (doses) 
 
E was calculated for all experiments in the present study. Open Field, E = 13; 
Light/Dark, E = 13; Elevated Plus Maze, E = 13; Homecage, E = 18; Novel 
Object Exploration, E = 13. According to Mead’s rule, E should be between 10 
and 20. If E is less than 10, increasing numbers would lead to good returns. If 




























3. Results  
All data were initially analysed using a two-way ANOVA for factors genotype 
and sex (Crusio et al., 2009). There was no significant effect of sex in any of 
the tests used and consequently the data for males and females were 
combined for subsequent analyses. 
 
3.1. Experiment 1: Open Field 
An open field test was performed in order to test locomotor activity and 
anxiety-like behaviour in a novel environment. ANOVA revealed a significant 
effect of genotype on the distance moved in the outer zone of the arena (F(2, 
15) = 9.53, p <0.01; Fig. 2.7b). Post-hoc Tukey test revealed that αCaMKII 
autophosphorylation-deficient (Mt) mice tended to move more in the outer 
zone of the arena compared to wildtype mice (p=0.053) and moved 
significantly more than heterozygous mutants (Ht) (p<0.001). Genotype had a 
significant effect on average speed in the outer zone (F(2, 15) = 11.18, 
p<0.001; Fig. 2.7d). Mt mice were found to move faster than both wild-type 
(WT) (p<0.01) and Ht (p<0.001) mice. Genotype also had a significant effect 
on average speed in the centre zone (F(2, 15) = 8.8102, p<0.01; Fig. 2.7c). As 
with speed in the outer zone, Mt mice were hyperactive compared to WT 
(p<0.05) and Ht (p<0.01) mice. Since there is no significant genotypic 
difference for the number of entries made (Fig. 2.7e), the distance moved 
(Fig. 2.7a) and time spent in the centre zone (Fig. 2.7f), but a significant trend 
for increased distance in the outer zone and speed moved in the outer and 
centre zones, results suggest that the Mt have increased locomotor activity 















Figure 2.7:  The effects of αCaMKII autophosphorylation deficiency on open field 
behaviour. Bars represent mean values ± standard error of the mean (SEM). Post-
hoc Tukey HSD test significance: $ p<0.05, Tukey HSD test vs. WT. # p<0.05, Tukey 











3.2. Experiment 2: Light/Dark Test  
The light/dark test showed no difference in the distance moved between 
groups in the dark compartment (Fig. 2.8a). There was however a genotype 
effect on the distance moved in the light compartment (F(2, 15) = 10.12, 
p<0.01; Fig. 2.8b), between Mt and both WT (p<0.05) and Ht (p<0.01) mice. 
Fig. 2.8c illustrates a difference in time spent in the dark (F(2, 15) = 4.86, 
p<0.05), seen between Mt and Ht mice (p<0.05) and as a tendency between 
Mt and WT (p=0.053). Furthermore, there was a significant effect of genotype 
regarding time spent in the light area (F(2, 15) =4.93, p <0.05; Fig. 2.8d) with 
Mt spending more time in the light area than WT (p<0.05) and Ht mice 
(p<0.05). The average speed in the dark compartment differed significantly 
(F(2, 15) = 9.42, p<0.05; Fig. 2.8e). Mt mice moved faster in the dark 
compartment compared to WT (p<0.01) and Ht (p<0.01) mice. Speed in the 
light compartment was also affected by genotype (F(2, 15) = 4.27, p<0.05; 
Fig. 2.8f), but only in Mt compared to Ht mice (p<0.05). In addition to these 
findings, the number of transitions between the two zones differed significantly 
between the genotypes (F(2, 15) = 10.45, p<0.001; Fig. 2.8g). Mt made more 
transitions than WT (p<0.01) and Ht mice (p<0.01), suggesting increased risk 
assessment behaviours in the αCaMKII mutant mice. Given the differences in 
activity and the time spent in the light area observed in the Mt group, an 
analysis of co-variance (ANCOVA) was conducted to assess which 
behavioural measure was contributing the most to the variance in the 
observed behaviour. Speed in the dark was used as a measure of locomotor 
activity, and time in the light was used as an anxiety trait. ANCOVA results 
showed a significant interaction effect (F(2, 14) = 39.6, p<0.001), but when 
each behavioural measure was individually co-varied out, the results were no 
longer significant, indicating that the behaviours were confounded and 
dependent on one another. The results of the light/dark test may superficially 
suggest a reduced anxiety in αCaMKII autophosphorylation-deficient mice in 
this novel environment. However, they also show a significantly enhanced 
locomotor response to the novel situation, so that genotype effects on anxiety 








Figure 2.8: The effects of αCaMKII autophosphorylation deficiency on behaviour in 
the Light/Dark test. Bars represent mean values ± standard error of the mean (SEM). 
Post-hoc Tukey HSD test significance: $ p<0.05, Tukey HSD test vs. WT. # p<0.05, 











3.3. Experiment 3: Elevated Plus Maze (EPM) 
The time spent on the open arms of the EPM was significantly different 
between the genotypes (F(2, 14) = 58.19, p<0.001; Fig. 2.9a); Mt differed from 
both WT (p<0.001) and Ht mice (p<0.001). There was also an opposite effect 
of genotype on time spent in the closed arms (F(2, 14) = 38.58, p<0.001; Fig. 
2.9b), with Mt mice spending less time in the closed arms than WT (p<0.001) 
and Ht mice (p<0.001). The genotype had a significant effect on the number 
of entries into the open arms of the maze (F(2, 14) = 26.46, p<0.001). Mutant 
mice made more entries than WT (p<0.001) and Ht (p<0.001) mice (Fig. 2.9c). 
This difference was not found for groups in the number of closed arm entries 
made (Fig. 2.9d) or distance moved in the closed arms (Fig. 2.9h). A 
significant difference was seen between groups in the average speed of 
movement (F(2, 14) = 25.28, p<0.001; Fig. 2.9e) and distance moved (F(2, 
14) = 86.4539, p<0.001; Fig. 2.9g) in the open arms of the maze. Mt moved 
significantly faster than both WT (p<0.001) and Ht mice (p<0.001), and Mt 
mice also moved significantly greater distances than WT (p<0.001) and Ht 
(p<0.001) mice. The same effect was seen between groups in the closed 
arms of the EPM (F(2, 14) = 10.21, p <0.01; Fig. 2.9f). Mt moved at a faster 
speed than WT (p<0.01) and Ht mice (p<0.01). These results confirm the 
hyperactive phenotype observed in the absence of αCaMKII 
autophosphorylation. To assess whether locomotor activity and anxiety 
measures were confounded in the EPM, an ANCOVA was performed to 
determine which behaviour (time in the open arms vs. speed in the closed 
arms) was contributing the most to the variance observed in the behaviour. 
The ANCOVA produced a significant interaction effect (F(2, 13) = 18.37, p 
<0.001), a result which retained significance when co-varying out locomotor 
activity (F(2, 13)=18.4, p <0.001). In contrast, when accounting for anxiety 
differences in the mice, the locomotor measure was no longer significant (F(2, 
13)= 0.06, p=0.94). This indicates that anxiety was influencing the locomotor 
activity in this test and suggests that Mt mice have essentially a reduced 










Figure 2.9: The effects of αCaMKII autophosphorylation deficiency on behaviour in 
the Elevated Plus Maze. Bars represent mean values ± standard error of the mean 
(SEM). Post-hoc Tukey HSD test significance: $ p<0.05, Tukey HSD test vs. WT. # 









3.4. Experiment 4: Homecage  
The homecage test provided a measure of spontaneous activity in a familiar 
environment. There were no significant differences in the total distance moved 
(Fig. 2.10a) or average speed (Fig. 2.10b) between the genotype groups 
during the two hour period (p>0.05). This suggests that the Mt mice are 
hyperactive only in novel, potentially threatening environments, but not in 






Figure 2.10: The effects of αCaMKII autophosphorylation deficiency on homecage 















3.5. Experiment 5: Novel Object Exploration 
This test examined reactivity to a novel (discrete) stimulus in a familiar arena. 
Statistical analysis showed a significant difference in exploratory time between 
genotypes (F(2, 16) = 4.52, p<0.05; Fig. 2.11a). Post-hoc tests showed a 
significant decrease in exploratory time in Mt mice compared to WT mice (p< 
0.05), but not to Ht mice (p>0.05). There were no significant differences 
between the distance (Fig. 2.11b) and average speed (Fig. 2.11c) of 
movement between groups. These results suggest that the hyperlocomotor 
response of the αCaMKII mutant mice does not occur towards novel, discrete 





Figure 2.11: The effects of αCaMKII autophosphorylation deficiency on novel object 
exploration. Bars represent mean values ± standard error of the mean (SEM). Post-









4. Discussion  
There is strong evidence for a crucial role of αCaMKII autophosphorylation in 
learning and memory. Importantly, this role was shown for aversively 
motivated tasks (Giese et al., 1998; Need and Giese, 2003; Irvine et al., 
2005), but not for appetitively motivated tasks (Carvalho et al., 2001). In 
addition, αCaMKII mutant mice with either a lack of, or knock down or over-
expression of αCaMKII show altered emotional behavior in combination with 
altered locomotor activity (Chen et al., 1994; Lo Iacono and Gross, 2008; 
Yamasaki et al., 2008; Hasegawa et al., 2009). These findings prompted the 
question whether αCaMKII autophosphorylation, as a specific function of 
αCaMKII, may be involved in the control of emotionality and the behavioral 
response to aversive stimuli.  
The present study aimed to explore how αCaMKII autophosphorylation 
may regulate and control anxiety-like behavioural responses towards 
threatening stimuli. Open field and light/dark-box tests assessed behaviour of 
αCaMKII autophosphorylation-deficient mice in novel environments which 
contain potentially threatening/aversive elements (Rodgers, 1997). Mutant 
mice were more active in the open field but there was no significant difference 
in anxiety in the open field. Locomotor results agree with previous reports 
from mice over-expressing αCaMKII, which showed a significantly reduced 
locomotor activity in the open field test (Hasegawa et al., 2009). Reduced 
anxiety-like behaviour in the open field was reported for heterozygous and 
homozygous αCaMKII deficient mice (Chen et al., 1994) but no differences in 
the time spent in the centre were observed in the present study. Anxiety-
related behaviours were reduced in αCaMKII autophosphorylation-deficient 
mice in the light/dark test. However, anxiety parameters were confounded by 
a hyperlocomotor phenotype of the αCaMKII autophosphorylation-deficient 
mice during testing.  These findings are also in line with previous reports on 
αCaMKII over-expressing mice in the light/dark box. These mice showed an 
increased latency to enter the light box and a significant reduction in 
transitions (Hasegawa et al., 2009). In the EPM, αCaMKII 
autophosphorylation-deficient mice showed significantly less anxiety related 
behaviour than WT controls and Ht littermates in the EPM. The EPM 
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distinguished best between anxiety and a hyperlocomotor phenotype. This 
analysis showed that anxiety was essentially influencing the locomotor 
activity. Thus αCaMKII autophosphorylation-deficient mice showed an altered 
response of reduced avoidance to the potentially threatening environment of 
the open and elevated arms rather than a hyperactive phenotype in this 
particular test.  
Animals may show normal behavioural activity in a familiar and non-
threatening environment. In order to test this, mice were monitored in their 
homecage without any observer interference. Data revealed that αCaMKII 
autophosphorylation does not play a role in spontaneous locomotor activity 
under resting conditions, i.e. in a familiar non-threatening environment. This 
confirmed that αCaMKII autophosphorylation only plays a role in novel 
situations, where there is a perceived threat. Previous studies which targeted 
all αCaMKII functions had shown that αCaMKII over-expressing mice showed 
a significant decrease in home cage activity (Hasegawa et al., 2009), while 
heterozygous αCaMKII deficiency resulted in an enhanced home cage activity 
(Yamasaki et al., 2008). Results suggest that while αCaMKII 
autophosphorylation is not required for spontaneous locomotor activity, the 
Ca2+ dependent function of αCaMKII may, nevertheless, modulate this 
behaviour in both directions.    
In order to test, whether discrete novel stimuli alone would drive hyper-
locomotion, the novel object exploration test was performed. This test 
assessed the behavioural response in a potentially non-threatening 
environment with a neutral object (Dere et al., 2007). Results showed no 
differences in locomotor activity between genotypes. αCaMKII 
autophosphorylation-deficient mice were, however, found to explore the novel 
object significantly less than WT and Ht littermates. Given that the Mt mice 
were actively searching and exploring novel environments in the other tests, a 
general neophobia may not account for the observed effects in this test. 
These findings further support the view that hyperactivity seen in αCaMKII 
autophosphorylation-deficient mice under test conditions is not induced by 
novel stimuli alone. Novel object exploration was reduced in the Mt mice 
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which may have been a result of the Mt mice actively avoiding the objects or 
simply due to a reduced exploratory drive.  
 A threatening stimulus can result in either a flight or fight behavioural 
response (Blanchard and Blanchard, 1989). Heterozygous αCaMKII deficient 
mice showed increased defensive aggression (Chen et al., 1994). Mice over-
expressing αCaMKII in the forebrain, in contrast, display reduced freezing and 
fearful behaviours in foot shock tests, but reduced offensive and defensive 
aggression (Hasegawa et al., 2009). These findings might suggest that 
αCaMKII facilitates threat-induced behavioural activation and several tests 
found that mice deficient in αCaMKII autophosphorylation responded to the 
novel environment with an increased locomotor reactivity.  
 A potential neuronal mechanism of how αCaMKII autophosphorylation 
affects behavioural responses to a novel, threatening environment may be 
found in brain areas which are involved in the processing of aversive stimuli 
and show a high level of αCaMKII activity. The amygdala is an important brain 
area when considering emotionality (LeDoux, 1995). It is well known to be 
associated with the processing of fear and threatening stimuli (Öhman and 
Soares, 1994; Morris et al., 1998; Carlsson et al., 2004) and it is involved in 
the processing and formation of emotional memories (Amunts et al., 2005). 
Damage to the amygdala has been shown to suppress behavioural fear 
responses to unconditioned and conditioned stimuli (Selden et al., 1991; 
Phillips and LeDoux, 1992; Armony and LeDoux, 1997). CaMKII is highly 
expressed in the lateral and basolateral amygdala (Miller and Kennedy, 1986). 
αCaMKII in particular is present in abundance in the basolateral amygdala 
(Moriya et al., 2000; Rodrigues et al., 2004), where it is found in pyramidal 
cells, but not in GABAergic interneurons (McDonald et al., 2002). This makes 
the basolateral amygdala an interesting candidate region for mediating the 
influence of αCaMKII autophosphorylation on threat-induced behaviour. 
Indeed c-fos activation has been found in CaMKII-positive neurons of the 
basolateral amygdala following restraint stress (Reznikov et al., 2008) or 
threatening ferret odour stimulation (Butler et al., 2011).   
An important projection of the amygdala aims at the periaqueductal 
gray (PAG) of the midbrain (Armony and LeDoux, 1997). Glutamatergic 
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receptors and the CaMKII pathway are expressed in PAG neurons (Garzón et 
al., 2008). The dorsal PAG (dPAG) is one of the key structures in panic 
disorder, and elicits flight and escape responses and defensive postures 
(Graeff, 1981; Jenck et al., 1995; Lovick, 2000; de Paula Soares and 
Zangrossi, 2009). The dPAG has also been suggested to evoke active flight 
behaviours such as trotting, galloping and jumping (Molchanov and 
Guimarães, 1999) and to reduce freezing behaviour (Walker et al., 1997). 
Deep brain stimulation of the dPAG elicits freezing and flight reactions in rats 
(Moers-Hornikx et al., 2011), exhibited by vigorous running and jumping (Lim 
et al., 2008). This mimics panic attack in humans (Schenberg et al., 2001; Lim 
et al., 2008). As threat approaches, brain activity shifts from the forebrain and 
the amygdala, to the midbrain and the PAG (Maren, 2007).  
A possible mechanism of how αCaMKII autophosphorylation controls 
the amygdala-PAG pathway may be by its effects on AMPA and NMDA 
receptor function. In an autophosphorylated state, αCaMKII phosphorylates 
the GluR1 and GluR2/3 subunits of the AMPA receptor and mediates 
trafficking and insertion of new AMPA receptors into the post synaptic 
membrane (Barria et al., 1997; Hayashi et al., 1997). This enhances AMPA 
receptor channel conductance (Derkach et al., 1999; Esteban, 2003). AMPA 
receptors are present in the dPAG (Albin et al., 1990). Research in cats 
suggests that the PAG is an important target for excitatory glutamatergic 
projections from the hypothalamus and amygdala in the modulation of the 
defensive response to threat (Shaikh et al., 1994; Adamec, 1997). Glutamate 
injected directly into the PAG has been found to elicit defensive behaviours 
such as freezing and flight responses (Bandler et al., 1985; Bandler and 
Carrive, 1988). Ferreira-Netto and colleagues (2005) proposed that glutamate 
induces defensive behaviours in two different ways. Firstly by activating 
AMPA receptors, producing a freezing response. Secondly, prolonged 
presence of glutamate in the cleft will subsequently potentiate NMDA 
receptors (Ferreira-Netto et al., 2005).  
A limitation of this study is the uneven numbers of males and females 
in each group. This was largely due to availability and additional strict 
exclusion criteria put in place, designed to eliminate mice which either 
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escaped from the apparatus, or were completely inactive during the test. 
However, there was no significant sex effects detected in the sample. 
Therefore data was pooled between sexes within genotype groups for further 
analysis (Crusio et al., 2009).  
The present study aimed to investigate how αCaMKII 
autophosphorylation controls behavioural responses towards novel, 
threatening situations. There was a significant reduction in anxiety-related 
measures in αCaMKII autophosphorylation-deficient mice throughout various 
tests of anxiety. However, virtually all anxiety parameters were found to be 
highly confounded by significantly enhanced locomotor activity. Therefore, the 
relationship between anxiety-related behaviours and locomotion was 
investigated. Analysis of covariance indicated that αCaMKII 
autophosphorylation-deficient mice show an increased locomotor activation 
induced by novel environments. This response, however, was not seen in a 
non-threatening environment (home cage) or in response to a discrete, novel 
stimulus. One might conclude that αCaMKII autophosphorylation does not 
simply modify anxiety. Instead data suggests that αCaMKII 
autophosphorylation influences locomotor reactivity to novel environments 
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αCaMKII is an important molecule for plasticity of the glutamatergic system in 
the brain. The autophosphorylation of αCaMKII allows activation of 
glutamatergic synapses to be potentiated for longer within the cell, thereby 
accelerating learning. Addiction involves a number of learning and memory 
processes and αCaMKII is well documented to be important for drug addiction 
as well as for memory formation. The present study investigated whether 
αCaMKII autophosphorylation affects the speed at which alcohol-addiction 
related behaviors were established. Alcohol drinking was initially diminished in 
αCaMKII autophosphorylation deficient (Mt) mice, but could be established to 
the same level as WT mice after repeated alcohol withdrawal and 
reinstatement of alcohol drinking. Alcohol-induced CPP developed at an 
accelerated rate in Mt compared to WT mice. Taking previous data into 
account, this may be due to the presence of fast acting negative 
reinforcement mechanisms in αCaMKII mice. αCaMKII autophosphorylation 
deficient mice showed no DA response in the NAcc to acute or chronic alcohol 
administration, but a large enhancement in the 5-HT response in the PFC.  
The attenuated DA response in mutants correlated with diminished drinking 
behaviour and altered c-Fos activation in the ventral tegmental area. These 
data suggest that αCaMKII autophosphorylation contributes towards the 
establishment of alcohol-addiction related behaviors by altering the DA – 5-HT 






Alcohol use can develop into addiction in a significant number of people, and 
yet the mechanism of transition between alcohol use and dependence is not 
sufficiently understood. The establishment of addiction remains largely 
unknown but it is thought to involve a number of distinct learning and memory 
processes. It is now widely believed that addiction and memory formation 
share molecular and anatomical pathways (Nestler, 2002a; Kelley, 2004; 
Hyman, 2005; Müller and Schumann, 2011). In order to investigate the link 
between these pathways more fully, the present study evaluates whether 
disruption in a protein which plays a key role in synaptic plasticity can alter 
measures of alcohol preference, and the rate at which these preferences are 
established. 
 
αCaMKII plays a key role in the plasticity of glutamatergic post-synapses of 
the forebrain (Colbran and Brown, 2004; Irvine et al., 2006; Wayman et al., 
2008). It is important for memory formation (Elgersma et al., 2004) as well for 
drug addiction (Anderson et al., 2008). αCaMKII becomes active in the 
presence of CaM. Upon activation, αCaMKII can switch to an autonomous 
mode of activity known as autophosphorylation (Giese et al., 1998). This 
renders the kinase active and free to phosphorylate both neighboring subunits 
of the holoenzyme at the T286 residue, and its downstream substrates even 
after the dissociation of the CaM complex. This allows the kinase to remain 
active for longer which results in signals being potentiated for longer within the 
cell, thereby accelerating learning. αCaMKII autophosphorylation deficient 
mice do not show Ca2+ independent activation but retain Ca2+ dependent 
activity. If CaMKII is unable to phosphorylate itself, more CaM molecules will 
be required to activate the entire holoenzyme in order to produce the same 
effect on learning. In line with this, αCaMKII autophosphorylation deficient 
mice show severe learning impairments (Irvine et al., 2005), suggesting that 
autophosphorylation controls the speed of normal learning (Lengyel et al., 
2004; Lee et al., 2009). This deficiency does not alter the capacity to learn, 
long term memory storage or memory retrieval (Irvine et al., 2006).  
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There is a growing body of research supporting a role for αCaMKII in 
drug addiction pathways. One of the ways in which alcohol exerts its effects is 
via the glutamatergic system (Spanagel, 2009), a system in which αCaMKII 
also plays an important role. Ethanol acts as an NMDA antagonist in 
dopamine (DA) rich areas of the midbrain including the ventral tegmental area 
(VTA) and the substantia nigra. These areas have implications for motivation, 
reward and addiction (Yang et al., 1996). Alcohol administration also 
enhances DA release from the mesolimbic pathway (Di Chiara and Imperato, 
1988) with preferential release from the nucleus accumbens (NAcc) (Pontieri 
et al., 1995). In addition, alcohol increases αCaMKII expression levels in rat 
cerebral cortex which can be attributed to Ca2+ influx during chronic alcohol 
exposure (Mahadev et al., 2001).  
 
Given the reported differences in learning and memory tasks and the potential 
interaction with drugs of abuse, αCaMKII autophosphorylation may play a role 
in the motivational and rewarding effects of alcohol. Consistent with previous 
findings the main hypothesis of this study states that αCaMKII 
autophosphorylation may control the speed at which alcohol-addiction related 
behaviors are established, but does not play a role in the processes 
responsible for the maintenance of addiction once established. In order to 
evaluate the establishment of alcohol preference, chronic alcohol drinking will 
be monitored in a two-bottle free-choice drinking paradigm, as well as alcohol-
induced conditioned place preference. Systemic alcohol measures will also be 
taken to rule out any confounding differences in the metabolism of alcohol. 
The acute positive reinforcing effects of alcohol are mediated by the 
recruitment of specific neurotransmitter systems in the reward centres of the 
brain (Koob et al., 1998a; McBride, 2010). In vivo microdialysis performed in 
brain regions associated with drug reward will therefore examine 
monoaminergic responses which might contribute to the incentive properties, 
emotional effects and potential arousal regulating effects of alcohol. Regions 
to be dialysed have been selected based on the degree of overlap between 
the regions in which DA and other monoamines are released in response to 
alcohol administration, and regions in which αCaMKII is abundantly 
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expressed. Alcohol administration induces DA release from the mesolimbic 
pathway, and the NAcc in particular (Pontieri et al., 1995; Di Chiara and 
Imperato, 1988). The αCaMKII isoform is most prominently expressed in the 
forebrain at glutamatergic post-synapses (Lisman et al., 2002; Colbran and 
Brown, 2004; Irvine et al., 2006; Wayman et al., 2008). For this reason, the 
NAcc was selected as the first target region. The prefrontal cortex (PFC) was 
nominated as the second target region. This selection was based on the 
previously mentioned criteria, and because the PFC receives input from 
projections of the NAcc. DA and 5-HT mediate the motivational and emotional 
effects of alcohol (Spanagel, 2009; McBride, 2010). To further investigate the 
mechanisms which may influence dopaminergic activation, neuronal activity 
will be measured in the VTA. c-Fos activation will be measured in the VTA 























2. Materials and Methods: 
All housing and experimental procedures were performed in accordance with 
the U.K. Home Office Animals (Experimental Procedures) Act 1986.  
 
2.1 Animals 
Male and female αCaMKIIT286A mice (Giese et al., 1998) were studied in sex 
balanced designs in all experiments (for details of the genetic background: 
see Chapter 2, Materials and Methods; section 2.1). This mutation blocks the 
autophosphorylation of CaMKII but does not affect the Ca2+ dependent activity 
(Giese et al., 1998). Animals were individually housed, provided with food and 
water ad libitum, and kept on a 12:12 hour light: dark cycle (lights on at 7.00 
am). Behavioral tests were performed during the light cycle between 09:00 
and 16:00 h. Room temperature was maintained between 19°C and 22°C at a 
humidity of 55% (±10%). Animals were housed in Tecniplast cages (32cm x 
16cm x 14cm), using Litaspen sawdust and nesting materials, (Sizzlenest, 
Datsand, Manchester UK).  
 
 
2.2 Alcohol drinking and deprivation effect 
Alcohol drinking was tested in naïve Mt (n=10), wild-type (WT; n=12) and 
heterozygous (Ht; n=12) animals using a two-bottle free-choice drinking 
paradigm. Each cage was equipped with two continuously available bottles, 
one of which contained tap water the other bottle contained alcohol in various 
concentrations. After an acclimatization period to establish a drinking baseline 
to the water in both bottles, animals received alcohol at increasing 
concentrations of 2, 4, 8, and 12 vol. %. Mice were exposed to each 
concentration of alcohol for 4 days before exposure to a higher concentration 
of alcohol. Thereafter, alcohol concentration was switched to 16 vol. % and 
animals were allowed to drink for 2 weeks. In order to measure the alcohol 
deprivation effect (Spanagel and Hölter, 2000), baseline consumption of 16 
vol % alcohol was measured. Alcohol was then removed for 3 weeks (both 
bottles contained tap water) before it was re-introduced for 4 days. This 
procedure was repeated once more. Bottles were changed and weighed daily. 
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The consumed amount of alcohol relative to body weight and the preference 
versus water were measured. Control cages holding only water and alcohol 
bottles were arranged alongside test cages. Spillage was measured and all 
data were corrected for bottle spillage prior to analysis. 
 
 
2.3 Taste preference test 
Alcohol experienced animals were used for this test (Mt: n=10; WT: n=12; Ht: 
n=12). Sucrose (0.5 and 5%) and quinine (10 and 20 mg/dl) preference was 
measured in a two-bottle free-choice test vs. water. Each dose was offered for 
3 days with the position of the bottles being changed and weighed daily 
(Spanagel et al., 2005a).   
 
 
2.4 Determination of blood alcohol levels 
Alcohol naïve animals were used for this test (Mt: n=11; WT: n=12; Ht: n=14). 
Animals were injected intraperitoneally (i.p.) with alcohol (3.5g/kg). Mice were 
left undisturbed and then systematically culled at 15, 30 and 60 minutes post 
injection. Animals were immediately sacrificed by cervical dislocation and 
trunk blood was collected. Blood was left at room temperature for 30-60 min to 
allow clotting. The blood was then placed in a centrifuge for 10-15 mins at 
3000-4000 rpm at room temperature. The supernatant was quickly aspirated 
taking care not to disturb the cell layer. Serum samples were stored at -80°C 
waiting further analysis. Analysis of the alcohol concentration in the serum 
samples was performed using a quantitative enzymatic method. Briefly, after 
predilution of the samples to obtain an appropriate volume, the samples were 
assayed with Integra 400 Plus (Roche) analyzer. In the presence of 
nicotinamide adenine dinucleotide (NAD+), alcohol dehydrogenase oxidizes 
ethanol to acetaldehyde. Simultaneously generated NADH, which is directly 
proportional to the ethanol concentration in the sample, is measured 





2.5 Conditioned place preference (CPP) 
The Conditioned Place Preference paradigm is a form of Pavlovian 
conditioning which is used to examine the rewarding (CPP) or aversively 
(Conditioned Place Aversion; CPA) motivating effects of stimuli (toys or food) 
or experiences (drugs of abuse) (Cunningham et al., 2006). In the following 
experiments, the CPP design was used to examine the rewarding effects of 
alcohol. Mice were essentially allowed to make a choice between a drug 
associated cue and a neutral cue, and then the motivational significance of 
the preferred compartment was assessed. The method used was a modified 
version of Cunningham’s experimental design (Cunningham et al., 2006). This 
included repeated preference testing systematically placed between CPP 
conditioning and extinction trials in order to determine a learning curve for 
CPP, according to the delayed establishment hypothesis.  
 While CPP cannot model addiction as a disease state, the paradigm 
can be used to assess aspects of addiction and related behaviours by looking 
at the motivational properties of various drugs and is useful for studying the 
effects of environmental cues associated with drug experiences (Bardo and 
Bevins, 2000). There are several advantages of using the CPP test design, 
including; simple methodology which does not require complex surgical 
procedures, the potential for high throughput, the ability to measure both 
appetitive and aversive effects in the same procedure, its sensitivity to low-
dose effects and the facility of measuring drug induced changes 
simultaneously to locomotor activation (Cunningham et al., 2006). There is 
some difficulty when using the CPP test design to study alcohol reward. 
Methodological parameters can greatly influence the outcome of these 
experiments (Tzschentke, 1998). Outcome may be dependent upon route of 
administration and the dosage used (van der Kooy et al., 1983; Asin et al., 
1985), and the relative timing of ethanol administration and subsequent 
exposure to the conditioned stimulus. For example, ethanol administration 
prior to exposure to the conditioned stimulus leads to CPP, and administration 
following exposure to the conditioned stimulus causes CPA to develop 
(Cunningham, et al., 1997). The precise timing of administration prior to 
testing (5, 10, 15 or 30 minutes) has also been shown to alter the 
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development of CPP (Cunningham, et al., 1997). The sensitivity of this 
procedure to ethanol’s rewarding effect appears to differ considerably 
between species (Cunningham et al., 1993). Differences have also been 
noted within species using different inbred and out-bred strains (Risinger and 
Oakes, 1996; Cunningham and Noble, 1992; Gevaerd and Takahashi, 1996), 
and even between selectively bred high and low sensitivity mouse strains  
Risinger et al., 1994) and in alcohol-preferring and non-preferring rat lines 
(Schechter, 1992). The CPP paradigm has been criticised as being less 
relevant for the study of drug reinforcement when compared to procedures in 
which animals self-administer drugs (Dworkin and Smith, 1988). However, 
contemporary approaches recognise the importance of Pavlovian learning 
processes in the development of drug addiction (Robinson and Berridge, 
1993; Everitt and Robbins, 2005).  
 
2.5.1 Apparatus 
The TSE Place Preference test boxes (Bad Homburg, Germany; Fig. 3.1) 
were made of non transparent PVC with standard inside dimensions of 40cm 
(L) x 15cm (W) x 20cm (H). The apparatus was divided into 3 fully automated 
compartments, the outer chambers measured 17cm in length, and the centre 
chamber 6cm. The floor of the left chamber (compartment A) was covered 
with a smooth black rubber mat. The floor of the right chamber (compartment 
B) was covered with a patterned black rubber mat. The centre chamber was 
not covered and coloured white (compartment C). Activity was recorded in 
each compartment using high-resolution infrared sensors. The system 
automatically recorded the number of entries made and distance moved in 
each compartment for each trial. An unbiased design was used, i.e. half the 







Figure 3.1: Conditioned Place Preference Apparatus (Bad Homburg, Germany) 
 
 
2.5.2 CPP Establishment 
Alcohol naïve animals (Mt: n=11; WT: n=12; Ht: n=14) were injected (i.p.) 
immediately before each trial with either saline, or ethanol solution at a dose 
of 2g/kg. Mice were instantly transferred to the testing suite and placed into 
the CPP boxes, signifying the beginning of the trial period (Fig. 3.2). The 
experiment involved four phases (Table 3.1); habituation trial (one session), 
conditioning trials (14 sessions), preference tests (5 sessions) and an 
incubation period (7 days). Trials were performed once daily. Habituation (day 
1): The habituation session was intended to acclimatise mice to the test 
procedure and apparatus prior to commencing the experiment. Mice were 
injected with saline and introduced into the centre compartment with free 
access to all three compartments for 20 minutes. Pre-test (day 2): The pre-
test was designed to establish a baseline level of preference for each 
individual animal. Mice were conditioned to either their preferred or non 
preferred compartment using a counterbalanced experimental design. Mice 
were injected with saline and introduced into the centre compartment with free 
access to all three compartments for 20 minutes. Conditioning trials (days 3-4, 
6-9 and 11-18): Conditioning trials were performed in pairs, odd numbered 
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pairings were conditioned with alcohol, and even numbered pairings were 
conditioned with saline, this was balanced across groups. All animals received 
7 pairings with saline and 7 pairings with alcohol. Mice were injected with 
either saline or an ethanol solution (2g/kg i.p.) and introduced into one of two 
compartments, with restricted access, for 5 minutes (Cunningham et al., 
2006). Preference tests (days 5, 10, 19 and 27): In order to monitor the time 
course of CPP establishment, preference tests were systematically dispersed 
between conditioning trials on days 5, 10, 19 and 27. Before each test, mice 
were injected with saline and introduced into the centre compartment with free 
access to all three compartments for 20 minutes. Incubation period (days 20-
26): In order to test the consolidation of CPP, animals were left undisturbed in 






Figure 3.2: Conditioned Place Preference procedure, illustrating the test procedure. 
Each mouse was removed from the homecage and injected with alcohol/saline 
solution. The mouse was then immediately transferred to the testing suite and placed 















Table 3.1: The entire experimental protocol each mouse was exposed to during the 
conditioned place preference procedure 
Trial Duration Treatment 
Habituation 5 mins Saline 
Pre Test 20 mins Saline 
Conditioning x 2 5 mins Alcohol/Saline 
Preference Test 1 20 mins Saline 
Conditioning x 4 5 mins Alcohol/Saline 
Preference Test 2 20 mins Saline 
Conditioning x 8 5 mins Alcohol/Saline 
Preference Test 3 20 mins Saline 
Incubation 7 days None 




2.5.3 CPP Extinction 
Extinction Trials (days 28, 30-31, 33-36 and 38-41): Extinction trials were 
designed to intentionally pair the previously alcohol-paired compartment with 
saline, in an attempt to extinguish any learnt preference. Two sessions were 
performed each day, one in each compartment. Mice were injected with saline 
before each trial and introduced into one of two compartments, with restricted 
access, for 5 minutes. Reconditioning trials (days 43-44): Reconditioning trials 
were performed in pairs, to mirror the conditioning trial procedure, to 
determine whether an extinguished, learnt behaviour could be reinstated 
using a single alcohol-paired conditioning trial. Mice were injected with either 
saline or an ethanol solution (2g/kg i.p.) and introduced into one of two 
compartments, with restricted access, for 5 minutes. One session was 
performed on each test day. Preference tests (days 29, 32, 37, 42 and 45): 
Preference tests were systematically placed between extinction trials to 
assess the time course of CPP extinction (Table 3.2). Before each test, mice 
were injected with saline and introduced into the centre compartment with free 
access to all three compartments for 20 minutes (refer to Fig. 3.2).  
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Table 3.2: The entire experimental protocol each mouse was exposed to during the 
conditioned place extinction and reinstatement procedure 
 
Trial Duration Treatment 
Extinction x 2 5 mins Saline 
Ext Pref Test 1 20 mins Saline 
Extinction x 4 5 mins Saline 
Ext Pref Test 2 20 mins Saline 
Extinction x 8 5 mins Saline 
Ext Pref Test 3 20 mins Saline 
Extinction x 8 5 mins Saline 
Ext Pref Test 4 20 mins Saline 
Re-Conditioning x 2 5 mins Alcohol/Saline 




2.6 Loss of righting reflex (LORR)   
Alcohol naïve animals were used for this test (Mt: n=5; WT: n=5; Ht: n=5). 
Animals were administered with an ethanol injection of 3.5g/kg (i.p.) 
(Spanagel et al., 2002) to induce LORR, and immediately placed in a clean 
and empty cage. LORR was observed when the animal became ataxic and 
stopped moving for at least 30 seconds. The animal was then placed on its 
back. Recovery from alcohol administration was defined as the animal being 
able to right itself three times within a minute. Some animals took a long time 
to recover, so a 2 hour cut off was used. The time taken for the animal to lose 
its righting reflex, and the time to recovery from alcohol’s effect on righting 
reflex, were observed and recorded. LORR was carried out on day one of the 
experiment when animals received the first of 8 alcohol injections (3.5g/kg, 
i.p.). Upon completion of the trial, the animal was returned to the home cage. 
Then, alcohol was administered once daily on days 2-7, i.e. between LORR 
experiments. Animals were weighed and injected 2g/kg (i.p.). LORR was 
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again tested on day eight of the experiment when animals received the last of 
8 alcohol injections (3.5g/kg, i.p.).  
 
 
2.7 In-vivo Microdialysis  
Reduced alcohol drinking behaviour seen in αCaMKII Mt mice suggested that 
the acute rewarding properties of ethanol may also be reduced. The DA 
system is critical to experience the acute reinforcing effects of alcohol (Koob, 
1992; McBride and Li, 1998; Nestler, 2005), with alcohol typically inducing 
around a 20% increase in DA levels in the NAcc (Doyon et al., 2003). In order 
to test whether the lack of αCaMKII autophosphorylation would lead to altered 
monoaminergic responses to acute or sub-chronic alcohol treatment, in vivo 
microdialysis was performed after acute and again after sub-chronic alcohol 
treatment in the same animals. This design allowed a direct comparison of 
acute and sub-chronic responses in the same animals. The aim was to 
investigate whether well defined dopaminergic, serotonergic and 
noradrenergic responses were altered. Acute alcohol challenge alters 
glutamate levels in the NAcc and affects the function of the reward system 
(Szumlinski et al., 2005). However, measuring extracellular glutamate levels 
require a different HPLC set-up with UV detection and cannot be measured 
alongside the other transmitters of interest. Not having access to an HPLC 
system capable of doing so meant that priority was given to the measure of 
extracellular DA, 5-HT and NA. Due to the high technical demand a strongly 
focused design was used, according to Spanagel et al., (2005b) and 
Szumlinski et al., (2005). 
 
2.7.1 Surgery 
The mice were deeply anaesthetised using a mixture of 4.12ml saline (NaCl), 
0.38ml Ketaset (containing 100mg/ml Ketamine) and 0.5ml Domitor 
(containing 1mg/ml Medetomidine hydrochloride) administered 
interaperitoneally (i.p.) at 0.1ml per 10g body weight. In addition 0.01ml 
Rimadyl (5mg/kg Carprofen) analgesia was given subcutaneously (s.c.). The 
animal was placed in a Kopf stereotaxic frame. Two guide cannulas 
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(Microbiotech/se AB, Stockholm, Sweden) were aimed at the PFC (A: +1.9; L: 
±0.8; V: -1.3 angle ±10º from midline) and the NAcc (A: +1.2; L: ±1.6; V: -4.3 
angle ±10º from midline) using coordinates relative to bregma (Franklin and 
Paxinos, 1997), and fixed in place using two anchor screws (stainless steel, 
d=1.4mm) and dental cement.  Anaesthesia was reversed by administering a 
mixture of 3.9ml saline (NaCl) and 0.1ml Antisedan (containing 5mg/ml 
Atipamezole) at 0.08ml/ 10g body weight (s.c.) after approximately 45 
minutes. Animals were kept warm and allowed to recover from the 
anaesthetic. Animals were then returned to their home cages and monitored 
daily, allowing at least 5 days for complete recovery (Fig. 3.3A). 
 
2.7.2 Procedure  
On the day of the experiment, microdialysis probes of a concentric design 
(Fig. 3.3B), membrane lengths were 2mm for the PFC (MAB 6.14.2.) and 
1mm (MAB 6.14.1.) for the NAcc, were inserted into the guide cannulae under 
a short (3-5min) Isoflurane anaesthesia (O2 at 1L/min, Isoflurane at 3% to 
induce and 2% to sustain). After probe insertion, the animal was placed into 
an open field (21x21x30cm) of a Truscan system (Coulbourn Instruments, 
Allentown, USA). Food and water were given ad libitum and room temperature 
maintained between 19- 22 ºC. The microdialysis probes were connected to a 
microinfusion pump (CMA 400, Carnegie, Sweden) via a swivel mounted on a 
balanced arm above the chamber, and were perfused with artificial 
cerebrospinal fluid (aCSF) (containing Na+ 147 mmol, K+ 4 mmol, Ca2+ 2.2 
mmol, Cl- 156 mmol, pH = 7.4) at room temperature (Müller et al., 2007). The 
flow rate was set to 1.5µl/min and allowed to stabilise for at least two hours 
until a stable baseline was obtained. Samples were collected every 20 
minutes into vials containing 2.73µl of antioxidant (0.1 M perchloric acid and 
500 pg dihydroxybenzylamine (DHBA) as internal standard). Three samples 
were taken during the first testing hour of the experiment to measure baseline 
quantities of the neurotransmitters DA, 5-HT and NA (Pum et al., 2008b). An 
injection of alcohol was then administered i.p. (2g/kg, vinj= 10 ml/kg). A further 












Figure 3.3: Microdialysis procedure set-up. A). In vivo microdialysis experimental 
design, reflecting test procedure for each mouse. B). Representation of microdialysis 
set-up and magnification of probe membrane, inserted into the NAcc and PFC and 
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2.7.3 Acute and subchronic alcohol effects 
Alcohol naïve animals were used for this test (Mt: n=12; WT: n=11; Ht: n=12). 
In-vivo microdialysis was carried out on day one of the experiment when 
animals received the first of 8 alcohol injections (2g/kg, i.p.). This provided an 
acute neurochemical and behavioural response to alcohol treatment. After the 
microdialysis trial was completed the animal was anaesthetised using an 
oxygen and Isoflurane mix (O2 at 1L/min, Isoflurane at 3%). The probes were 
removed and guides re-inserted. The animal was then returned to the home 
cage. Alcohol was then administered once daily on days 2-7 i.e. between in 
vivo microdialysis trials (2g/kg, i.p.). In vivo microdialysis was carried out 
again on day eight of the experiment providing a subchronic neurochemical 
and behavioural response to alcohol treatment. Once microdialysis 
experiments were complete, animals were sacrificed by cervical dislocation. 
Brains were fixed in 4% formaldehyde solution and stored at 4 °C. Brains 
were sliced on a microtome and stained with cresyl violet for analysis of probe 
placement (Fig. 3.4 & 3.5). Since all probes were surgically inserted 
accurately within the PFC and the NAcc regions, all animals were considered 






Figure 3.4: Lines represent target coordinates for active membrane surface of 






Figure 3.5: Lines represent target coordinates for active membrane surface of 





2.7.4 High Performance Liquid Chromatography with Electrochemical 
Detection (HPLC-ED) analysis 
All samples were analysed using HPLC-ED to measure DA, 5-HT and NA 
levels (see Fig. 3.6 & 3.7). The column was an ET 125/2, Nucleosil 120-5, C-
18 reversed phase column (Macherey–Nagel, Germany) perfused with a 
mobile phase composed of 75 mM NaH2PO4, 4 mM KCl, 20µM 
ethylenediamine tetraacetic acid (EDTA), 1.5 mM sodium dodecyl sulfate, 100 
µl/l diethylamine, 12% methanol, and 12% acetonitrile adjusted to pH 6.0 
using phosphoric acid. The electrochemical detector (Intro, Antec, The 
Netherlands) was set at 500 mV vs. an in situ Ag/AgCl (ISAAC) reference 
electrode (Antec, Leyden, Netherlands) at 30°C. Thi s setup allows the 
simultaneous measurement of NA, DA and 5-HT. The concentration of many 
neurotransmitters in the extracellular space is quite low (in the nM – pM 
range). As a result, the dialysate collected is only a reflection (a few percent) 
of the true extracellular levels (Sarre and Michotte, 2007). The detection limit 
of the assay was 0.1pg for all neurotransmitters with a signal–noise ratio of 












Figure 3.6: Chromatogram report. Example of an HPLC-ED chromatogram of a 
standard solution containing known amounts of DA, 5-HT, NA and the internal 
standard DHBA, used for calibration. Peaks are integrated and the area under the 
peak is calculated. This area is compared to that of DHBA and used to generate 












Figure 3.7: Real chromatogram report of a sample trace. Trace is from a WT mouse, 
taken from the NAcc during an acute microdialysis trial, immediately after alcohol 
injection. Integrated transmitter peak area is compared to that of DHBA and the 









2.7.5 Behavioural analysis 
Locomotor activity was measured concurrent with the in-vivo microdialysis 
experiments. Locomotor activity was automatically measured by a TruScan 
system (Coulbourn Instruments, Allentown, USA).  
 
 
2.8 c-Fos activation after acute and subchronic alcohol treatment 
 
2.8.1 Procedure 
Alcohol naïve animals were used for this test (Mt: n=12; WT: n=12). Animals 
were transferred from the homecage, to a temporary cage and injected either 
once (acute) or on seven consecutive days (subchronic) with ethanol at a 
dose of 2g/kg (i.p.). Mice were left undisturbed for 70 minutes after injection 
minimising further stimuli. After 70 minutes mice were culled under isoflurane 
narcosis and transcardially perfused with 0.1M PBS for 10 minutes and then 
fixed with 4% paraformaldehyde (PFA) solution for a further 10 min (flow rate 
4ml/min). The brain was removed and left in 4% PFA solution overnight at 
4°C. Brains were then transferred to a 30% saccharo se solution and stored at 
4°C until the brains were  fully submerged.  Brains were then snap frozen in 
isopentane at -60°C and stored at -80°C until the w hole brain was cut into 40 
µm coronal sections by cryosectioning. All sections were collected and then 
stored at -20°C in an anti-freezing solution until processed for 
immunohistochemical staining. The floating coronal sections were incubated 
with an anti-c-Fos rabbit polyclonal antibody (1:30.000, Calbiochem, 
Germany) for 20 hours. c-Fos immunoreactive cells were visualized using a 
biotinylated donkey anti-rabbit secondary antibody (1:500, Santa Cruz, 
Germany) and the avidin-biotin complex (ABC-Elite kit rabbit, Vector 
Laboratories, Germany) (Richter et al., 2005).  
 
2.8.2 Stereological quantification  
The number of c-Fos-immunoreactive cells in the rostral and caudal VTA was 
determined using stereological quantification. The examined regions were 
defined according to the stereotaxic coordinates (Franklin and Paxinos, 1997). 
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Stereological quantification of the c-Fos positive cells was carried out strictly 
blind to the experimental conditions with the optical fractionator estimating 
total numbers of c-Fos positive cells (Gundersen, 1986; Schmitz et al., 2000; 
von Horsten et al., 2000). After histological processing the sections had a 
mounted section thickness of 30 µm, a fixed distance of 2 µm and an optical 
dissector height of 26 µm, measured with an electronic microtator attached to 
the microscope. All counting procedures and measurements of reference 
volumes were conducted on a light microscope (Nikon Eclipse 80i) equipped 
with a semiautomatic stereology system (Stereoinvestigator, Version 8.27, 
MicroBrightField, Colchester, Vermont, USA). C-Fos-positive cells were 
counted within a 70x70 µm counting frame, which was spaced in a 90x90 µm 
counting grid. Positive cells were counted, if their nucleus came into focus. 
Positive cells, which intersected the uppermost focal plane (exclusion plane) 
or the lateral exclusion boundaries of the counting frame were not counted. 
The total counts of positive c-Fos cells were multiplied by the ratio of 
reference volume to sampling volume in order to obtain the estimated number 
of c-Fos-positive cells for each structure.  
 
 
2.9 Statistical Analysis 
All graphical output data is expressed as a mean ± SEM. Alcohol drinking: 
Drinking and taste preference data were analysed using two-way ANOVA 
followed by planned pairwise comparisons using Fisher’s LSD with Bonferroni 
correction. Microdialysis: Baseline neurochemical and behavioural data were 
analysed using one way ANOVA and planned pairwise Fisher’s LSD tests. 
Planned pair-wise comparisons (independent by variable t-tests) were 
performed to determine differences between acute and subchronic time points 
within each genotype group. Alcohol induced neurochemical effects were 
expressed as a percentage of the mean of the three baseline samples which 
were taken as 100%. Data were compared using two-way ANOVA for the 
factors genotype (3) and time (12). To compare alcohol effects at certain time 
points, pairwise comparisons were performed using Fisher’s LSD tests. 
Planned t-test pairwise comparisons were performed to determine differences 
  
 98
between acute and subchronic time points within each genotype group. 
LORR: Data were analysed using two-way ANOVA for the factors genotype 
(3) and time (2). To compare alcohol effects across time, within genotype 
groups, planned pairwise comparisons were performed using Fisher’s LSD 
tests. Blood alcohol levels:  Data were analysed using two-way ANOVA for 
the factors genotype (3) and time (3). To compare alcohol effects across time 
and within genotype groups, pairwise comparisons were performed using 
Fisher’s LSD tests. CPP: all data were analysed using two-way ANOVA 
followed by planned pairwise Fisher’s LSD tests. c-Fos expression: all data 
were analyzed by one-way ANOVA followed by t-tests. Although sex 
differences are well known in alcoholism-related behaviors (Desrivières et al., 
2011; Lenz et al., 2011), there were no significant sex differences in this 
study. Therefore, data were collapsed for analysis. The software SPSS 17.0 
and Statistica 9 were used. A significance level of p <0.05 was used to test for 
statistical significance.  
 
As discussed in Chapter 2, Section 2.3. Statistical Analysis, the present study 
retrospectively used the ‘Resource Equation’ (Mead, 1988) method to quantify 
the probability that experiments detected biologically important effects. Mead’s 
resource equation (not using blocking) states: 
 
E = (total number of experimental units) – (number of treatment combinations) 
 
E was calculated for all experiments in the present study. Alcohol drinking, E 
= 28; Blood alcohol levels, E = 31; CPP, E = 31; LORR, E = 9; MD, E = 29; c-
Fos, E = 18. According to Mead’s rule, E should be between 10 and 20. If E is 
less than 10, increasing numbers would lead to good returns. If E is over 20, 
resources may be wasted.  
 
There are some circumstances where it is justifiable for E to be greater than 
20. 
i. When experimental units are cheap and non-sentient. 
  
 99
ii. When the experiments are complex and involve several factors (such 
as treatments), both sexes, different time points, more than one 
genotype etc.  
iii. When it is desirable that the numbers in each experimental sub group 
are balanced. This may not be possible if E is fixed. In such cases it 
may be acceptable for E to range up to 40 or more. 
iv. When the aim of the experiment is the magnitude of a treatment effect, 







3.1. Deficiency in αCaMKII autophosphorylation reduces alcohol 
drinking  
In order to test a potential involvement of αCaMKII autophosphorylation in 
alcohol drinking behaviour a two-bottle free-choice paradigm was used. Mt 
and Ht animals drank significantly less alcohol than WT animals (Fig. 3.8A; 
ANOVA, genotype: F2,124=11.17, p<0.0001; dose: F3,124=55.10; p<0.0001; 
interaction: F6,124=2.04, p=0.065). Planned pairwise comparisons showed that 
there were significant differences between Mt and WT animals at 8 vol.% 
(p=0.016) and 12 vol.% (p<0.0001). In addition, Ht alcohol consumption was 
reduced vs. WT at 12 vol.% (p=0.0002). Alcohol preference vs. water was 
significantly reduced in Mt compared to WT animals (Fig. 3.8B; genotype 
F2,124=5.74, p=0.0041; dose: F3,124=19.94, p<0.0001; interaction: F6,124=1.50, 
p=0.18). Pairwise comparisons showed a significant difference between Mt 
and WT animals at 4 vol.% (p=0.022) and a tendency for 12 vol.% (p<0.058). 
These findings suggest that αCaMKII autophosphorylation may be required 
for the establishment of alcohol drinking and alcohol preference over water in 
a standard drinking test.  
 
 
3.2. Repeated alcohol withdrawal eliminates αCaMKII 
autophosphorylation effects on drinking behaviour 
Initial alcohol preference was reduced in Mt mice. This initial difference could 
be overcome by repeated withdrawal from alcohol. Voluntary alcohol 
consumption is known to escalate after repeated withdrawal periods, which is 
known as the alcohol deprivation effect (ADE; (Spanagel and Hölter, 2000). 
Mt as well as Ht animals consumed significantly less alcohol during baseline 
when offered a 16 vol.% alcohol solution (Fig. 3.8C; genotype F2,124=11.67, 
p<0.0001; time: F3,124=0.65; p=0.58; interaction: F6,124=0.97, p=0.45). Planned 
pairwise comparisons vs. WT confirmed this (Mt: p<0.0001; Ht: p<0.0001). 
Alcohol preference vs. water was altered in Mt and Ht animals during baseline 
(Fig. 3.8D; genotype F2,124=15.15, p<0.0001; time: F3,124=1.93; p=0.13; 
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interaction: F6,124=1.67, p=0.13). Planned pairwise comparisons vs. WT 
showed a reduction for Mt (p<0.0001) and Ht animals (p<0.0001).  
After the first withdrawal period, alcohol consumption increased in the Mt and 
Ht animals across 4 days of reinstatement (genotype F2,124=10.40, p<0.0001; 
time: F3,124=2.59; p=0.056; interaction: F6,124=2.20, p=0.048). However, Mt 
(p=0.0006) consumption was still below WT levels, the same was not true of 
Ht mice (p>0.05). Alcohol preference vs. water increased during this interval 
(genotype F2,124=7.20, p<0.001; time: F3,124=0.94; p=0.42; interaction: 
F6,124=4.80, p=0.0002). Preference was still lower in Mt (p=0.007), but not in 
Ht mice (p>0.05) compared with WT animals.  
After the second 3 week withdrawal period, consumption increased 
temporarily in all animals suggesting a clear ADE (genotype F2,124=6.08, 
p=0.003; time: F3,124=52.59; p<0.0001; interaction: F6,124=1.76, p=0.11), 
interestingly Mt consumed alcohol at the same level as WT animals (p>0.05). 
While the ADE was comparable between all genotypes on day 1 of 
reinstatement of drinking behaviour, it decreased to a greater extent in the Ht 
animals from days 2-4 (p=0.0018). This effect was reflected when alcohol 
preference was measured (ANOVA; genotype F2,124=7.67, p=0.0007; time: 
F3,124=10.83; p<0.0001; interaction: F6,124=0.41, p=0.87). While the second 
withdrawal increased absolute preference over water on day 1 of 
reinstatement, it eliminated the difference between Mt and WT animals 
(p>0.05). However, Ht animals still preferred alcohol less than WT animals 
(p=0.0012). Data suggest that the reduced alcohol preference in Mt mice can 
be overcome by repeated withdrawal. Upon reinstatement, alcohol 
consumption and preference increase to WT levels in the Mt mice. Findings 
might suggest that αCaMKII autophosphorylation may not control the capacity 
to consume alcohol, but controls the speed at which alcohol consumption is 







3.3. Deficiency in αCaMKII autophosphorylation reduces sucrose 
preference  
Alcohol consumption may be influenced in part by differences in taste 
perception. To control for altered taste sensitivity, preference for low and high 
concentrations of sucrose and avoidance of bitter tasting quinine were 
monitored. There was no genotype difference in the preference of 0.5% 
sucrose (Fig. 3.8E; p>0.05). However, a 5% sucrose solution was preferred 
less by the Mt, but not by Ht, mice (genotype: F2,93=6.20, p=0.003; time: 
F2,93=0.76; p=0.47; interaction: F4,93=0.31, p=0.87). Pairwise comparisons 
between genotype groups showed a significant difference vs. WT (p=0.002). 
Quinine was less preferred than water by all mice. The 10 mg/dl concentration 
was avoided most by Ht animals (genotype: F2,93=10.38, p<0.0001; time: 
F2,93=5.25; p=0.007; interaction: F4,93=0.72, p=0.58), which differed from WT 
(p<0.014). There was no genotype difference in the avoidance of a 20 mg/dl 
quinine solution (p<0.05). These data suggest that while taste sensitivity is not 
disturbed by a deficit in αCaMKII autophosphorylation, it may, nevertheless, 
reduce preference of sweet solutions at higher concentration. The degree of 
sucrose preference over water is an indicator of its hedonic value and 
rewarding properties (Papp et al., 1991). A reduced preference may therefore 
suggest that αCaMKII autophosphorylation is required for the establishment of 
the incentive properties of a consumed stimulus.   
 
 
3.4. αCaMKII autophosphorylation has no effect on bioavailability of 
alcohol 
In order to test whether αCaMKII autophosphorylation deficiency may change 
alcohol consumption by altering its bioavailability, blood alcohol levels were 
measured at three different time points after a 3.5 g/Kg alcohol i.p. injection. 
There was no effect of genotype (F2,21=0.38, p=0.69) or time (F2,21=3.45; 
p=0.05), nor interaction (F4,21=2.58, p=0.07) on blood alcohol levels after a 
single alcohol injection (Fig. 3.8F). These findings suggest comparable 





Figure 3.8: Alcohol drinking and blood alcohol levels. αCaMKII autophosphorylation 
deficient (Mt) mice initially drank less alcohol but eventually reach WT level after 
repeated withdrawal. Mice showed a largely preserved taste preference and 
avoidance and comparable alcohol bioavailability. (A) Mean alcohol consumption 
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measured over 4 days for each dose. (B) Mean alcohol preference vs. water 
measured over 4 days for each dose ($ p<0.05, $$$ p<0.001 vs. WT). (C) Mean 
consumption of a 16 vol. % alcohol solution per day. Alcohol deprivation effect on 
consumption after 2 three week withdrawal periods (hatched bars). (D) Mean 
preference vs. water of a 16 vol.% alcohol solution per day. Alcohol deprivation effect 
on preference after 2 three week withdrawal periods (hatched bars). (E) Mean 
preference of sucrose and quinine solution over water measured over three 
consecutive days, respectively. (F) Blood alcohol levels (mean +SEM) after a 3.5 
g/Kg (i.p.) injection of alcohol. For more statistical details: see main text. 
 
 
3.5. αCaMKII autophosphorylation controls speed of alcohol-induced 
CPP establishment and extinction 
αCaMKII deficiency affects learning processes by delaying the speed, but not 
the capacity, at which new behaviors are acquired (Giese et al., 1998; Irvine 
et al., 2005). The motivational properties of alcohol in a CPP paradigm and 
the speed of CPP establishment were assessed. Alcohol-induced CPP is 
established faster in Mt mice than in WT mice (Fig. 3.9A). Two-way ANOVA 
revealed a significant test effect (F4,136= 8.19, p=0.001) and significant test x 
genotype effect (F8,136=2.82, p=0.006). Planned pairwise comparisons show 
that WT mice establish alcohol-induced CPP at preference test 3 (p<0.001), 
i.e. after seven conditioning trials. This preference is maintained after an 
incubation period of 7 days (p=0.005). In contrast, CPP is established in Mt 
mice after only a single conditioning trial, at preference test 1 (p=0.002). Mt 
mice maintain this high preference (test 2, p<0.001; test 3, p=0.002; 
incubation test, p=0.001) through-out the experiment. Interestingly, Ht mice do 
not develop a significant CPP (p>0.05).  
Two-way ANOVA for the extinction (Fig. 3.9B) of a preference for the alcohol-
paired compartment revealed a significant test effect (F5,170=6.38, p<0.001) 
and test x genotype interaction (F10,170=2.66, p=0.004). Pairwise comparisons 
suggest that WT CPP does not extinguish much compared to baseline (test 1, 
p=0.01; test 2, p=0.008; test 3, p=0.005; test 4, p=0.03). There was an 
enhancement of CPP observed in WT mice (p<0.001) after reinstatement. Mt 
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mice maintain CPP after 3 extinction trials (test 1, p<0.001; test 2, p<0.001), 
an effect which disappears after preference test 3 (p>0.05) when Mt mice 
appear to have no preference for the alcohol-paired compartment over the 
saline-paired compartment. A CPP was observed in preference test 4 
(p=0.02), although less pronounced than before. The CPP was enhanced 
after a further reinstatement conditioning trial (p=0.03). Ht mice did not 
develop CPP and therefore could not extinguish the behaviour. However, after 




3.6. Alcohol administration produces an acute sedating effect in 
αCaMKII autophosphorylation-deficient mice, but not in wild-types 
Activity in the alcohol-paired compartment during all conditioning trials (Fig. 
3.9C) showed a significant test effect (F7,238=26.25, p=0.001), and a significant 
test x genotype interaction effect (F14,238=7.11, p<0.001). WT locomotor 
response to alcohol does not diminish compared to baseline after alcohol 
injection. However, a slight decline in locomotion was observed after the 3rd 
(p=0.004), 5th (p=0.05), 6th (p=0.04) and 7th (p=0.001) alcohol injection. Ht 
mice showed no reduction in activity levels after the first injection, but did 
show diminished locomotor activity after 2nd (p=0.03), 3rd (p<0.001), 5th 
(p<0.001), 6th (p=0.008), and 7th (p<0.001) alcohol injection. At baseline, Mt 
mice responded in a hyperactive manner to the test arena when compared to 
WT animals. However, after a single alcohol injection, Mt mice show a 
significant sedating effect on locomotor response (p<0.001), an effect which 
was maintained through-out all remaining conditioning trials (all: p<0.001). 
These results suggest that alcohol reduces the hyperactivity that may be 
induced by novel threatening situations (Easton et al., 2011; Chapter 2) in the 
Mt mice. As such, the fast CPP establishment in the Mt mice may be due to 
fast acting, highly persistent, anxiolytic and negative reinforcing effect of the 





3.7. Conditioned sedation effects in αCaMKII autophosphorylation-
deficient mice  
In Mt mice, there was a conditioned sedation effect observed during repeated 
testing. Two-way ANOVA showed a significant test effect (F4,136=9.47, 
p<0.001) and test x genotype interaction (F8,136=7.86, p<0.001) for 
conditioned locomotor effects in the alcohol compartment for CPP 
establishment (Fig. 3.9D). Similar effects are seen during extinction (Fig. 3.9E; 
test: F5,170=8.77, p<0.001; test x genotype interaction: F10,170=4.91, p<0.001). 
There are no conditioned locomotor effects seen in the Ht group. WT mice did 
not establish a conditioned sedation effect until preference test 3 (Fig. 3.9D; 
p=0.03). This effect was lost after the incubation period (p>0.05). Activity 
levels in WT mice remain at baseline through-out the extinction procedure 
(Fig. 3.9E), with a slight decrease in activity after extinction preference test 4 
(p=0.008). Mt mice, however, show a robust decline in locomotor activity in 
the alcohol-paired compartment (Fig. 3.9D), becoming more in line with the 
response of the WT mice. This effect is stable across all trials (all: p<0.001). 
The sedation effect does not extinguish after repeated extinction trials and the 
reinstatement preference test (Fig. 3.9E; all: p<0.001). 
 
 
3.8. Habituation effects cannot account for the decrease in activity seen 
in response to alcohol in αCaMKII autophosphorylation-deficient mice 
Activity levels in the saline compartment during preference tests in CPP 
establishment (Fig. 3.9F) showed a significant test effect (F4,136=3.61, 
p=0.007). Activity during CPP extinction reveals significant genotype 
(F2,34=6.81, p=0.003) and test effects (F5,170=2.74, p=0.02). WT mice showed 
an initial decrease in activity in response to saline treatment (Fig. 3.9F; test 1: 
p=0.02; test 2: p=0.03). However, levels return to baseline after preference 
test 3 (p>0.05). Activity levels are not significantly different from baseline for 
the majority of the extinction procedure (Fig. 3.9G), with a slight decrease in 
response after preference test 4 (p=0.009) and the reinstatement test 
(p=0.01). Mt activity levels slowly declined in the saline compartment during 
CPP establishment (Fig. 3.9F; test 3: p<0.001). This decrease is not as great 
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as the effect seen after alcohol administration. It is therefore unlikely that 
basic habituation effects account for the reduction in locomotor activity in 
response to alcohol. This basal activity response is maintained through-out 










Figure 3.9: Conditioned Place Preference. The anxiolytic/negative reinforcing 
properties of alcohol may account for the accelerated establishment of alcohol-
induced conditioned place preference (CPP) in Mt mice compared to WT mice. Time 
spent in the conditioning (alcohol paired) compartment during the establishment of 
CPP (A) and extinction of place preference (B). Distance travelled during the first 5 
minutes of baseline pre-test, and in alcohol-paired 5 minute conditioning trials (C) 
compared to baseline. Conditioned locomotor effects of alcohol during CPP testing 
for the alcohol-paired compartments (D,E) and saline-paired compartments (F,G). 
Planned pairwise comparisons to baseline, *p<0.05, **p<0.01, ***p<0.001. 
 
 
3.9. No role of αCaMKII autophosphorylation in the hypnotic effects of 
alcohol 
There was no difference in the hypnotic effects of alcohol between groups of 
alcohol naïve mice following an acute alcohol injection (p>0.05; Fig. 3.10A). 
After subchronic alcohol treatment (7 daily alcohol injections) Ht mice were 
less sensitive to the hypnotic properties of alcohol (time: F2,12=12.19, p=0.004; 
Fig. 3.10A) and were significantly more tolerant to the hypnotic effects of 
alcohol than both Mt (p=0.04) and WT mice (p=0.02; Fig. 3.10A). Figure 3.10B 
illustrates the amount of time mice spent in an ataxic state as a result of a 
high alcohol dose. This was not different between groups of alcohol naïve 
mice following an acute alcohol injection (p>0.05). After alcohol treatment 
increased, Mt (p=0.04) and Ht (p=0.04) alcohol-experienced mice were 
significantly more tolerant to the ataxic effects induced by a high alcohol dose, 
thus spending less time in an ataxic state (time: F1,12=9.97, p=0.008; Fig. 








Figure 3.10: Loss of Righting Reflex. The hypnotic effects of alcohol were 
experienced similarly by αCaMKII autophosphorylation deficient, Ht and WT alcohol 
naïve mice. Loss of righting reflex (LORR) to sedation (A) and LORR duration (B) 
after acute and subchronic (after seven prior alcohol treatments) alcohol (3.5g/Kg, 
i.p.) treatment. Planned pairwise comparisons: $p<0.05 vs. WT; #p<0.05 vs. Ht; 
£p<0.05 ££p<0.01, acute genotype group v subchronic genotype group.  
 
 
3.10. Acute locomotor activating effects of alcohol are absent in αCaMKII 
autophosphorylation deficient mice  
In contrast to the relatively new environment of a CPP box, alcohol naïve mice 
showed no differences between genotypes in locomotor activity in a well 
habituated environment of the in-vivo microdialysis test (p>0.05; Fig. 3.11A). 
An acute alcohol injection increased locomotor activity in WT, but not in Mt or 
Ht mice. Although two-way ANOVA failed to show significant genotype effects 
or interactions (p>0.05), pairwise comparisons revealed a significant 
difference between Mt and WT mice 60 minutes after acute alcohol injection 
(p=0.03; Fig. 3.11B). 
Basal (no alcohol on board) behavioural activation levels of Mt mice changed 
after alcohol pre-treatment (subchronic exposure), and showed a significant 
increase in basal activation (p<0.05; Fig. 3.11A). Subchronic Mt activation 
levels were also elevated compared to alcohol experienced WT (<0.0001) and 
  
 111
Ht (<0.001) mice. Following seven prior daily alcohol treatments, two-way 
ANOVA revealed a further alcohol injection produced a significant increase in 
activity in WT and Ht but not Mt mice (time: F11,231=2.97, p=0.001; interaction: 
F22,231=1.83, p=0.02; Fig. 3.11C). Pairwise comparisons showed a significant 
difference between groups at 20 minutes (Mt vs. WT p=0.05) and 160 minutes 
(WT vs. Ht p=0.04) post injection. Data suggest that the acute locomotor 








Figure 3.11: Locomotor Activity. The effects of an alcohol (2 g/Kg, i.p.) injection on 
αCaMKII autophosphorylation deficient and wild-type mice in a well habituated (>2h 
before baseline) open field. Baseline behavioural activity was not different between 
genotypes; Planned pairwise comparisons: $$$p<0.001 vs. WT; ###p<0.001 vs. Ht; 
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£p<0.05 acute genotype group v subchronic genotype group (A). Locomotor activity 
recorded after acute (B) and subchronic (seven) alcohol treatments (C). Arrow 
indicates time of alcohol injection. Planned pairwise comparisons using Fisher’s LSD 
tests: @p<0.05 Mt vs. WT; &p<0.05 WT vs. Ht. 
 
 
3.11. There is no difference in basal DA levels in the NAcc and the PFC 
in alcohol naïve αCaMKII autophosphorylation deficient and wild type 
mice. 
Neurotransmitter levels were measured in the NAcc and PFC in alcohol naïve 
αCaMKII autophosphorylation deficient (Mt), Ht and WT mice, prior to an 
acute alcohol challenge. There were no differences in DA levels in the NAcc 
(Fig. 3.12A) or PFC (Fig. 3.12B) between genotype groups prior to alcohol 
administration in alcohol naïve animals. Alcohol naïve Het mice were shown 
to have elevated 5-HT levels in both the NAcc and PFC. Ht NAcc levels (F2, 
88=11.67, p<0.001; Fig. 3.12C) were significantly different compared to WT 
(p<0.001) and Mt (p<0.001) mice. In the PFC (F2, 89=17.56, p<0.001; Fig. 
3.12D) Ht 5-HT levels were also significantly different compared to both WT 
(p<0.001) and Mt (p<0.001) mice. NA levels in the NAcc were not significantly 
different between genotype groups (Fig. 3.12E). However, In the PFC (F2, 
90=4.93, p=0.009; Fig. 3.12F) Mt were found to have significantly higher NA 
levels than both WT (p=0.02) and Ht (p=0.004) mice.  
 
 
3.12. NAcc DA levels are elevated after subchronic alcohol treatment in 
αCaMKII autophosphorylation deficient mice. 
Neurotransmitter levels were measured in the NAcc and PFC in alcohol 
experienced αCaMKII autophosphorylation deficient (Mt), Ht and WT mice, 
prior to an alcohol challenge. After 7 previous alcohol treatments, there were 
no differences in basal DA levels between genotype groups in the NAcc. 
However, planned pairwise comparisons revealed a significant increase 
overtime in Mt (p=0.002; Fig. 3.12A), but not in Ht or WT mice. In the PFC 
there was a difference in basal DA levels seen between alcohol experienced 
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groups (F2, 68=4.08, p= 0.02; Fig. 3.12B), where Ht were significantly different 
from WT (p=0.02) and Mt (p=0.01) mice, but Mt and WT mice were not 
significantly different from one another. Planned pairwise comparisons 
revealed a significant increase overtime in Ht (p=0.02; Fig. 3.12B), but not in 
Mt or WT mice. The degree of alcohol exposure did not affect resting 5-HT 
levels in the NAcc and PFC. Alcohol experienced Ht mice were shown to have 
elevated basal 5-HT levels in both the NAcc and PFC. NAcc levels (F2, 
79=11.51, p<0.001; Fig. 3.12C) were significantly different from WT (p<0.001) 
and Mt (p<0.001) mice. In the PFC (F2, 75=11.40, p<0.001; Fig. 3.12D) 5-HT 
levels were also significantly different compared to both WT (p<0.001) and Mt 
(p<0.001) mice. These effects of genotype were not influenced by the degree 
of alcohol exposure. Subchronic alcohol treatment was seen to affect basal 
NA levels in the NAcc (F2, 80=3.75, p=0.03; p<0.001 WT vs, Ht; Fig. 3.12E), 
with an observed increase in NAcc resting NA levels after subchronic alcohol 
administration in WT mice (p<0.001; Fig. 3.12E) only. In the PFC, Ht mice had 
decreased resting NA levels after subchronic alcohol treatment (F2, 72=5.07, 
p=0.008; Fig. 3.12F) compared to WT (p=0.002) and Mt (p=0.04) mice. The 
increase in WT NA levels in response to alcohol administration between naïve 






Figure 3.12: Baseline monoamine levels adapted after subchronic (seven prior 
alcohol treatments) alcohol exposure. Bars represent neurotransmitter levels in the 
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NAcc prior to and after alcohol treatment for DA (A); 5-HT (C); and NA (E). Baseline 
neurotransmitter levels in the PFC prior to and after alcohol treatment for DA (B); 5-
HT (D); and NA (F). Planned pairwise comparisons: $p<0.05 ,$$p<0.01, $$$p<0.001 vs. 
WT; #p<0.05, ##p<0.01, ###p<0.001 vs. Ht; £p<0.05, ££p<0.01, £££p<0.001, acute 
genotype group v subchronic genotype group. 
 
 
3.13. The acute dopaminergic effects of alcohol in the NAcc are absent 
in αCaMKII autophosphorylation deficient mice 
αCaMKII autophosphorylation may control the incentive properties of alcohol. 
Results from alcohol drinking experiments suggest that neurochemical 
markers for the incentive and behaviourally activating properties of alcohol 
would be reduced in Mt mice after initial exposure. Given that alcohol drinking 
reached WT level after subchronic exposure, neurochemical responses to 
alcohol might be expected to normalize to WT levels with repeated exposure. 
Acute alcohol administration increased extracellular DA levels in the NAcc of 
WT mice. This alcohol-induced DA increase was absent in Mt and Ht mice. 
Two-way ANOVA showed a significant genotype (F2,26=4.20, p=0.03) and time 
effects (F11,286=2.21, p=0.01), but no significant genotype x time interaction 
(p>0.05; Fig. 3.13A). Planned pairwise comparisons revealed a significant 
alcohol-induced increase in DA levels in the NAcc in WT mice only (40 mins: 
WT vs. Ht, p=0.02; 80 mins: WT vs. Mt, p=0.01; 100 mins: WT vs. Mt, p=0.01 
and WT vs. Ht, p=0.01; 120 mins: WT vs. Mt, p=0.04 and WT vs. Ht, p=0.02; 
Fig. 3.13A). DA levels in the PFC of all mice did not change in response to an 
acute alcohol challenge (Fig. 3.13C) despite a significant genotype x time 
interaction, as revealed by two-way ANOVA (F22,286=1.70, p=0.03). 
 
 
3.14. Subchronic alcohol treatment reduces DA response differences 
between genotype groups in the NAcc 
After subchronic alcohol exposure for 7 days, an acute alcohol injection led to 
a slight increase in NAcc DA levels in WT mice, which was far less 
pronounced than in naïve animals. There was no such effect in Mt or Ht mice 
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(Fig. 3.13B). Two-way ANOVA did not show significant genotype effects or an 
interaction (p<0.05). However, planned pairwise comparisons revealed 
significant group differences at 100 minutes (Mt vs. WT p=0.02) and 140 
minutes (Mt vs. Ht p=0.02) post alcohol administration. Data suggest that after 
several alcohol pre-treatments, the NAcc DA response is greatly diminished in 
WT mice, remaining unchanged in Mt and Ht groups, after a further alcohol 
challenge, thus reducing response differences between genotype groups. 
Subchronic DA levels in the PFC were not significantly different between 





























Figure 3.13: In vivo microdialysis dopamine levels. The acute dopaminergic 
effects of alcohol in the nucleus accumbens (NAcc) were absent in αCaMKII 
autophosphorylation deficient mice. Differences between genotype groups diminish 
over time and after increased alcohol exposure. Extracellular dopamine (DA) levels in 
the NAcc after acute (A) and subchronic (following seven prior alcohol treatments) 
(B) alcohol treatments as percent of baseline. Extracellular DA levels in the prefrontal 
cortex (PFC) after acute (C) and subchronic (D) alcohol treatments. Arrow indicates 
time of alcohol injection. Planned pairwise comparisons using Fisher’s LSD tests 
between groups at each time point: @p<0.05, @@p<0.01 MT vs. WT; &p<0.05, 




3.15. Deficiency in αCaMKII autophosphorylation leads to an increased 
5-HT response in the PFC after acute alcohol treatment  
An initial difference in alcohol consumption/preference, which normalizes with 
repeated exposure, may be due to a deregulation in the serotonergic system 
in Mt mice with potential neurochemical differences normalizing to WT levels 
after subchronic exposure. To test this hypothesis extracellular 5-HT levels 
were monitored after acute alcohol exposure and after repeated exposure. 
After the first alcohol treatment, 5-HT in the NAcc was not significantly 
different between groups (p>0.05). Two-way ANOVA revealed a significant 
time effect (F11,308=2.02, p=0.03; Fig. 3.14A), as a gradual reduction in 5-HT 
was observed over time in all genotype groups. In WT and Ht animals, there 
was no effect of acute alcohol administration on 5-HT levels in the PFC. 
However, in Mt mice, alcohol led to an increase in 5-HT. A two-way ANOVA 
showed a significant genotype x time interaction (F22,319=2.22, p=0.001; Fig. 
3.14C). Planned pairwise comparisons indicate significant differences 
between Mt and the other genotype groups at 20 minutes (Mt vs. WT 
p=0.008; Mt vs. Ht p=0.02) and 40 minutes (Mt vs. WT p<0.001; Mt vs. Ht 
p=0.002) post alcohol administration.  
 
 
3.16. Subchronic alcohol treatment does not alter the serotonergic 
response to alcohol in the PFC 
After repeated alcohol treatments, a further acute alcohol challenge does not 
alter serotonergic response in the NAcc (p>0.05; Fig. 3.14B). In the PFC, 
there was no effect of alcohol on 5-HT levels in WT or Ht animals, but there 
was a small, non-significant increase in Mt mice (Fig. 3.14D). Although two-
way ANOVA did not find significant genotype or interaction effects (p>0.05), 
pairwise comparisons between groups revealed significant differences at 40 
minutes (Mt vs. Ht p=0.04), 120 minutes (WT vs. Mt p=0.05) and 160 minutes 







Figure 3.14: In vivo microdialysis serotonin levels. Serotonergic responses to alcohol 
in the nucleus accumbens (NAcc) and prefrontal cortex (PFC) revealed a 
deregulation of the reward system. The response remains unchanged after several 
alcohol pre-treatments. Extracellular serotonin (5-HT) levels in the NAcc after acute 
(A) and subchronic (following seven prior alcohol treatments) (B) alcohol treatments 
as percent of baseline. Extracellular 5-HT levels in the PFC after acute (C) and 
subchronic (D) alcohol treatment. Arrow indicates time of alcohol injection. Planned 















3.17. The acute noradrenergic effects of alcohol in the NAcc are absent 
in αCaMKII autophosphorylation deficient mice 
Deficiency in αCaMKII autophosphorylation led to a deregulation of 
noradrenergic responses to alcohol in the NAcc and the PFC. In the NAcc, 
alcohol induced a gradual increase in extracellular NA levels. This effect was 
attenuated in Mt mice and absent in the Ht mice. Two-way ANOVA showed a 
significant time effect (F11,341=2.27, p=0.01) and genotype x time interaction 
(F22,341=1.69, p=0.03; Fig. 3.15A). Pairwise comparisons revealed a significant 
difference between genotype groups 40 minutes (WT vs. Ht p=0.04), 60 
minutes (WT vs. Ht p=0.05), 140 minutes (WT vs. Mt p=0.05; WT vs. Ht 
p=0.02) and 160 minutes (WT vs. Mt p=0.02; WT vs. Ht p=0.008) post alcohol 
administration. In the PFC, acute alcohol had no effect on NA levels (p>0.05; 
Fig. 3.15C).  
 
 
3.18. Subchronic alcohol treatment alters acute NA responses  
After subchronic alcohol treatment, an acute alcohol injection no longer had 
an effect on extracellular NA levels in the NAcc (time: F11,286=2.67, p=0.002; 
pre-planned: p>0.05; Fig. 3.15B) and there were no longer any significant 
differences between groups (p>0.05). After subchronic alcohol treatment, an 
acute alcohol injection caused an increase of PFC NA levels in WT, but not in 
Mt or Ht mice (Fig. 3.15D). While an ANOVA failed to yield a significant 
genotype or interaction effect (p>0.05), planned pairwise comparisons 
revealed WT NA levels to be significantly different from Ht and Mt groups 20 
minutes (WT vs. Mt p=0.05), 40 minutes (WT vs. Mt p=0.04), 80 minutes (WT 
vs. Mt p=0.02; WT vs. Ht p=0.04), 100 minutes (WT vs. Ht p=0.03) and 140 







Figure 3.15: In vivo microdialysis noradrenaline levels. Alcohol increased 
noradrenaline (NA) levels in the nucleus accumbens (NAcc) of wild-type (WT), but 
not αCaMKII autophosphorylation deficient (Mt) or heterozygous (Ht) mice. 
Extracellular NA levels in the NAcc after acute (A) and subchronic (following seven 
prior alcohol treatments) (B) alcohol treatments as percent of baseline. Extracellular 
NA levels in the prefrontal cortex (PFC) after acute (C) and subchronic (D) alcohol 
treatments. Arrow indicates time of alcohol injection. Planned pairwise comparisons 















3.19. αCaMKII autophosphorylation-deficient mice show enhanced c-Fos 
activation in the rostral but not caudal VTA following alcohol exposure 
The effects of acute and subchronic alcohol administration on c-Fos activation 
in the rostral and caudal VTA of Mt and WT mice (Fig. 3.16) were measured in 
order to determine the origin of altered DA responses to alcohol. Mt mice 
showed an increased c-Fos expression in the rostral part of the VTA after both 
acute (F1,10=6.32, p<0.05) and subchronic (F1,9=20.7, p<0.01) alcohol 
treatment. There was no significant difference between Mt and WT animals in 
c-Fos expression in the caudal part of the VTA under both treatment 




Figure 3.16: c-Fos activation. αCaMKII autophosphorylation deficient mice showed 
increased c-Fos expression in the rostral, but not caudal, ventral tegmental area 
(VTA) after both acute and subchronic alcohol treatment. c-Fos labelling of the 
caudal (A, C, E, G) and rostral (B, D, F, H) VTA after acute or 7 days subchronic 
alcohol (2 g/Kg, i.p.) treatment. C-Fos was determined 70 min after last alcohol 
injection (t-tests, $p<0.05 vs. WT, $$p<0.01 vs. WT). Panels E-H show c-Fos labelled 





4. Discussion  
αCaMKII is implicated in addictive pathways and alcohol, in particular, can 
alter αCaMKII expression levels in the brain after chronic alcohol exposure 
(Mahadev et al., 2001). However, the specific role of αCaMKII and related 
molecular mechanisms are unclear. The present study reported that 
αCaMKIIT286A Mt mice self-administer alcohol significantly less, and prefer 
alcohol less, than WT animals especially at higher percent alcohol solutions. 
This difference was no longer observed when mice were taken through 
repeated periods of withdrawal and reinstatement. Taste sensitivity remained 
largely unaffected, though a reduction in the incentive properties of a sucrose 
solution was observed in Mt mice. Blood alcohol levels were found to be 
comparable across genotype groups, thereby ruling out a difference in the 
bioavailability of alcohol as the cause of the altered alcohol consumption rates 
observed in Mt mice. These data suggest that αCaMKII autophosphorylation 
may control the speed at which a preference for alcohol is established, but not 
the capacity to consume alcohol.  
The CPP test is designed to assess the motivationally rewarding 
properties of an alcohol associated cue (Cunningham et al., 2006). Present 
data showed that αCaMKII autophosphorylation may control the speed at 
which alcohol-induced CPP was established and extinguished. Preference for 
the alcohol-paired compartment was established after seven conditioning 
trials in WT mice, which is in line with classical alcohol CPP establishment 
(Risinger and Oakes, 1996; Liu et al., 2008). Rather unexpectedly, Mt mice 
established a profound alcohol CPP after a single alcohol conditioning trial, 
despite the fact that alcohol drinking behaviour was seen to develop at a 
slower rate in Mt compared to WT mice. The disparity between the 
establishment of alcohol drinking and CPP may be explained by considering 
the acute effects of alcohol in the CPP paradigm. Previous work (Easton et 
al., 2011; Chapter 2) shows that αCaMKIIT286A Mt mice have heightened 
activity in response to potentially threatening situations and environments 
while showing no altered behaviour in well-habituated environments (Easton 
et al., 2011). Arguably one key component to compulsive drug seeking is the 
alleviation of a negative affective state by a negative reinforcement 
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mechanism (Koob, 2011). Alcohol drinking behaviour was measured in a 
familiar homecage environment. In contrast, CPP rewarding effects were 
measured in a less familiar environment, which might together with the 
injection process represent an aversive or threatening procedure, although 
this was not empirically tested. This view was supported by the observed 
hyperactivity in Mt mice showed in both the CPP baseline trial in this study 
and in a novel open field, but not in familiar home cages (Easton et al., 2011). 
In contrast to WT mice, 2g/kg alcohol had an acute and persistent sedating 
effect in the αCaMKII autophosphorylation-deficient mice. One possible 
explanation of this effect is that the alcohol alleviated the threat-induced 
behavioural responses in Mt mice in a potentially aversive novel test situation. 
Furthermore, a single alcohol pairing was sufficient to induce a significant 
conditioned sedation effect in the Mt, but not in WT or Ht mice. Therefore, it is 
possible that the reduction of an aversive state enhanced conditioned effects 
during the CPP testing in Mt mice. Altogether, these data suggest a fast acting 
negative reinforcement mechanism acting in the Mt mice may be causing a 
faster establishment of CPP to alcohol, although this hypothesis requires 
further investigation.   
The hypnotic properties of a high dose of alcohol following a single 
alcohol injection, as measured by the LORR procedure, was not affected by a 
deficit in αCaMKII autophosphorylation. The hypnotic effects of alcohol are 
most likely mediated through interaction with GABAA receptors (Spanagel, 
2009), and does not seem not to be under the control of αCaMKII 
autophosphorylation in the present study. Following subchronic alcohol 
exposure, all genotype groups were more tolerant to, and recovered sooner 
from, the hypnotic properties of alcohol to a similar degree. The differential 
involvement of αCaMKII autophosphorylation in the emotional, rewarding and 
hypnotic effects of alcohol was not surprising given the multiple mechanisms 
of action of alcohol at the molecular level. CaMKII is known to play an 
important role in the plasticity of glutamatergic synapses (Colbran and Brown, 
2004; Irvine et al., 2006; Wayman et al., 2008), where as the anxiolytic and 
hypnotic properties of alcohol are mediated by the GABAergic system, in 
particular GABAA receptors (Mehta and Ticku, 1988; Allan et al., 1991). This is 
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in line with a role for αCaMKII autophosphorylation in the plasticity of 
glutamatergic, but not GABAergic synapses (Lamsa et al., 2007).  
The acute positive reinforcing effects of alcohol are mediated by the 
recruitment of specific neurotransmitter systems in the reward centres of the 
brain (Koob et al., 1998a; McBride, 2010). In-vivo microdialysis was used to 
examine monoaminergic responses which might contribute to the incentive 
properties, emotional effects and potential arousal regulating effects of 
alcohol. In agreement with CPP data, alcohol induced an acute sedating effect 
in Mt mice, an effect which was maintained as alcohol treatments continued. 
In contrast, alcohol induced a hyperlocomotor response in WT mice. The DA 
system is critical to experience the acute reinforcing effects of alcohol (Koob, 
1992; McBride and Li, 1998; Nestler, 2005), with alcohol typically inducing 
around a 20% increase in DA levels in the NAcc (Doyon et al., 2003). In the 
present study, fluid was collected from the NAcc and PFC. Fluid collected 
from these regions was merely a reflection (a few percent) of the true 
extracellular concentrations of transmitter present in the brain. Prior to acute 
alcohol administration, there were no differences in basal DA levels between 
genotype groups. Microdialysis data showed that an acute alcohol challenge 
induced a DA increase in the NAcc of WT mice, a response which was 
entirely absent in Ht and Mt mice. The observation that there are reduced DA 
levels in the NAcc and reduced drinking behaviours in Mt mice suggests that 
the diminished DA response may interfere with the experience of the acute 
rewarding properties of alcohol. This may therefore contribute towards the 
initially delayed alcohol preference in Mt mice. This study lacks saline control 
groups, which greatly limits the interpretation of the present data. The design 
used assumes that the injection procedure affects all genotype groups in the 
same way (Szumlinski et al., 2005; Spanagel et al., 2005b). However, based 
on the findings from Chapter 2 (published in Easton et al., 2011), this 
assumption may be flawed.  (Discussed in full in Chapter 6, 4. Strengths and 
Limitations). 
Activation of the dopaminergic neurons in the VTA is believed to be 
critically involved in the development of addiction (Robbins and Everitt, 1996; 
Koob et al., 1998b). Projections from the VTA extend to other important 
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regions implicated in the rewarding potential of drugs of abuse, including the 
NAcc (Van Bockstaele and Pickel, 1995; Olson et al., 2005), PFC (Carr and 
Sesack, 2000) and other corticolimbic structures (Albanese and Minciacchi, 
1983; Oades and Halliday, 1987). The VTA can be separated into two distinct 
sub-regions: the rostral and the caudal VTA (Ikemoto et al., 1997b; Ikemoto et 
al., 1998). These regions contain different neuronal populations (Olson et al., 
2005) with more GABAergic neurons present in the rostral VTA as opposed to 
the caudal sub-region (Olson et al., 2005; Lee et al., 2007; Olson and Nestler, 
2007). GABAergic projections originating from the NAcc to the VTA DA 
neurons represent a potential target for the ethanol modulation of 
dopaminergic activity (Thielen et al., 2002) and act by disinhibiting VTA DA 
mediated release (Xiao et al., 2007). Activation of the VTA dopaminergic 
neurons is one of the cellular bases for ethanol reinforcement (Brodie et al., 
1999; Xiao et al., 2009). However, it is the ratio of dopaminergic versus non-
dopaminergic neurons in the VTA that has been suggested to contribute to 
the difference in the functional properties of these sub-regions (Olson and 
Nestler, 2007). Ethanol has been shown to inhibit GABA release in 
posterior/caudal DA neurons but facilitate GABA release in the anterior/rostral 
VTA DA neurons (Guan et al., 2011). Several studies demonstrate that as 
GABAergic activity in the rostral VTA increases, dopaminergic activity 
decreases, resulting in a diminished experience of reward and reinforcement. 
Injections of GABAA receptor agonists directly into the rostral VTA can 
decrease the rate of cocaine self-administration in rats (Corrigall et al., 2000). 
Correspondingly, by blocking GABAA receptors in anterior/rostral VTA, DA 
levels increase in the NAcc of rats (Ikemoto et al., 1997a; Ding et al., 2009). 
Rats have also been shown to self administer GABAA receptor antagonists 
into the anterior/rostral VTA (Ikemoto et al., 1997b). In the present study Mt 
mice showed enhanced c-Fos activation after an acute alcohol injection 
compared to WT mice in the rostral, but not caudal VTA. This suggests an 
enhanced GABAergic activity in the rostral VTA, and may be linked to the 
reduced DA response in the NAcc of the Mt mice. These effects were also 
observed after an acute alcohol challenge following subchronic administration. 
As it stands, data were insufficient to be able to directly demonstrate whether 
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increased cFos expression occurred in the GABAergic neurons. Experiments 
performing GABAergic neuron and cFos double-labelling would be required in 
order to more accurately interpret the current cFos data and test the potential 
contribution of GABAergic neurons to alcohol preference in Mt mice.  
Repeated ethanol exposure can induce sensitisation of DRD2 (Perra et 
al., 2011). As DRD2 is activated Ca2+ is released from intracellular stores and 
CaMKII becomes active (Takeuchi et al., 2002). This activation of CaMKII 
mediates the calcium dependent desensitisation of DRD2 signalling in DA 
neurons (Perra et al., 2011) resulting in a loss of receptor function due to 
continuous agonistic stimulation. This mechanism may be implicated in the 
diminished DA response seen in the NAcc of WT mice upon subchronic 
alcohol administration in the present study. Taking past and present data into 
account, there is strong evidence for the involvement of αCaMKII and 
αCaMKII autophosphorylation in the adaptation of the DA system in the 
establishment of alcohol-addiction related behaviors.  
 
It is widely documented that upon alcohol administration, 5-HT activity is 
increased in the ventral hippocampus (McBride et al., 1993; Virkkunen and 
Linnoila, 1997; Bare et al., 1998; Thielen et al., 2002). In the current study 
alcohol did not affect 5-HT activity in the NAcc or PFC in WT or Ht animals. In 
Mt animals, however, alcohol induced a significant 5-HT increase in the PFC. 
Deficiencies in brain 5-HT have previously been associated with high ethanol 
drinking responses (Murphy et al., 1982; McBride et al., 1993; Virkkunen and 
Linnoila, 1997). Likewise, artificially induced increases in extracellular 5-HT 
can reduce ethanol drinking (Boyce-Rustay et al., 2006). Alcohol-induced 5-
HT increases in the PFC of Mt mice might therefore contribute towards the 
reduced alcohol drinking behaviours seen in these mice. 5-HT is released in 
response to alcohol (Daws et al., 2006) and is thought to contribute towards 
the rewarding effects of alcohol. There is a strong link between CaMKII and 
serotonergic function in the brain. Tryptophan hydroxylase (TPH) is the rate 
limiting enzyme in the biosynthesis of 5-HT (Kuhn et al., 2007), and CaMKII is 
required for the activation of TPH, by phosphorylation (Hamon et al., 1981; 
Kuhn and Lovenberg, 1982; Ehret et al., 1989). The administration of the 
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CaMKII inhibitor, KN-62, increases the firing rate of 5-HT neurons (Liu et al., 
2005). This finding may be extrapolated to the present data, whereby a 
reduction in CaMKII function may have caused increased 5-HT firing and 
therefore transmitter release into the cleft. Microdialysis data showed that 
alcohol induced 5-HT increases in the PFC of Mt mice. Uncontrollable 
(inescapable) stressors activate 5-HT neurons in the dorsal raphe nucleus 
and its projections far more than exposure to escapable stressors (Amat et al., 
2005). Taken together, data might suggest that 5-HT increases in the PFC 
could be due to Mt mice being exposed to an uncontrollable stressor, lending 
support to the negative reinforcement theory suggested above. 
 
The present study shows that αCaMKII autophosphorylation is important for 
the normal development of alcohol reinforcement and may act by altering both 
DA and 5-HT in the meso-corticolimbic system. In light of current findings, one 
might speculate that alcohol preference is driven by a positive reinforcement 
mechanism. In Mt mice, both a reduced alcohol preference and a diminished 
DA response in the NAcc were observed. Alcohol CPP, however, was 
established at an accelerated rate and may relate to the increased 5-HT levels 
seen in the PFC of Mt mice in response to alcohol. Previous research 
suggests that this response may be driven by a negative reinforcement 
mechanism. Interestingly, Ht mice showed neither a strong DA nor 5-HT 
response, perhaps suggesting an absence of both positive and negative 
reinforcement. This was in line with their behaviour since they were the most 
delayed group in establishing alcohol drinking and alcohol CPP.  
 
NA plays a role in several brain functions including attention and arousal as 
well as learning and memory (Huether, 1996; Sved et al., 2001). While 
stimulants have been shown to induce synaptic increases in NA levels (Bardo, 
1998; White and Kalivas, 1998), lesions of the noradrenergic system (Roberts 
et al., 1977) and NA transporter (NET) inhibitors (Wee and Woolverton, 2004; 
Wee et al., 2006) do not affect cocaine self-administration behaviour. Ethanol 
consumption has been shown to significantly decrease the rate of NA turnover 
in specific brain areas such as the NAcc, PFC and amygdala (Smith et al., 
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2008), and such changes have been hypothesised to contribute to 
behavioural changes associated with binge drinking (Smith et al., 2008). The 
present study reported acute noradrenergic increases in the NAcc of WT, but 
not in Ht or Mt mice, with the effect seen in WT mice normalising over time. 
The opposite effects were seen in the PFC, with differences in NA levels seen 
following subchronic, but not acute alcohol treatment. The WT response 
increased after a further alcohol injection. No such effect was seen in Mt or Ht 
mice. Basal neurotransmitter levels represent resting DA, 5-HT and NA levels, 
prior to alcohol treatment, in the NAcc and PFC of alcohol naïve (acute) and 
alcohol experienced (subchronic) Mt, WT and Ht mice. Data reflected the 
influence of subchronic alcohol use and the adaptation of the noradrenergic 
system, and the reward system in general, at baseline between genotype 
groups. Together, data suggests that alterations in NA transmission may not 
be critical for, but may contribute to the development of addictive behaviours 
(Sofuoglu and Sewell, 2009). The observed alcohol-induced NA response 
may play a part in alcohol drinking. 
 
Both male and female mice were used in all experiments of the present study, 
and balanced across groups. Sex differences are well known in alcoholism-
related behaviors (Desrivières et al., 2011; Lenz et al., 2011), however there 
were no significant sex differences detected in this study. Data was therefore 
collapsed for analysis although a subtle sex specific role for αCaMKII in the 
development of alcohol-related behaviours cannot be ruled out and may be a 
limitation for the current analyses. The absence of saline injected groups is a 
major drawback in the present thesis and significantly limits the interpretation 
of the data. Inclusion of saline groups for each genotype would have helped to 
identify injection stress-induced increases in behavioural and neurochemical 
levels, especially since threatening situations and stimuli have been identified 
as a potential confound (Chapter 2 and Easton et al., 2011). There is a role for 
DA in processing both rewarding and aversive events (Brischoux et al., 2009). 
It is therefore possible that an aversive stimulus, such as an injection, will 
increase dopaminergic activity in the NAcc and PFC (Abercrombie et al., 
1989; Kalivas and Duffy, 1995). Thus, injection stress cannot be ruled out as a 
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contributing factor and it is not possible to distinguish between responses 
caused solely by alcohol from those responses caused by the injection 
procedure. (Discussed in full in Chapter 6, 4. Strengths and Limitations). 
 
Taken together, the present study showed that αCaMKII autophosphorylation 
is important for the establishment of alcohol related behaviors. αCaMKII 
autophosphorylation may therefore play a part in the positive reinforcing 
properties of alcohol mediated by a VTA driven dopaminergic activation of the 
NAcc. A deficiency in αCaMKII autophosphorylation enhances susceptibility to 
threatening stimuli, an effect which potentially renders animals vulnerable to 
the negative reinforcing effects of alcohol. This may be driven by serotonergic 
activation of the PFC.  Taken together, data demonstrate that manipulation of 
the αCaMKII autophosphorylation mechanism does appear to alter the 
development of alcohol preference and the rate at which preference is 
established. This seems to be related to modifications of the dopaminergic 
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Cocaine is the most commonly used illicit psycho-stimulant drug in the U.K. 
Addiction to cocaine develops in a considerable number of individuals. It is 
widely believed that addiction and memory formation share a number of 
molecular and anatomical pathways. Interestingly, αCaMKII a key mediator of 
LTP, has been shown to become phosphorylated with chronic cocaine use. 
The aim of the present study was to investigate whether a deficit in the 
function of αCaMKII alters preference to cocaine and the rate at which 
cocaine preference is established. Data indicated a difference in the time-
course of the DA increase in the extracellular space of the NAcc following 
cocaine administration and the pattern of establishment of CPP in αCaMKII 
Mt mice. 5-HT is also required for the development of CPP and baseline 5-HT 
levels in the NAcc and PFC were altered in αCaMKII Mt mice. αCaMKII 
autophosphorylation did not appear to be required for the development of 
other cocaine-related behaviours associated with chronic administration such 
as conditioned hyperactivity and behavioural sensitisation. These effects 
remained stable over time as did noradrenergic levels in the NAcc and PFC. 
Data generated in the present study suggests that there are other 
mechanisms at play in the development of addictive states as altered 
αCaMKII autophosphorylation does not solely account for the development of 














20% of the U.S. population using illicit drugs also meet the criteria for 
dependence (Glantz et al., 2009). Cocaine is the most commonly used illicit 
psycho-stimulant drug in the U.K. (UNODC, 2011) and develops into addiction 
in a significant number of individuals. Despite this, the underlying mechanisms 
associated with addiction remain largely unknown, although it is now widely 
believed that addiction may be due to dysfunction in the learning and memory 
pathways (Nestler, 2002a; Kelley, 2004; Hyman, 2005; Müller and Schumann, 
2011).  
 
CaMKII activation contributes to the development and maintenance of 
addictive states (Noda and Nabeshima, 2004; Tang et al., 2006). Chronic 
cocaine exposure can increase αCaMKII expression levels in the NAcc, which 
in turn may be essential for the motivation to self administer cocaine (Wang et 
al., 2010).  αCaMKII influences synaptic plasticity and learning and memory 
processes by interfering with LTP (described in detail in Thesis Chapter 1, 
section 4.4.1). αCaMKII plays an important role at glutamatergic post-
synapses (Fukunaga et al., 1993; Colbran and Brown, 2004; Lengyel et al., 
2004; Uys and LaLumiere, 2008) by affecting the trafficking of AMPA 
glutamate receptors to the synapse (Boehm and Malinow, 2005). Activation of 
AMPA receptors in the NAcc has been shown to reinstate cocaine seeking 
(Kalivas et al., 2005; Schmidt et al., 2005), and conversely, AMPA receptor 
antagonists have been shown to attenuate cocaine reinstatement (Cornish et 
al., 1999; Park et al., 2002; Suto et al., 2004). Evidence suggests that CaMKII 
may contribute to the reinstatement of cocaine seeking behaviours. Cocaine is 
also known to exert its effects by influencing monoaminergic functioning (Ritz 
et al., 1990) by blockade of the relative transporters, and thereby the re-
uptake of monoamines into the pre-synaptic cell (Uhl et al., 2002; Hall et al., 
2004; Jones et al., 2009). This causes the synaptic cleft to become flooded 
with transmitter molecules (Di Chiara and Imperato, 1988; Carboni et al., 
1989), resulting in the over stimulation of receptors (Nestler, 2005). This over-
stimulation can induce a LTP-like state at the cellular level (Saal et al., 2003; 
Thomas and Malenka, 2003; Kauer, 2004). Enhancement of synaptic 
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transmission and lasting potentiation of cell signalling is the major mechanism 
underlying normal learning and memory formation and is also important for 
drug memories (Ungless et al., 2001). Disruption of the LTP mechanism, and 
consequently of learning and memory, may therefore have the potential to 
affect the establishment of drug addiction. 
αCaMKII has been identified as a link between the molecular pathways 
of addiction (Li et al., 2008), a theory which is supported by the important 
contributions of the glutamatergic and dopaminergic systems in the 
development of cocaine-related behaviours (Anderson et al., 2008). Anderson 
and colleagues (2008) report that cocaine reinstatement (following cocaine 
self-administration and extinction phases) is successively associated with the 
enhancement of; DRD1-like (DRD1 and DRD5) receptor activation, L-type 
voltage-gated Ca2+ channel stimulation, Ca2+ influx through L-type channels, 
subsequent CaMKII activation, phosphorylation of CaMKII at Thr286, 
glutamate receptor 1 (GluR1) subunit containing AMPA receptors on Ser831 
(a CaMKII phosphorylation site), and cell surface expression of GluR1 
containing AMPA receptors. In concordance with these findings, impairment of 
GluR1 trafficking to the cell surface was found to attenuate cocaine-induced 
reinstatement behaviour. There is strong evidence for a link between the 
dopaminergic and glutamatergic transmitter systems, more specifically 
between cocaine-induced DRD1 activation, downstream CaMKII activation 
and AMPA trafficking (Anderson et al., 2008). Interestingly, the 
phosphorylation site on CaMKII (Thr286) mentioned in the Anderson (2008) 
study is also the site of the targeted mutation in the mice used in the present 
study. 
Psychostimulants typically increase extracellular DA in the NAcc and 
striatum (Kalivas and Stewart, 1991; Robinson and Berridge, 1993; Pierce 
and Kalivas, 1997b). L- or N-type Ca2+ channel antagonism or inhibition of 
CaMKII blocks amphetamine-induced DA release into the NAcc (Pierce and 
Kalivas, 1997a). L-type Ca2+ channel antagonism also blocked cocaine-
induced increases in extracellular DA in the neostriatum of cocaine sensitised 
rats (Pani et al., 1990). A growing body of research indicates that Ca2+ and 
Ca2+ mediated second messenger systems influence behavioural sensitisation 
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to psychostimulants via the elimination of this DA increase (Pierce et al., 
1998). Specifically, CaMKII inhibition impairs the behavioural expression of 
sensitization to cocaine (Pierce et al., 1998). 
 
There is an increasing amount of literature implicating αCaMKII in the 
development of addiction. Continuing on from the investigation into the role of 
αCaMKII in the establishment of alcoholism-related behaviors (Thesis Chapter 
3), the effect of αCaMKII on preference and response to a drug from a 
different class, cocaine, was undertaken. The main hypothesis proposes that 
since αCaMKII autophosphorylation deficiency has previously been shown to 
modify alcohol addiction behaviours (Thesis Chapter 3), this deficit will also 
alter the speed at which cocaine preference is established. In order to further 
evaluate the development of addictive behaviours, the establishment of 
cocaine-induced conditioned place preference was assessed. Since cocaine 
exerts its effects by influencing monoaminergic functioning (Ritz et al., 1990), 
the acute positive reinforcing effects of cocaine was also monitored using in 
vivo microdialysis performed in brain regions associated with drug reward. 
Regions to be dialysed (NAcc and PFC) were selected based on the degree 
of overlap between the regions in which DA and other monoamines are 
released in response to cocaine administration, and regions in which αCaMKII 
is abundantly expressed. This selection was based on the previously 
mentioned criteria, and that the PFC receives input from projections of the 
NAcc. 
Changes in monoaminergic functioning may modulate the incentive 
properties, emotional effects and potential arousal regulating effects of 
cocaine.  The current study aims to establish whether the motivational effects 









2. Materials and Methods: 
All housing and experimental procedures were performed in accordance with 




Male and female αCaMKIIT286A mice (Giese et al., 1998) were studied in sex 
balanced designs in all experiments (for details of the genetic background: 
see Chapter 2, Materials and Methods; section 2.1). This mutation blocks the 
autophosphorylation of CaMKII but does not affect the Ca2+-dependent activity 
(Giese et al., 1998). Animals were individually housed in Tecniplast cages 
(32cm x 16cm x 14cm), using Litaspen sawdust and nesting materials, 
(Sizzlenest, Datsand, Manchester UK). Mice were provided with food and 
water ad libitum, and kept on a 12:12 hour light: dark cycle (lights on at 7.00 
am). Behavioral tests were performed during the light cycle between 09:00 
and 16:00 h. Room temperature was maintained between 19°C and 22°C at a 
humidity of 55% (±10%).  
 
 
2.2 Conditioned place preference (CPP) 
 
2.2.1 Apparatus 
For details see Chapter 3, Materials and Methods section 2.5.1.  
 
2.2.2 CPP Establishment 
Cocaine naïve animals (Mt: n=14; WT: n=14; Ht: n=16) were injected (i.p.) 
immediately before each trial with either saline, or cocaine solution at a dose 
of 20mg/kg. Mice were then instantly transferred to the testing suite and 
placed into the CPP boxes, signifying the beginning of the trial period (see 
Chapter 3, Materials and Methods section 2.5.2. Fig. 3.2A). The experiment 
involved four phases (Table 4.1); habituation trial (one session), conditioning 
trials (14 sessions), preference tests (5 sessions) and an incubation period (6 
days). Trials were performed once daily. Habituation (day 1): The intention of 
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the habituation session was to acclimatise mice to the test procedure and 
apparatus prior to commencing the experiment. Mice were injected with saline 
and introduced into the centre compartment with free access to all three 
compartments for 20 minutes. Pre-test (day 2): The pre-test was designed to 
establish a baseline level of preference for each individual animal. Mice were 
conditioned to either their preferred or non preferred compartment using a 
counterbalanced experimental design. Mice were injected with saline and 
introduced into the centre compartment with free access to all three 
compartments for 20 minutes. Conditioning trials (days 3-4, 6-9 and 11-18): 
Conditioning trials were performed in pairs, odd numbered pairings were 
conditioned with cocaine, and even numbered pairings were conditioned with 
saline, this was balanced across groups. All animals received 7 pairings with 
saline and 7 pairings with cocaine in total. Mice were injected with either 
saline or a cocaine solution (20mg/kg i.p.) and introduced into one of two 
compartments, with restricted access, for 20 minutes. Preference tests (days 
5, 10, 19 and 26): In order to monitor the time course of CPP establishment, 
preference tests were systematically dispersed between conditioning trials on 
days 5, 10, 19 and 26. Thus, preference tests were performed after 1 pair of 
conditioning trials (consisting of 1 cocaine pairing and 1 saline pairing), after 3 
pairings and again after 7 pairings (represented in the figures). Before each 
test, mice were injected with saline and introduced into the centre 
compartment with free access to all three compartments for 20 minutes. 
Incubation period (days 20-25): In order to test the consolidation of CPP, 
animals were left undisturbed in their home cages on days 20-25, and then re-











Table 4.1: The entire experimental protocol each mouse was exposed to during the 
conditioned place preference procedure 
Trial Duration Treatment 
Habituation 5 mins Saline 
Pre Test 20 mins Saline 
Conditioning x 2 20 mins Cocaine/Saline 
Preference Test 1 20 mins Saline 
Conditioning x 4 20 mins Cocaine/Saline 
Preference Test 2 20 mins Saline 
Conditioning x 8 20 mins Cocaine/Saline 
Preference Test 3 20 mins Saline 
Incubation 6 days None 




2.3 In-vivo Microdialysis  
In order to test whether the lack of αCaMKII autophosphorylation would lead 
to altered monoaminergic responses to cocaine treatment, in vivo 
microdialysis was performed and dopaminergic, serotonergic and 
noradrenergic levels measured. Cocaine influences monoaminergic 
functioning (Ritz et al., 1990) by blocking the relative transporters, and thereby 
the re-uptake of monoamines into the pre-synaptic cell (Uhl et al., 2002; Hall 
et al., 2004; Jones et al., 2009). Transmitter flooding of the synaptic cleft (Di 
Chiara and Imperato, 1988; Carboni et al., 1989), results in the over 
stimulation of receptors (Nestler, 2005) and can induce a LTP-like state at the 
cellular level (Saal et al., 2003; Thomas and Malenka, 2003; Kauer, 2004). It 
is this enhancement of synaptic transmission and lasting potentiation of 
cellular signalling which underlies normal learning and memory formation, and 
is also important for the formation of drug-related memories (Ungless et al., 
2001). Activation of AMPA receptors in the NAcc can reinstate cocaine 
seeking (Kalivas et al., 2005; Schmidt et al., 2005) whereas antagonism of 
these receptors can attenuate cocaine reinstatement (Cornish et al., 1999; 
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Park et al., 2002; Suto et al., 2004). Although assessment of glutamate levels 
in the present study was clearly warranted, it was not possible to measure 
glutamate alongside the other transmitters of interest as an HPLC set-up with 
UV detection would have been required. As such, an HPLC system was not 
available, priority was given to the measure of extracellular DA, 5-HT and NA. 
Due to the high technical demand of dialysis, a strongly focused design was 
used, according to Spanagel et al., (2005b) and Szumlinski et al., (2005). 
 
2.3.1 Surgery 
For details see Chapter 3, Materials and Methods section 2.7.1. 
 
2.3.2 Procedure  
For details see Chapter 3, Materials and Methods section 2.7.2.  
 
2.3.3 Acute cocaine effects 
Cocaine naïve animals were used for this test (Mt: n=8; WT: n=8; Ht: n=8). In-
vivo microdialysis was performed, during which animals received a single 
injection of cocaine (20mg/kg, i.p.). This provided an acute neurochemical 
response to cocaine treatment. Once microdialysis experiments were 
complete, animals were sacrificed by cervical dislocation. Brains were fixed in 
4% formaldehyde solution and stored at 4 °C. Brains  were sliced on a 
microtome and stained with cresyl violet for analysis of probe placement. 
Since all probes were surgically inserted accurately within the NAcc and PFC 
regions, all animals were considered for data analysis. For details see 
Chapter 3, Materials and Methods section 2.7.3. Fig. 3.4 & 3.5.  
 
2.3.4 HPLC-ED analysis 
All samples were analysed using HPLC-ED to measure DA, 5-HT and NA 
levels in response to cocaine administration. For details see Chapter 3, 






2.4 Statistical Analysis 
All graphical output data is expressed as a mean ± SEM. CPP: place 
preference data were initially log transformed for the analysis presented in 
Fig. 4.1 only. The logarithmic transformation is widely used to normalise 
skewed data (Sedgwick, 2012; Feng et al., 2013). This is a valuable method 
since it makes data more interpretable and helps to meet assumptions of 
statistical tests. The main advantage of this is that it permits the use of 
parametric tests as opposed to non-parametric ones (Sedgwick, 2012). A 
logarithmic transformation is typically used to stabilise the variance of a 
sample if it was not already present (Bland, 2000; Sedgwick, 2012), and was 
the reason for the data transformation. All data were analysed using one-way 
or two-way ANOVA followed by planned pairwise comparisons Fisher’s LSD 
tests or Bonferroni corrected t-tests. Microdialysis: Baseline neurochemical 
data were analysed using one way ANOVA and planned Fisher’s LSD tests. 
Cocaine induced neurochemical effects were expressed as a percentage of 
the mean of the three baseline samples which were taken as 100% in an 
attempt to standardise the data across groups. Data were compared using 
two-way ANOVA with factors genotype (3) and time (12). To compare cocaine 
effects of certain time points, planned pairwise comparisons were performed 
using Fisher’s LSD tests. One way repeated measures ANOVA and post hoc 
Fisher LSD tests were performed and used to determine differences between 
pairs of values within groups. Sex differences have been well established in 
clinical and rodent studies of cocaine-related behaviors (Festa and Quinones-
Jenab, 2004) but we did not see significant sex differences in this study. 
Therefore, data were collapsed for analysis. The software SPSS 17.0 and 
Statistica 9 were used. A significance level of p <0.05 was used to test for 
statistical significance.  
 
As discussed in Chapter 2, Section 2.3. Statistical Analysis, the present study 
retrospectively used the ‘Resource Equation’ (Mead, 1988) method to quantify 
the probability that experiments detected biologically important effects. Mead’s 




E = (total number of experimental units) – (number of treatment combinations) 
 
E was calculated for all experiments in the present study. CPP, E = 28; MD, E 
= 18; According to Mead’s rule, E should be between 10 and 20. If E is less 
than 10, increasing numbers would lead to good returns. If E is over 20, 
resources may be wasted. As reasoned in Chapter 3, Section 2.9. Statistical 
Analysis, there are circumstances where it is justifiable for E to be greater 
than 20. Such as, when experiments are complex and involve several factors 





























3.1. Establishment of cocaine place preference is delayed in αCaMKII 
deficient mice 
The place preference data presented in Fig. 4.1 were log transformed to 
stabilise the variance in the sample (Bland, 2000; Sedgwick, 2012). Two-way 
ANOVA for CPP establishment (test trials 1-3) revealed a significant effect of 
the genotype (F2,41=3.64, p=0.035) and test trial (F2,82=3.26, p=0.043), but no 
significant interaction (p>0.05; Fig. 4.1). After a single cocaine pairing, Mt 
mice showed a reduced preference for the cocaine-paired compartment 
compared to WT (t=2.19, p=0.002) animals. After three cocaine pairings, 
preference increases in all groups and WT preference is significantly 
increased compare to Mt (t=2.29, p=0.0002) but not Ht animals (p>0.05). After 
seven cocaine pairings preference slightly diminishes in all genotype groups, 
but WT mice still exhibit a significantly higher CPP than Mt (t=2.08, p<0.0001) 
and Ht (t=2.13, p<0.0001) mice. After a seven day period with no cocaine 
treatment or conditioning, Mt mice showed the same level of preference as Ht 













Figure 4.1: Conditioned place preference (CPP) is impaired in αCaMKII 
autophosphorylation deficient mice. Preference vs. baseline (sec.) in the conditioning 
(cocaine paired) compartment during a 20 minute test trial. Planned pairwise 
comparisons, T-test, $$p<0.01, $$$p<0.001 vs. WT. 
 
 
3.2. Conditioned cocaine-induced hyperactivity is not altered by 
genotype 
Two-way ANOVA revealed a significant time effect (F4,152=10.60, p<0.0001) of 
cocaine-induced hyperactivity in the cocaine-paired compartment. There was 
a significant conditioned hyperlocomotion effect seen in all genotype groups in 
the cocaine compartment (Fig 4.2A; BL vs. trial 1: t= -2.45, p=0.019; BL vs. 
trial 3: t= -5.55, p<0.0001; BL vs. trial 7: t= -3.72, p=0.001; BL vs. INC: t= -
3.68, p=0.001) but not in the saline compartment (Fig 4.2B; All, p>0.05) 
compared to baseline. This suggests that the αCaMKII autophosphorylation 
mechanism does not influence conditional hyperactivity, a type of behaviour 
associated with cocaine administration.                         








Figure 4.2: αCaMKII autophosphorylation does not affect conditioned hyperactivity to 
cocaine. Distance moved (units) in the conditioning (cocaine paired) compartment (A) 
and the pseudo-conditioning (saline paired) compartment (B) during a 20 minute test 
trial. t-test for test trial vs. baseline (BL) *p<0.05, **p<0.01, ***p<0.001. 
 
 
3.3. Sensitisation effects of cocaine are not altered by genotype 
The acute locomotor responses to cocaine (Fig 4.3A) and saline (Fig 4.3B) 
were identical in all groups (p>0.05) and do not appear to be affected by the 
absence of αCaMKII autophosphorylation. Two-way ANOVA revealed a 
significant time effect (F1,42=28.25, p<0.0001), but no genotype effect or 
interaction (p>0.05). Planned pairwise comparisons confirmed a significant 
increase in activity after seven cocaine pairings compared to activity levels 
after only one pairing (Fig 4.3A; WT: t= -2.92, p=0.011; Ht: t= -3.47, p=0.003; 
Mt: t= -2.85, p=0.014). This effect was not seen in the saline-paired 
compartment (Fig 4.3B; p>0.05). Data show that cocaine produces 
considerable behavioural stimulating effects in all genotypes which sensitises 









Figure 4.3: αCaMKII autophosphorylation is not required for the conditioned 
behavioural sensitisation effects of cocaine. Distance moved (units) in the 
conditioning (cocaine paired) compartment (A) and the pseudo-conditioning (saline 
paired) compartment (B) during a 20 minute test trial after one and seven pairings. t-
test for trial 7 vs. trial 1 £p<0.05, ££p<0.01. 
 
 
3.4. Basal transmitter levels may explain blunted monoamine 
responses to cocaine administration  
DA levels in the NAcc were comparable between WT and Mt mice, but 
significantly elevated in Ht mice (F2,55= 16.25, p<0.001; LSD: vs. WT, 
p<0.001; vs. Mt, p<0.001; Fig. 4.4A). DA levels in the PFC (Fig. 4.4B) were 
significantly greater in Ht and Mt mice compared to WT levels (F2,60= 4.13, 
p=0.02; LSD: vs. Ht, p=0.03; vs. Mt, p=0.01). Baseline 5-HT levels were 
elevated in the NAcc (Fig. 4.4C) of Ht and Mt mice compared to WT (F2,59= 
5.43, p=0.007; LSD vs. Ht, p=0.006; vs. Mt, p=0.004). Levels of 5-HT in the 
PFC (Fig. 4.4D) were greater in the Mt compared to both WT and Ht mice 
(F2,64= 10.45, p<0.001; LSD: vs. WT, p=0.003; vs. Ht, p=<0.001). NA levels in 
the NAcc (Fig. 4.4E) were comparable between Mt and WT mice, although 
levels of NA in Ht mice were elevated compared to other groups (F2,58= 4.25, 
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p=0.02; LSD: vs. WT, p=0.006 ; vs. Mt, p=0.05). Basal NA levels in the PFC 
(Fig 4.4F) were significantly lower in Mt mice (F2,61= 5.31, p=0.007; LSD: vs. 





Figure 4.4: Baseline monoamine levels. Bars represent Neurotransmitter levels in 
the NAcc prior to cocaine treatment for DA (A); 5-HT (C); and NA (E). Baseline 
Neurotransmitter levels in the PFC prior to cocaine treatment for DA (B); 5-HT (D); 
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and NA (F). Fisher LSD; $p<0.05, $$p<0.01, $$$p<0.001  vs. WT; #p<0.05, ##p<0.01, 
###p<0.001  vs. Ht. 
 
 
3.5. Cocaine alters extracellular cocaine-induced DA levels in the 
NAcc of αCaMKII autophosphorylation deficient mice 
Two-way ANOVA revealed significant effects of time and genotype (time: 
F11,165= 2.04, p=0.03; genotype: F2,15= 6.41, p=0.01) and a significant 
interaction (time x genotype: F22,165= 2.12, p=0.004; Fig. 4.5). Post hoc LSD 
analysis reveals a difference between Mt and Ht mice (LSD: Ht vs. Mt, 40mins 
p=0.013, 80mins p=0.010, 100mins p=0.011, 120mins p=0.003, 140mins 
p=0.032 after alcohol injection; Fig. 4.5). Data suggest that after cocaine 
administration, WT mice showed a tendency towards an increased DA 
response in the NAcc, which lasted for 40 minutes. The DA response in the Mt 
group did not show the same activation pattern and slowly climbed during the 





Figure 4.5: Speed of initiation of dopamine (DA) peak response in the nucleus 
accumbens (NAcc) may account for the difference in the development of cocaine-
induced conditioned place preference (CPP) between αCaMKII autophosphorylation 
deficient and WT mice. Extracellular DA levels above baseline in the NAcc after 
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cocaine treatment. Each point represents a 20 minute time window. Arrow indicates 
time of cocaine treatment. Planned pairwise comparisons using Fisher’s LSD test 




p<0.01 Mt vs. Ht. 
 
 
3.6. DA levels following an acute injection of cocaine in the PFC are 
significantly blunted in αCaMKII autophosphorylation deficient mice 
There was an increase in extracellular DA following cocaine treatment (two-
way ANOVA; time: F11,110= 8.61, p<0.001; Fig. 4.6) which peaked 40 minutes 
after cocaine injection in all groups.This increase in extracellular DA was 
diminished in the PFC in αCaMKII autophosphorylation deficient mice after a 
cocaine injection (Fig. 4.6). There was an effect of genotype (genotype: F2,10= 
4.42, p=0.04; LSD: WT vs. Ht, 60mins p=0.015 after alcohol injection) since 
the DA response was diminished in Mt and Ht mice compared to WT.  
 
     
 
Figure 4.6: Dopamine (DA) response in the prefrontal cortex (PFC) is diminished in 
αCaMKII autophosphorylation deficient mice compared to WT animals after cocaine 
administration, and may contribute towards the speed of establishment of cocaine-
induced CPP. Extracellular DA levels above baseline in the PFC after cocaine 
treatment. Each point represents a 20 minute time window. Arrow indicates cocaine 
treatment. Planned pairwise comparisons using Fisher’s LSD test between groups at 
each time point, &p<0.05 WT vs. Ht. 
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3.7. 5-HT response to cocaine administration is not altered in 
αCaMKIIT286A mice 
5-HT levels were increased in response to cocaine in the NAcc (two-way 
ANOVA; time: F11,176= 1.99, p = 0.032; LSD, 20mins p=0.05 after alcohol 
injection WT vs. Ht; Fig. 4.7A). Although, there was no effect of genotype 
(genotype: F2,16= 1.49, p = 0.25). In the PFC there were no significant effects 
revealed by two-way ANOVA, although exploratory post hoc analysis 
indicated a genotype difference 60mins post alcohol injection (LSD: p=0.012 






Figure 4.7: Serotonin (5-HT) response in the nucleus accumbens (NAcc) and 
prefrontal cortex (PFC) is absent in αCaMKII autophosphorylation deficient mice after 
cocaine administration, and may contribute towards the delayed establishment of 
cocaine-induced conditioned place preference (CPP). Extracellular 5-HT levels 
above baseline in the NAcc (A) and PFC (B) after cocaine treatment. Each point 
represents a 20 minute time window. Arrow indicates time of cocaine treatment. 
Planned pairwise comparisons using Fisher’s LSD test between groups at each time 




3.8. αCaMKII autophosphorylation is not required for cocaine-induced 
NA increases in the NAcc and PFC 
NA levels in the NAcc increased in all genotype groups after cocaine 
treatment (time: F11,176= 14.5, p<0.001; Fig. 4.8A). This response was also 
seen in the PFC (time: F11,187= 10.62, p<0.001; LSD; 20mins after alcohol 











Figure 4.8: Noradrenaline (NA) response in the nucleus accumbens (NAcc) and 
prefrontal cortex (PFC) is comparable between genotype groups after cocaine 
administration, and may account for the observed behavioural stimulating effects of 
cocaine. Extracellular NA levels in the NAcc (A) and PFC (B) after cocaine treatment. 
Each point represents a 20 minute time window. Arrow indicates cocaine treatment. 
Planned pairwise comparisons using Fisher’s LSD test between groups at each time 






The activation of CaMKII has been shown to contribute to the development of 
addictive states (Noda and Nabeshima, 2004; Tang et al., 2006). Increased 
αCaMKII expression levels in the NAcc has been reported following chronic 
cocaine exposure and thought to be essential for cocaine self-administration 
behaviour (Wang et al., 2010). Given the evidence for a connection between 
αCaMKII autophosphorylation and alcohol-related behaviours (Chapter 3), the 
specific role of αCaMKII autophosphorylation in the development of cocaine 
preference was investigated in the present study. αCaMKII 
autophosphorylation deficiency causes learning impairments (Irvine et al., 
2005), but does not alter the capacity to learn, long term memory storage or 
memory retrieval (Irvine et al., 2006). This suggests that autophosphorylation 
may affect the speed of normal learning (Lengyel et al., 2004; Lee et al., 
2009). Therefore, the hypothesis tested was that the behavioural and 
motivational properties associated with cocaine use would initially be 
attenuated in Mt mice, and the effect should normalise to WT levels after 
repeated treatments. Furthermore, the initial delay should coincide with 
changes in the monoaminergic system. 
 
Data suggest that αCaMKII autophosphorylation deficient (Mt) mice were 
initially impaired in their ability to develop cocaine-induced CPP compared to 
Ht and WT mice. Cocaine can induce a robust CPP (Seale and Carney, 1991; 
Cunningham et al., 1999), and the typical CPP acquisition pattern was 
established in WT mice in the present study. Mt mice developed CPP after 
repeated cocaine treatments and an incubation period of 6 days, during which 
CPP was consolidated. Cocaine’s effects may not be experienced similarly by 
all genotypes and may have caused the altered development of CPP in 
αCaMKII Mt mice. Conditioned hyperactivity, as measured in the CPP test 
design, was not affected by genotype. The acute locomotor and conditioned 
behavioural sensitisation effects of cocaine were also comparable across 
genotype groups. Data indicate that the establishment of these behaviours 
may not require the specific involvement of the αCaMKII autophosphorylation 
mechanism. There were no cocaine-induced behavioural differences 
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contributing to the establishment of CPP in αCaMKII mice. Therefore, 
microdialysis experiments focused on whether alterations in the reward 
system could be responsible for the establishment of cocaine preference. 
Resting monoamine levels and changes in these transmitters in response to a 
cocaine injection were measured in the mesolimbic system since the 
rewarding and motivational properties of cocaine may be experienced 
differently by αCaMKII genotype groups and may contribute to the 
development of cocaine preference.  
 
Cocaine induced DA increases in the NAcc of WT and Mt, but not Ht mice. 
Data showed a statistically significant difference between Mt and Ht groups 
only. WT mice showed a tendency towards an increased DA response in the 
NAcc immediately after cocaine injection. The same activation pattern was not 
seen in Mt mice in which DA response increased slowly over the three hours 
following cocaine administration. 
It is widely believed that the faster the delivery of a drug with addictive 
potential into the reward system of the brain, the greater the susceptibility to 
addiction (Gossop et al., 1992; Hatsukami and Fischman, 1996; Winger et al., 
2004). It has been suggested that rapid administration of drugs increases the 
addictive potential because they produce greater euphoric effects (de Wit et 
al., 1993; Hatsukami and Fischman, 1996). Drugs are capable of reorganising 
brain regions implicated in reward and motivation (Samaha and Robinson, 
2005). Repeated drug exposure can therefore cause drugs and drug-cues to 
become increasingly able to control successive behaviours (Robinson and 
Berridge, 1993; Robinson and Berridge, 2003). Samaha and Robinson (2005) 
conclude that neuroadaptive processes are clearly initiated and altered by 
drugs of abuse, and are sensitive to the rate of drug administration. The 
authors suggest that rate of administration will therefore facilitate 
neurobehavioural plasticity, which in turn contributes to excessive drug use. 
The tendency for immediate cocaine-induced increase in extracellular DA in 
the NAcc of WT mice in the present study may contribute towards the 
enhanced development of CPP. The slower initiation of this response in Mt 
mice could therefore account for the delay in cocaine-induced CPP. Results in 
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the present study are based on genotype comparisons rather than within 
group comparisons to baseline DA levels. Saline injected groups are also 
missing from this study and as a result the identification of cocaine specific 
response cannot be fully determined. Data should therefore be interpreted 
with caution . 
The DA response in the PFC was blunted in Mt compared to WT mice 
although this difference was not statistically significant. Activation of the VTA 
DA system, particularly within the shell sub-region of the NAcc, plays a key 
role in brain reward mechanisms and mediates the behaviour measured in the 
CPP task (McBride et al., 1999). The VTA projects into several important 
regions implicated in the motivationally rewarding properties of drugs of abuse 
including the NAcc (Van Bockstaele and Pickel, 1995; Olson et al., 2005) and 
the PFC (Carr and Sesack, 2000). While DA is important for the establishment 
of CPP, it is not sufficient to produce preference, as demonstrated using DAT 
KO mice which retain cocaine-induced CPP (Sora et al., 1998). DA 
impairment in the PFC may therefore contribute towards, but cannot solely 
account for, the impaired development of cocaine-induced CPP. 
 
5-HT is a major contributor in the establishment of cocaine preference and 
based on research using 5-HT transporter (SERT) KO mice, 5-HT also has 
been shown to contribute to the development of CPP (Sora et al., 1998; Hall 
et al., 2002; Hall et al., 2009). Depletion of 5-HT levels in the medial PFC also 
significantly reduces cocaine-induced CPP (Pum et al., 2008a). Present data 
showed that cocaine did not induce any robust 5-HT increases in the 
mesolimbic system. WT mice did show a tendency towards cocaine-induced 
5-HT increases in both the NAcc and PFC of WT mice, but this effect was not 
seen in Ht or Mt mice. 
Cocaine induces dose-dependent increases in 5-HT levels in the PFC 
(Pum et al., 2007) and the NAcc (Müller et al., 2002). A reduction of 90% in 5-
HT in the PFC significantly reduces cocaine-induced CPP and also attenuates 
cocaine-induced hyperlocomotion (Pum et al., 2008a). In the present study, 
WT mice developed CPP at a typical rate and also showed a mild trend for 
cocaine-induced increases in 5-HT levels in the NAcc and PFC. Absence of a 
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cocaine-induced 5-HT response in Mt mice may have contributed towards the 
observed CPP deficit. The response of Ht mice to cocaine administration was 
rather ambiguous since the mice developed CPP at the same rate as WT 
mice, but had no cocaine-induced 5-HT response in either brain region. 
CaMKII activation has been reported to play a key role in the development 
and maintenance of an addictive state (Li et al., 2008). αCaMKII is robustly 
induced by chronic cocaine use and is required for the maintenance of 
motivation for cocaine (Wang et al., 2010), highlighting αCaMKII as a key 
molecule in the regulation of cocaine reward. Taking WT and Ht data together, 
one may theorize that αCaMKII autophosphorylation contributes to, but is not 
exclusively responsible for, the serotonergic mediation of cocaine preference.  
 
Previous work by Sora and colleagues (1998) using transporter KO mice 
shows that neither dopamine transport (DAT) nor SERT deletion alone can 
prevent cocaine CPP (Sora et al., 1998), but that concurrent deletion of both 
DAT and SERT can stop the development of CPP to cocaine. Past and 
present data suggest that CaMKII may play a part in the cocaine-induced 
dopaminergic alterations of the NAcc. This theory is supported by Anderson 
and colleagues (2008). Increased phosphorylation at the T286 site of CaMKII 
has been associated with reinstatement of cocaine seeking (Anderson et al., 
2008). The T286 site is the same site which has been manipulated in the 
present study and the mechanism by which phosphorylation is disrupted in Mt 
mice. This may contribute towards the delay in the establishment of cocaine 
preference. 
 
Stimulants have been shown to increase extracellular NA levels (Bardo, 1998; 
White and Kalivas, 1998). Present data showed no difference in the NA 
response in the NAcc or the PFC in response to cocaine administration in 
αCaMKII mice, suggesting that there was probably no role for αCaMKII 
autophosphorylation in the development of cocaine preference.  
Cocaine is a stimulant which enhances CNS activity, and is known for 
its behavioural activating effects (Gass and Olive, 2008; Thomas et al., 2008; 
Uys and LaLumiere, 2008). Injection of the CaMKII inhibitor KN-93 into the 
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VTA prior to daily cocaine treatment can impair the development of 
behavioural sensitisation. The development of sensitisation is attenuated in 
CaMKII KO mice (Licata et al., 2004). In addition, behavioural hyperactivity is 
enhanced in αCaMKII KO mice after cocaine (Licata et al., 2004). In the 
present study, the CPP test design identified a significant conditioned 
hyperlocomotion in all genotype groups. This suggests that αCaMKII 
autophosphorylation is not specifically required for this type of cocaine-
associated behaviour. Behavioural sensitisation is defined as the increased 
responsiveness to drugs which develops as a result of their repeated 
administration (Boudreau et al., 2009). In the case of stimulant drugs, 
sensitisation to both the locomotor activating effects and incentive-
motivational effects can occur (Robinson and Berridge, 2008). The present 
study revealed similar behaviourally activating effects after an acute cocaine 
challenge, providing indirect evidence that there are no significant differences 
in the bioavailability of cocaine between genotype groups. As this behaviour 
sensitises in all genotype groups, αCaMKII autophosphorylation deficiency 
does not appear to be important for this behaviour.  
NA transmission in the NAcc, VTA and PFC has been reported to be 
important for psycho-stimulant induced hyperactivity and sensitisation (Nicola 
and Malenka, 1998; Vanderschuren et al., 1999; Shi et al., 2000). NA is a key 
transmitter in stimulant-induced arousal (Huether, 1996; Sved et al., 2001) 
and the observed lack of genotype effect on the acute behavioural activating 
effects of cocaine may be accounted for by the comparable NA response, as 
measured by in vivo microdialysis. Since there was no difference observed in 
the behavioural activating effects of cocaine in the present experiment, it 
seems unlikely that there would be an adaptation in the noradrenergic system 
either. Data from the current study showed that NA levels in the NAcc and 
PFC, conditioned hyperactivity, acute locomotor and sensitisation effects were 
all stable across groups and over time. Therefore NA appears to be less 
important for the rewarding and motivational effects of cocaine, but seems to 
contribute more towards the arousal component and locomotor activating 




Baseline transmitter levels were measured prior to acute cocaine 
administration and may provide an explanation for some of the microdialysis 
results. Basal DA levels in the NAcc of Ht mice were approximately twice as 
great as either WT or MT levels, and may represent a ceiling effect. 
Therefore, further enhancement of cocaine-induced DA response may not 
have been possible in Ht mice and this may help explain the absence of a DA 
response in the NAcc of Ht mice. Similarly, baseline DA levels were lower in 
WT compared to Ht and Mt mice in the PFC. The DA response to an injection 
of cocaine in the Ht and Mt mice were similarly blunted compared to WT mice. 
WT baseline DA levels were lower which suggests that there may have been 
a greater capacity for enhanced dopaminergic activity in WT’s compared to 
either Ht or Mt mice. Basal Mt 5-HT levels were approximately twice that of 
WT mice, and perhaps prevented the further enhancement of activation in 
both the NAcc and PFC. The same was true of Ht mice in the NAcc, but not 
the PFC where baseline 5-HT levels were significantly lower than those 
measured in Mt mice. Baseline 5-HT levels in the PFC cannot offer an 
explanation as to why Ht mice did not respond to an acute cocaine injection. 
There was no difference in cocaine-induced NA response in the NAcc and 
PFC between genotype groups. Baseline NA levels however were not 
comparable across groups. Together, resting DA, 5-HT and NA levels prior to 
cocaine treatment may reflect a complex role for αCaMKII 
autophosphorylation in the resting state of the reward system, influencing 
response to cocaine administration. CaMKII can phosphorylate a number of 
intracellular targets including AMPA receptors (Poncer et al., 2002), NMDA 
receptors (Bayer et al., 2001), L-type Ca2+ channels (Dzhura et al., 2000) and 
tyrosine hydroxylase (Griffith and Schulman, 1988). Tyrosine hydroxylase 
(TH) is the rate limiting enzyme in DA synthesis, which in turn is a precursor 
for NA. TH, CaM and CaMKII are co-distributed in the NAcc, and it has been 
suggested that TH activity and DA synthesis is regulated by 
Ca2+/CaM/CaMKII in the NAcc and other areas (Sutoo et al., 2002). TPH is 
the initial and rate-limiting enzyme in the biosynthesis of 5-HT and exists in 
two isoforms, TPH1 and TPH2 (Kuhn et al., 2007). TPH2 is specifically 
expressed in the CNS and is activated by CaMKII (Hamon et al., 1977; 1978; 
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Kuhn et al., 1980; Yamauchi and Fujisawa, 1981). Alterations in the activity of 
CaMKII, and consequently activity of TRP2, could ultimately influence the 
function of serotonergic nerve endings by increasing or decreasing the 
amount of transmitter available for release into the extracellular space. 
Evidence implicates CaMKII in the regulation of DA, 5-HT and NA synthesis in 
the CNS, suggesting that CaMKII may act as a mediator for basal and 
cocaine-induced activity for all three transmitters.  
 
Both male and female mice were used in all experiments of the present study, 
and balanced across groups. Both clinical and rodent studies report sex 
differences in the behavioural response to cocaine (Festa and Quinones-
Jenab, 2004), however the present study did not detect any sex effects. Data 
were therefore collapsed for the final analysis, although a subtle sex specific 
role for αCaMKII in the development of cocaine related behaviours cannot be 
ruled out and is a limitation in the current study. The absence of saline 
injected groups is a major drawback in the present thesis. Inclusion of saline 
groups may have helped to identify injection stress-induced increases in 
behavioural and neurochemical levels, especially since threatening situations 
and stimuli have been identified as a potential confound (Chapter 2 and 
Easton et al., 2011). Thus, injection stress cannot be ruled out as a 
contributing factor and it is not possible to distinguish between responses 
caused solely by cocaine from those responses caused by the injection 
procedure (Discussed in full in Chapter 6, 4. Strengths and Limitations). 
The glutamatergic system is an important mediator of cocaine reward, 
increasing synaptic expression of AMPA receptors and thus enhancing 
neuronal excitability and plasticity. Cocaine increases extracellular glutamate 
levels (Smith et al., 1995) and is associated with increased sensitivity of 
dopaminergic neurons to glutamatergic stimulation (White et al., 1995; Zhang 
et al., 1997) and glutamate subunit expression in the NAcc and VTA (Churchill 
et al., 1999). Although glutamate was not measured in the present study, 
alterations in the glutamatergic system may be important and could account 
for behaviours in the establishment of cocaine preference which cannot be 
explained by the current data. Further experiments should investigate whether 
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disruption of αCaMKII autophosphorylation influences the glutamatergic 
system. 
 
The current study illustrates a complex role of the αCaMKII 
autophosphorylation mechanism in the development of cocaine preference. 
αCaMKII autophosphorylation may contribute towards the establishment of 
cocaine-induced CPP via the monoaminergic system. Present data indicated 
a difference in the time-course of DA increase in the extracellular space of the 
NAcc following cocaine administration. This mechanism may facilitate the 
modulation of CPP. 5-HT is also required for the development of CPP, 
although the influence on this system via αCaMKII autophosphorylation in the 
NAcc and PFC is not clear. αCaMKII autophosphorylation did not seem to be 
required for the development of other cocaine-related behaviours associated 
with chronic cocaine administration such as conditioned hyperactivity and 
behavioural sensitisation effects. These effects remained stable over time, as 
did noradrenergic activity in the NAcc and PFC. There may be other 
transmitter systems involved in response to cocaine which were not assessed 
in the present study. Further experiments should investigate the effect of 
αCaMKII autophosphorylation deficiency on the glutamatergic system in 
response to cocaine administration. While CaMKII may be important in 
mediating the effects of cocaine, the specific involvement of αCaMKII 
autophosphorylation in the development of cocaine preference remains 
unclear. αCaMKII autophosphorylation cannot solely account for the 
development of cocaine preference, but may contribute to the fast 
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A novel candidate in the study of addiction was tested to provide further 
eveidence for the role of this gene in addiction. RasGRF2 belongs to the 
family of CaM associated guanine nucleotide exchange factors and acts as an 
‘on-off’ switch in cells. Ras-GRF2 is involved in the induction of LTD and LTP 
and Ras-GRF2 KO mice have impaired LTP induction. A recent genome wide 
analysis of 28,188 people found Ras-GRF2 to be associated with alcohol 
consumption. Ras-GRF2 KO mice were also found to consume significantly 
less alcohol and had reduced preference for alcohol compared to their WT 
counterparts. Data implicate Ras-GRF2 as a novel candidate in the regulation 
of alcohol-related behaviours. Using in vivo microdialysis, the current study 
presents evidence for a link between Ras-GRF2 and activity in the 
monoaminergic system in alcohol consumption. DA and 5-HT alcohol-induced 
increases were absent in the NAcc and CPu of Ras-GRF2 KO mice. Ras-
GRF2 deletion appears to result in the failure of elements of the 
monoaminergic system to adapt in the normal way in response to alcohol, and 
may to some extent explain why Ras-GRF2 KO mice consume less alcohol 
and have a reduced alcohol preference compared to WT controls. Data 
suggest that Ras-GRF2 deletion may make the animal less vulnerable to 
alcohol’s rewarding properties and it would be interesting to investigate 














RasGRF2 belongs to the family of CaM associated guanine nucleotide 
exchange factors and acts as an ‘on-off’ switch in cells. Ras-GRF2 becomes 
active in the presence of CaM, Ras-GRF2 in turn activates the RAS protein 
which is known to be involved in the MAPK/ERK signal transduction pathway 
(Agell et al., 2002) by allowing the exchange of GDP for GTP, thereby 
regulating signalling pathways in cells. Ras-GRF2 is known to play a crucial 
role in glutamatergic signal transduction and the Ras-MAPK signalling 
cascade. This is activated via NMDA receptors and is involved in the induction 
of LTD and LTP (Thomas and Huganir, 2004; Li et al., 2006). Ras-GRF2 KO 
mice are impaired in LTP induction and a recent study has shown that 
disruption of this pathway alters ethanol drinking behaviour in mice (Stacey et 
al., 2012).  
 
RAS-MAPK/ERK pathway activation typically promotes cell division and is 
thought to contribute to approximately 30% of all human cancers (Bos, 1989). 
Crucially, Ras-GRF2 has not previously been associated with any drug of 
abuse, despite acting on pathways which are also implicated in addiction, 
such as the dopaminergic system. The RAS-MAPK/ERK pathway has been 
linked to DRD1 (Tian et al., 2004; Girault et al., 2007), and has also been 
isolated as a binding partner of DAT (Maiya et al., 2007). These studies 
suggest a role for Ras-GRF2 at the synapse in the regulation of extracellular 
transmitter levels and in neurotransmitter release (Bloch-Shilderman et al., 
2001). Drugs of abuse ‘hijack’ the natural reward system in the brain (Nestler, 
2002b; Kelley, 2004; Hyman, 2005) resulting in the modification of  some 
major transmitter systems in brain regions including the NAcc and PFC 
(Pontieri et al., 1995), thereby mediating the rewarding potential of these 
drugs (Koob et al., 1998b; Wise, 1998; Swanson, 2000; Nestler, 2001; Everitt 
and Wolf, 2002). Taking this into account, a role for Ras-GRF2 in the 
development of addictive behaviours certainly warrants further investigation. 
 
Ras-GRF2 has recently been implicated as a novel candidate in the regulation 
of alcohol consumption (Stacey et al., 2012). A genome wide analysis of 
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28,188 people found polymorphisms of Ras-GRF2 to be significantly 
associated with alcohol consumption. Ras-GRF2 KO mice also consume 
significantly less alcohol and have a reduced alcohol preference compared to 
their WT counterparts and show no difference in taste sensitivity or blood 
alcohol elimination (Stacey et al., 2012). The aim of the current study was to 
examine the reason for diminished alcohol drinking behaviours seen in Ras-
GRF2 KO mice. The central hypothesis states that Ras-GRF2 KO mice do not 
experience the motivationally rewarding properties of alcohol to the same 
extent as WT mice, which causes reduced consumption and preference for 
alcohol. This may be accounted for by dysfunction of neurochemistry in the 
reward system. This was assessed using in vivo microdialysis measuring 
alcohol-induced changes in DA, 5-HT and NA levels in the NAcc and CPu, 
concurrent with locomotor activation. NAcc and CPu were selected for dialysis 
based on the degree of overlap between the regions in which DA and other 
monoamines are released in response to alcohol administration, and regions 




















2. Materials and Methods 
All housing and experimental procedures were performed in accordance with 




Male wild type (Ras +/+ WT) and null mutant (Ras -/- KO) Rasgrf2tm1Esn 
(Fernández-Medarde et al., 2002) mice were studied. Mice were generated 
using a gene targeting strategy (Fig 5.1). The method inactivates the Grf2 
locus by targeting its CDC25-H catalytic domain, thereby disrupting the 
guanine nucleotide exchange factor (GEF) activity of Ras-GRF2. A portion of 
the CDC25-H domain, a highly conserved region of the gene, was replaced 
with a PGK-neo cassette via homologous recombination. Absence of gene 
expression in homozygous mutant animals was confirmed by RT-PCR 
analysis of brain RNA and absence of protein product was demonstrated by 
Western blot of brain and lung extracts using an antibody directed against a 
region of the protein upstream of the disruption. (Fernández-Medarde et al., 
2002). 
Lambda genomic clones containing several exons of the CDC25-H 
domain of Grf2 were isolated from a 129 SVJ mouse genomic library 
(Stratagene). Electroporation of CJ7 embryonic stem (ES) cell line and 
selection of transfected clones was performed and targeted ES cell clones for 
the GRF2 gene were injected into C57BL/6 blastocysts. Chimeras were 
generated in which the mutated allele has been transmitted to the progeny. 
Mice were kept on a genetic background of 129/S-J and C57BL/6 and bred in 
a specific-pathogen-free facility.  
Animals were individually housed in Tecniplast cages (32cm x 16cm x 
14cm), using Litaspen sawdust and nesting materials, (Sizzlenest, Datsand, 
Manchester UK). Mice were provided with food and water ad libitum, and kept 
on a 12:12 hour light: dark cycle (lights on at 7.00 am). Experiments were 
performed during the light cycle between 09:00 and 16:00 h, in a 
pseudorandom order. Room temperature was maintained between 19°C and 







Figure 5.1: Schematic representation of the mouse GRF2 genomic locus and the 
targeting vector used for replacement of an exon inside the CDC25-H domain. The 
positions of boundaries of the individual exons coding for the C- terminal portion of 
Grf2, including the CDC25-H domain, are indicated by the vertical marks. In the 
schematics for the wild-type allele and the targeting vector, filled boxes represent the 
exons, whereas open boxes represent the selectable markers (pgk-neo and pkg-tk). 
Taken from Fernández-Medarde et al., 2002. 
 
 
2.2. Loss of righting reflex (LORR)   
Alcohol naïve animals were used for this test (KO: n=5; WT: n=5). For details 
see Chapter 3, Materials and Methods section 2.6. 
 
 
2.3. In vivo microdialysis 
Ras-GRF2 KO mice consume and prefer alcohol less than their WT 
counterparts (Stacey et al., 2012). The DA system is critical to experience the 
acute reinforcing effects of alcohol (Koob, 1992; McBride and Li, 1998; 
Nestler, 2005). Ras-GRF2 has also been linked to DRD1 (Tian et al., 2004; 
Girault et al., 2007) and isolated as a binding partner of DAT (Maiya et al., 
2007). An alcohol challenge produces a change in glutamate levels in the 
NAcc (Szumlinski et al., 2005) and may be associated with altered function of 
the reward circuitry. However, based on what is known about the reinforcing 
action of drugs of abuse and the potential involvement of Ras-GRF2, DA 
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response analysis was chosen over that of glutamate (Spanagel, 2009). In 
addition, the measurement of extracellular glutamate levels requires a 
different HPLC set-up with UV detection and cannot be measured alongside 
the other transmitters of interest. Not having access to an HPLC system with 
UV detection meant that priority was given to the measurement of 
extracellular DA, 5-HT and NA. The current study aims to examine whether 
dysfunction of neurochemistry in the reward system will alter the 
motivationally rewarding properties of alcohol which might cause Ras-GRF2 
KO mice to drink and prefer alcohol less.  
 
2.3.1. Surgery 
Two guide cannulas (Microbiotech/se AB, Stockholm, Sweden) were aimed at 
the CPu (A: +0.5; L: ±2.3; V: -2.4 angle ±10º from midline) and the NAcc (A: 
+1.2; L: ±1.6; V: -4.3 angle ±10º from midline) using coordinates relative to 
bregma (Franklin and Paxinos, 1997). For details see Chapter 3, Materials 
and Methods section 2.7.1. 
 
2.3.2. Procedure 
On the day of the experiment, microdialysis probes of a concentric design 
(see Chapter 3, Fig. 3.3B), membrane lengths were 2mm for the CPu (MAB 
6.14.2.) and 1mm (MAB 6.14.1.) for the NAcc, were inserted into the guide 
cannulae under a short (3-5min) Isoflurane anaesthesia (O2 at 1L/min, 
Isoflurane at 3% to induce and 2% to sustain). For details see Chapter 3, 
Materials and Methods section 2.7.2.  
 
2.3.3. Acute alcohol effects 
Alcohol naïve male mice were used for this test (Ras -/-: n=8; Ras +/+: n=8). 
In-vivo microdialysis was carried out at least 5 days after surgery on day one 
of the experiment during which animals received an alcohol injection (2g/kg, 
i.p.). This provided an acute neurochemical and behavioural response to 
alcohol treatment. Once microdialysis experiments were complete, animals 
were sacrificed by cervical dislocation. Brains were fixed in 4% formaldehyde 
solution and stored at 4 °C. Brains were sliced on a microtome and stained 
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with cresyl violet for analysis of probe placement. Only animals with probe 
placement within the CPu and the NAcc were considered for data analysis. 
Since all probes were surgically inserted accurately within the CPu and the 
NAcc regions, all animals were considered for data analysis. 
 
2.3.4. HPLC-ED analysis 
All samples were analysed using HPLC-ED to measure DA, 5-HT and NA 
levels in response to alcohol administration. For details see Chapter 3, 
Materials and Methods section 2.7.4.  
 
2.3.5. Behavioural Analysis 
For details see Chapter 3, Materials and Methods section 2.7.5. 
 
 
2.4. Statistical Analysis 
All graphical output data is expressed as a mean ± SEM. Microdialysis: 
Baseline neurochemical and behavioural data were analysed using one way 
ANOVA. Alcohol induced neurochemical effects were expressed as a 
percentage of the mean of the three baseline samples which were taken as 
100% in an attempt to standardise the data across groups. Data were 
compared using two-way ANOVA with factors genotype (2) and time (13). To 
compare alcohol effects of certain time points, pre-planned comparisons were 
performed using Fisher’s LSD tests. One way repeated measures ANOVAs 
and post hoc Fisher LSD tests were performed and used to determine 
differences between pairs of values within groups. To compare alcohol effects 
of certain time points pre-planned t-test comparisons, independent by 
variable, were performed versus a 100% average baseline value. Probability 
values were subsequently Bonferroni corrected for multiple testing. LORR: 
Data were analysed using one-way ANOVA to compare alcohol effects 
between groups. The software SPSS 17.0 and Statistica 9 were used. A 




As discussed in Chapter 2, Section 2.3. Statistical Analysis, the present study 
retrospectively used the ‘Resource Equation’ (Mead, 1988) method to quantify 
the probability that experiments detected biologically important effects. Mead’s 
resource equation (not using blocking) states: 
 
E = (total number of experimental units) – (number of treatment combinations) 
 
E was calculated for all experiments in the present study. LORR, E = 8; MD, E 
= 14; According to Mead’s rule, E should be between 10 and 20. If E is less 
than 10, increasing numbers would lead to good returns. If E is over 20, 



























3.1. The hypnotic effects of alcohol are experienced similarly by Ras-
GRF2 KO and WT alcohol naïve mice. 
The sedating properties of alcohol were experienced in the same way by Ras-
GRF2 KO and WT alcohol naïve mice, as a result of an acute alcohol injection 
(p>0.05; Fig. 5.1A). Figure 5.1B illustrates the amount of time mice spent in 
an ataxic state following a high alcohol dose. This was not different between 
groups of alcohol naïve Ras-GRF2 KO and WT mice following alcohol 






Figure 5.1: The hypnotic effects of alcohol are experienced similarly by Ras-GRF2 
KO and WT alcohol naïve mice. Loss of righting reflex (LORR) time to sedation (A) 








3.2. Ras-GRF2 does not alter behavioural responses to alcohol treatment 
Basal locomotor activity was greater in alcohol naïve Ras-GRF2 KO mice 
compared to WT’s (F1,34 =7.33, p=0.01; Fig. 5.2A). Behaviour was monitored 
through-out microdialysis tests, during which an alcohol injection was 
administered. Two-way ANOVA revealed a significant effect of time (F12,108 
=2.53, p=0.006) but not of genotype (F1,9 = 3.00, p=0.12) or interaction (time x 
genotype: F12,108 = 0.88, p=0.56) on locomotor activity during microdialysis 







Figure 5.2: Ras-GRF2 does not alter behavioural responses to alcohol treatment. 
Baseline behavioural activity prior to alcohol administration (A). Locomotor activity 
recorded during microdialysis trial after alcohol treatment (B). Arrow indicates time of 
alcohol injection. ANOVA; $$p<0.01 vs. WT. 
 
 
3.3. Elevated basal DA and 5-HT levels of Ras-GRF2 KO compared to WT 
mice may hinder further alcohol–induced increases in the NAcc. 
Basal DA levels in the NAcc of alcohol naïve mice were higher in Ras-GRF2 
KO mice compared to WT’s (F1,40 =20.52, p<0.001; Fig. 5.3A). Baseline DA 
levels were comparable between groups in the CPu (F1,38 =0.06, p=0.80; Fig. 
5.3B). Resting 5-HT levels were again greater in the NAcc of Ras-GRF2 KO 
vs. WT mice (F1,37 =23.72, p<0.001; Fig. 5.3C). In contrast, 5-HT levels were 
lower in the CPu in KO mice (F1,38 =14.28, p<0.001; Fig 5.3D). Baseline NA 
levels were consistently greater in KO mice compared to WT’s in both the 
NAcc (F1,37 =18.65, p<0.001; Fig. 5.3E) and the CPu (F1,37 =30.88, p<0.001; 








Figure 5.3: Baseline monoamine levels. Bars represent neurotransmitter levels in 
the NAcc prior to alcohol treatment for DA (A); 5-HT (C); and NA (E). Baseline 
neurotransmitter levels in the CPu prior to alcohol treatment for DA (B); 5-HT (D); 
and NA (F). ANOVA; $$$p<0.001. 
 
 
3.4. DA response in the NAcc and CPu is absent in Ras-GRF2 KO mice 
compared to WT animals after alcohol administration 
Two-way ANOVA revealed significant effects of time and genotype (time: 
F12,84 =2.86, p=0.002; genotype: F1,7 =12.82, p=0.009) and a significant 
interaction (time x genotype: F12,84 =2.80, p=0.003) in the NAcc (Fig. 5.4A). 
WT DA levels were significantly elevated in response to alcohol treatment for 
40 minutes post administration (20 mins: p=0.03; 40 mins: p=0.006) compared 
to KO levels which remained at basal levels through-out the test.  
In the CPu two-way ANOVA showed significant effects of time and genotype 
(time: F12,84 =2.71, p=0.004; genotype: F1,7 =6.63, p=0.04) but not significant 
interaction ((time x genotype: F12,84 = 1.37, p=0.20; Fig 5.4B). WT showed a 
trend for increased DA levels in response to an alcohol injection and was 
significantly different from KO mice 120 minutes (p=0.04) and 140 minutes 
(p=0.04) after alcohol was administered (Fig. 5.4B). DA levels in the CPu of 











Figure 5.4: Dopamine (DA) response in the NAcc (A) and CPu (B) is absent in Ras-
GRF2 KO mice compared to WT animals after alcohol administration. Extracellular 
DA levels as percent baseline in the NAcc and CPu after alcohol treatment. Each 
point represents a 20 minute time window. Arrow indicates time of alcohol treatment. 
Planned pairwise comparisons using Fisher’s LSD tests between groups at each time 





3.5. There is no 5-HT response to alcohol administration in the NAcc and 
CPu of Ras-GRF2 KO compared to WT mice 
Two-way ANOVA of 5-HT levels in the NAcc revealed significant effects of 
time and genotype (time: F12,108 =2.02, p=0.03; genotype: F1,9 =17.41, 
p=0.002), but no significant interaction (time x genotype: F12,108 =1.571, 
p=0.11; Fig. 5.5A). Immediately after alcohol administration, WT 5-HT 
response in the NAcc increased compared to Ras-GRF2 KO mice (p=0.03). 
This trend remained for a further 60 minutes post-alcohol treatment before WT 
levels returned to baseline. A significant difference in 5-HT response was 
seen at 160 minutes after alcohol was administered (p=0.02). Ras-GRF2 KO 
5-HT levels remained at baseline for the entire test. 
5-HT levels in the CPu were also elevated in comparison to KO mice in 
response to an alcohol injection. Two-way ANOVA showed significant effects 
of genotype (F1,10 =11.81, p=0.006) but not of time (F12,120 =0.97, p=0.48), 
although the time x genotype interaction was significant (F12,120 =1.91, p=0.04; 
Fig 5.5B). WT 5-HT levels were significantly elevated compared to KO mice 
and increased immediately after alcohol administration. WT and KO genotype 
groups were significantly different at 20 minutes (p=0.02), 60 minutes (p=0.05) 
and 120 minutes (p=0.02) post alcohol injection. Just as seen in the NAcc, 5-
HT levels in the CPu of Ras-GRF2 KO mice remained at baseline for the 










Figure 5.5: There is no 5-HT response to alcohol administration in the NAcc (A) and 
CPu (B) of Ras-GRF2 KO mice compared to WT mice. Extracellular 5-HT levels as 
percent baseline in the NAcc and CP after alcohol treatment. Each point represents a 
20 minute time window. Arrow indicates time of alcohol treatment. Planned pairwise 





3.6. Rasgrf2 contributes to noradrenergic activation after acute alcohol 
treatment. 
NA levels in the NAcc increased in all genotype groups in a similar way after 
alcohol treatment. Two-way ANOVA revealed significant effects of time (time 
F12,120 =7.38, p<0.001; Fig. 5.6A) but not of genotype, or time x genotype 
interaction. Further exploratory within group analysis using planned pairwise 
comparisons and suggests that, compared to baseline, WT mice show a 
significantly increased level of NA at 100 minutes (p=0.03), 120 minutes 
(p=0.05) and at 200 minutes (p=0.05), after an acute injection of alcohol. KO 
mice show no significant differences in NA levels after the same alcohol 
treatment. 
NA response to alcohol in the CPu showed a similar profile to those 
seen in the NAcc. There was a significant effect of time (F12,120= 5.03, 
p<0.001; Fig 1E), but no genotype or genotype x time interaction. Within 
group analysis showed significantly increased NA levels in WT mice at 100 
minutes (p=0.01), 120 minutes (p<0.001), after acute alcohol administration. 









Figure 5.6: Rasgrf2 contributes to noradrenergic activation and behavioral activity 
after acute alcohol treatment. Extracellular NA levels as percent baseline in the NAcc 
(A) and CPu (B) after alcohol treatment. Each point represents a 20 minute time 
window. Arrow indicates time of alcohol treatment. Planned t-test pair-wise 








Ras-GRF2 is a CaM associated guanine nucleotide exchange factor and acts 
as an ‘on-off switch’ in cells, regulating cell signalling via the MAPK/ERK 
pathway. Activated through NMDA receptors, the Ras-MAPK signalling 
cascade is important for the induction of LTP (Thomas and Huganir, 2004; Li 
et al., 2006), the major cellular mechanism underlying normal learning and 
memory formation. Disruption of the learning and memory pathway via Ras-
GRF2 has recently been associated with alcohol consumption in a genome 
wide analysis of 28,188 people. In addition Ras-GRF2 KO mice consume 
significantly less alcohol and have a reduced alcohol preference compared to 
their WT counterparts (Stacey et al., 2012). This work implicates Ras-GRF2 
as a novel candidate in the regulation of alcohol consumption. The present 
study assessed how Ras-GRF2 disruption might contribute towards the 
previously reported diminished drinking behaviours in Ras-GRF2 KO mice. To 
expand upon previous data suggesting a role for Ras-GRF2 in the regulation 
of alcohol consumption and preference, in vivo microdialysis was used to 
evaluate the motivationally rewarding properties of alcohol by measuring DA, 
5-HT and NA levels in the NAcc and CPu, before and after an acute alcohol 
challenge. 
 
Given the diminished alcohol consumption behaviour seen in both a human 
population sample and Ras-GRF2 KO mice, it was important to measure the 
sedating/hypnotic effects of alcohol, as measured by the LORR procedure, to 
test whether alcohol was being experienced similarly by both KO and WT 
mice. This behaviour was not affected by Ras-GRF2 deletion and therefore 
cannot account for the reduced alcohol intake observed in these mice. In 
addition, locomotor activity was monitored before and after an acute alcohol 
challenge. Baseline activity levels, monitored prior to alcohol administration, 
were elevated in the Ras-GRF2 KO compared to WT mice, and could explain, 
in part, why there was no further enhancement of locomotor activity in KO 
mice, which remained at basal levels through-out the test. 
In order to experience the acute reinforcing effects of alcohol, certain 
neurotransmitter systems in the reward centres of the brain are recruited 
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(Koob et al., 1998a; McBride, 2010). In-vivo microdialysis was used to 
examine monoaminergic responses in the NAcc and CPu to assess which of 
these transmitters might contribute to the motivational and incentive properties 
of alcohol. Results revealed that alcohol induced increases in DA and 5-HT 
levels in both the NAcc and CPu in Ras-GRF2 WT mice may contribute 
towards the establishment of drinking behaviours previously reported in these 
mice. The monoaminergic system is consistently implicated in the modulation 
of alcohol’s effects on the reward system (Vengeliene et al., 2008; Spanagel, 
2009; Fahlke et al., 2011). DA levels in the NAcc in response to an alcohol 
challenge, is an indicator of the incentive properties of alcohol (Di Chiara and 
Imperato, 1988; Koob, 1992). Ras-GRF2 has not previously been associated 
with any drug of abuse, despite acting on pathways which are also implicated 
in addiction, such as the dopaminergic system. Ras-GRF2 has been isolated 
as a binding partner of DAT (Maiya et al., 2007), the primary mechanism for 
synaptic DA clearance in the striatum and is responsible for the re-uptake of 
DA into the pre-synapse. The RAS-MAPK/ERK pathway has also been 
associated with DA D1 receptors (Tian et al., 2004; Girault et al., 2007). 
These studies suggest an important role for Ras-GRF2 at the synapse in the 
regulation of reinforcement via dopaminergic signalling (Maiya et al., 2007). 
Unfortunately these mechanisms cannot explain the difference in DA 
response seen in the present study since both require initial neurotransmitter 
release into the synaptic cleft, a response which is absent in Ras-GRF2 KO 
mice. It may be that Ras-GRF2 is involved in another cellular signalling 
pathway at the synapse which has not previously been investigated.  
The noradrenergic system has been implicated in the long term 
adaptive changes caused by alcohol consumption (Nutt and Glue, 1988; 
Fahlke et al., 1999; Berggren et al., 2002), and NA is also involved in the 
modulation of alcohol’s behavioural and neurochemical effects (Fahlke et al., 
2011). In the present study, additional exploratory analysis was conducted in 
order to identify subtle differences which were undetected by statistical 
analysis methods. WT animals demonstrate a subtle alcohol-induced NA 
increase in both the NAcc and the CPu compared to basal levels, although 
there was only a trend for an increase in locomotor activity in WT mice. A 
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similar increase in NA was seen in Ras-GRF2 KO mice after the same acute 
alcohol challenge, but, there was no evidence for a change in the locomotor 
response compared to WT animals. NA is a modulatory transmitter which is 
involved in the acute and subchronic behavioural effects of alcohol (Fahlke et 
al., 2011), and may account for the comparable locomotor effects seen in 
these mice. Ethanol consumption significantly decreases the rate of NA 
turnover in specific brain areas such as the NAcc, PFC and amygdala (Smith 
et al., 2008), and such changes are thought to contribute to behavioural 
changes associated with binge drinking (Smith et al., 2008). NA signaled 
through the α2 adrenoceptor is involved in the negative feedback control 
mechanism at neuronal synapses, normally preventing NA release from the 
presynaptic nerve terminals of the CNS (Schwartz, 1997; Starke, 2001; Brede, 
2004). Data may suggest that Ras-GRF2 is capable of controlling the amount 
of NA present in the synaptic cleft under baseline conditions, although we 
cannot definitively say in what way this is regulated. Ras-GRF2 activates the 
Ras protein and thereby stimulates the MAPK/ERK signaling pathway. 
Adrenoceptors have been shown to differentially alter the activation of the 
MAPK/ERK pathway (Williams et al., 1998). Williams and colleagues 
demonstrate that stimulation of the β1 adrenoceptors results in ERK 
activation, and stimulation of α2 adrenoceptors does not, although this 
contradicts earlier studies suggesting that α2 adrenoceptors also activate the 
MAPK/ERK pathway (Howe and Marshall, 1993; Alblas et al., 1993; Winitz et 
al., 1993).  
Baseline transmitter levels in the NAcc and CPu were recorded prior to 
alcohol administration in Ras-GRF2 KO and WT mice; elevated basal levels 
have the potential to limit the maximum capacity of alcohol-induced 
neurotransmitter responses. Basal monoamine levels in the NAcc were 
consistently elevated in Ras-GRF2 KO compared to WT mice. NAcc DA and 
5-HT levels were approximately twice as great as in KO mice, and NA levels 
were around 50% greater than WT animals. One possibility is that transmitter 
levels may have reached ceiling levels, limiting further increases in DA and 5-
HT following exposure to alcohol. Different basal transmitter levels were 
observed in the CPu. NA levels remain higher in KO mice than in WT’s which 
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coincided with baseline locomotor activity. DA levels in the CPu were 
equivalent between WT and KO mice, and 5-HT levels were higher in WT 
mice. Despite the microdialysis results showing the same pattern across both 
brain areas, it is possible that basal extracellular monoamine levels may not 
be as important in the regulation of transmitter response to alcohol in the CPu 
as they are in the NAcc.  
 
The absence of saline injected groups is a major drawback in the present 
thesis. Inclusion of saline groups would have helped to identify injection 
stress-induced increases in behavioural and neurochemical levels. Stress 
induced changes in catecholamine release are relatively common in the 
mesolimbic system (Abercrombie et al., 1989; Keller et al., 1983). However, 
recent data report contradictory information regarding levels of DA and DA 
metabolites in the NAcc in response to injection stress (Imperato et al., 1993; 
Johnson and Glick, 1994). Thus, injection stress cannot be ruled out as a 
contributing factor and it was not possible to distinguish between responses 
caused solely by alcohol from those responses caused by injection stress. 
(Discussed in full in Chapter 6, 4. Strengths and Limitations). 
 
Data collected in the present study suggest an important contribution of Ras-
GRF2 to DA and 5-HT transmitter release which has not previously been 
investigated. The current study strengthens the link between this gene and 
addiction by providing further evidence that disruption of this pathway can 
alter addictive processes. In this case, Ras-GRF2 does so by modulating 
activity of the monoaminergic system in response to alcohol administration. 
Absence of Ras-GRF2 appears to result in the failure of the monoaminergic 
system to adapt in the normal way in response to alcohol, which may make 
the animal less vulnerable to alcohol’s rewarding properties. One might 
speculate as to whether Ras-GRF2 deletion can serve as neuro-protective 


































1. Research Summary 
One of the major cellular mechanisms underlying normal learning and 
memory formation is long-term potentiation (LTP). This process may also be 
important for drug memories and addiction. At the cellular and molecular level, 
many drugs of abuse have been documented to induce an LTP-like state in 
DA neurons of the VTA (Bonci et al., 2003; Saal et al., 2003; Thomas and 
Malenka, 2003; Borgland et al., 2004; Kauer, 2004), and work by enhancing 
synaptic transmission, potentiating signals for longer within the cell. In order to 
investigate the link between these pathways more fully, , the present thesis 
evaluated whether manipulation of two genes, αCaMKII and Ras-GRF2, can 
influence measures of drug preference, and the rate at which these 
preferences are established. This research was carried out using an in vivo 
approach in which specific components of the LTP system were disrupted. 
Two separate genes (αCaMKII and Ras-GRF2) were studied, each of which 
code for different CaM activated proteins involved in synaptic plasticity and 
learning and memory pathways. However, it does not automatically follow that 
manipulation of these genes and the impact on addiction related behaviours is 
due to their roles in learning. The thesis initially outlined and aimed to address 




 αCaMKII autophosphorylation will alter behavioural responses towards 
potentially threatening situations. 
The question of differential threat reactivity and anxiety-like responses was 
raised in relation to αCaMKII autophosphorylation deficient mice. αCaMKII 
has been implicated in behavioural responses to threat and fearful stimuli 
(Chen et al., 1994; Hasegawa et al., 2009; Thesis Chapter 2). Prior to 
commencing experiments, levels of anxiety in response to a novel 
environment were measured in αCaMKII autophosphorylation deficient mice 
compared to WT mice. Since the relief of a negative affective state such as 
anxiety or stress can affect susceptibility to addiction and is closely associated 
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with compulsive disorders (Koob, 2011), the first step was to further 
characterise spontaneous behaviours before assessing the mice in other 
more complex behavioural tasks. The first study was therefore deemed an 
important control experiment and investigated how αCaMKII 
autophosphorylation controls behavioural responses towards potentially 
threatening situations. This is especially important since the internal emotional 
state has the potential to impact upon behavioural outcomes used in the 
succeeding studies. By undertaking a comprehensive and systematic battery 
of spontaneous behaviour tests using homozygous and heterozygous T286A 
αCaMKII autophosphorylation deficient and WT mice, this molecular 
mechanism was found to influence locomotor reactivity to novel threatening 
environments. Therefore, due consideration of this reactivity was made in 
subsequent studies presented in this thesis. 
 
 
Hypothesis 2:  
 The lack of autophosphorylation should lead to a delay in the 
establishment of addiction related behaviours. 
 This should not limit the capacity to establish these behaviours after 
prolonged drug exposure, or play a role in the maintenance of an 
addictive state once established. 
 The initial delay should coincide with changes in the monoaminergic 
system 
The thesis attempted to address these hypotheses using the same 
experimental paradigms with two different drugs. 
 
1) Alcohol can increase αCaMKII expression levels in rat cerebral cortex, 
an effect which can be attributed to Ca2+ influx during chronic alcohol 
exposure (Mahadev et al., 2001). Chapter 3 therefore tested the above 
hypotheses in relation to alcohol use.  
Alcohol drinking was initially diminished in αCaMKII mutants, but adapted and 
became more in line with the WT response after repeated periods of 
withdrawal and reinstatement. Data were in-line with the original hypotheses 
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which stated that αCaMKII autophosphorylation would initially cause a delay 
in the establishment of addiction related behaviours, but that the mechanism 
would not play a role in the capacity to establish these behaviours. In vivo 
microdialysis data suggested that αCaMKII autophosphorylation modifies 
alcohol-induced changes in DA increases in the NAcc of WT mice. Data were 
again in-line with the original hypothesis which stated that these behavioural 
alterations would coincide with changes in the monoaminergic system. The 
blunted DA response seen in Mt mice may in turn be attributed to VTA DA 
neuron disinhibition. This highlights the involvement of αCaMKII 
autophosphorylation in the adaptation of the DA system for the establishment 
of alcohol-related drinking behaviours. However, this cannot be fully 
determined based on current data. Contrary to what may have been expected 
given the pattern of establishment of drinking preference, αCaMKII mutants 
developed alcohol-induced CPP at an accelerated rate, while CPP was 
established at a classical rate in WT mice (Risinger and Oakes, 1996; Liu et 
al., 2008). 
Taking everything into account, the present study showed that 
αCaMKII autophosphorylation is important for the establishment of 
alcoholism-related behaviours.  αCaMKII autophosphorylation appears to 
contribute to both positive and negative reinforcement mechanisms 
associated with alcohol addiction and this effect may be mediated by a DA-5-
HT balance in the meso-corticolimbic system. The positive reinforcing 
properties of alcohol may be mediated by a VTA driven dopaminergic 
activation of the NAcc. In αCaMKII mutant mice alcohol preference is reduced 
and the DA response is absent. However, alcohol CPP is established at an 
accelerated rate. Deficiency in αCaMKII autophosphorylation may enhance 
susceptibility to threatening stimuli, an effect which could render animals 
vulnerable to the negative reinforcing effects of alcohol. This can be linked to 
serotonergic activation of the PFC. Interestingly, Ht mice showed neither a 
strong DA nor 5-HT response, suggesting an absence of either positive or 
negative reinforcement. This is in line with their behaviour since they are the 
most delayed group in establishing alcohol drinking and alcohol CPP. Taken 
together, manipulation of αCaMKII autophosphorylation, does appear to alter 
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the development of alcohol preference and the rate at which preference is 
established as well as influencing the response of the dopaminergic and 
serotonergic systems to alcohol. 
  
2) Cocaine reinstatement is associated with CaMKII activation and 
phosphorylation of CaMKII at the Thr286 site (Anderson et al., 2008). 
Chapter 4 therefore investigates the involvement of cocaine relative to 
the above hypotheses. 
Given the current body of work investigating the role of αCaMKII 
autophosphorylation in alcohol-related behaviours, it was important to explore 
whether αCaMKII would play the same role in addictive behaviours when a 
stimulant such as cocaine is administered, as opposed to a depressant.  
Data showed that αCaMKII autophosphorylation deficient (Mt) mice 
were initially impaired in their ability to develop cocaine-induced CPP 
compared to Ht and WT mice. Mt mice developed CPP after repeated cocaine 
treatments and an incubation period during which CPP was consolidated. 
Data were in-line with the original hypotheses which stated that αCaMKII 
autophosphorylation deficiency would initially cause a delay in the 
establishment of addiction related behaviours, but that the mechanism would 
be less important over time following prolonged drug exposure. While the 
degree of cocaine preference was altered by the absence of αCaMKII 
autophosphorylation, other behaviours remained unchanged. Conditioned 
hyperactivity and the acute locomotor and conditioned behavioural 
sensitisation effects of cocaine were comparable across genotype groups. 
Data suggested that establishment of these behaviours may not require the 
specific involvement of the αCaMKII autophosphorylation mechanism. In vivo 
microdialysis experiments indicated that αCaMKII autophosphorylation 
deficiency resulted in a difference in the time-course of DA increase in the 
extracellular space of the NAcc following cocaine administration. This 
mechanism may facilitate the modulation of CPP and is in-line with the original 
hypothesis. However, the contribution of the serotonergic and noradrenergic 
systems in the development of cocaine related behaviours cannot be fully 
elucidated using current data. There was a difference in resting monoamine 
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levels in key regions of the reward system between WT, Ht and Mt mice. 
These data may explain the lack of response of the monoaminergic system 
and may represent ceiling effects, whereby further enhancement of cocaine-
induced response would not have been possible. 
The work in this thesis illustrates a complex role of the αCaMKII 
autophosphorylation mechanism in the development of cocaine preference. 
Present data suggests that there are other mechanisms at play in the 
development of addictive states which have not been measured here. Further 
experiments should investigate the effect of αCaMKII autophosphorylation 
deficiency on the glutamatergic system in response to cocaine administration. 
αCaMKII autophosphorylation cannot solely account for the development of 




Hypothesis 3:  
 Ras-GRF2 KO mice do not experience the motivationally rewarding 
properties of alcohol to the same extent as wild-type mice. 
 This may be accounted for by dysfunction of neurochemistry in the 
reward system. 
Polymorphisms in the human RASGRF2 gene are significantly associated 
with alcohol consumption. Ras-GRF2 KO mice also consume and prefer 
alcohol less than controls (Stacey et al., 2012). The studies in Chapter 5 
further examined the functional mechanisms responsible for these differences 
in consumption behaviour. 
Data showed that Ras-GRF2 KO mice do not experience the 
motivationally rewarding properties of alcohol to the same extent as WT mice, 
which may cause them to drink and prefer alcohol less than WT mice. This 
may be accounted for by dysfunction of the reward system and is in-line with 
the original hypotheses. Ras-GRF2 KO mice did not experience alcohol-
induced dopaminergic or serotonergic increases in key reward centres of the 
brain. In addition, noradrenergic alterations in response to alcohol in the NAcc 
and CPu were attenuated in Ras-GRF2 KO mice. These data suggest an 
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important contribution of Ras-GRF2 to transmitter release and regulation at 
the synapse which has not previously been investigated. In this case, Ras-
GRF2 does so by modulating activity of the monoaminergic system in 
response to alcohol administration. Absence of Ras-GRF2 appears to result in 
the failure of the monoaminergic system to adapt in the normal way in 
response to alcohol, potentially making the animal less vulnerable to alcohol’s 
rewarding properties. One might speculate as to whether Ras-GRF2 deletion 





























2. Alcohol vs. Cocaine 
The major advantage of assessing the response to two different classes of 
drugs using the same experimental paradigms in the same genetic model is 
the ability to examine the broader role of αCaMKII in addiction. While the 
similarities between alcohol and cocaine are important, it is arguably the 
differences between the drugs which provide the greatest insight and perhaps 
the most interesting and fundamental data regarding the specific processes of 
action of αCaMKII. Alcohol is a rather globally acting drug in the central 
nervous system compared to cocaine. There are several ethanol targets in the 
brain (McBride et al., 2002; Harris et al., 2008; Spanagel, 2009) including the 
NMDA receptors of the glutamatergic system (Lovinger, 1997; Narahashi, 
2000), the GABAergic system (Koob et al., 1998a), and DA activity in the 
mesolimbic system (Di Chiara and Imperato, 1988; Pontieri et al., 1995). 
Cocaine’s effects on the brain are far more localised, it’s most specific target 
being the dopaminergic system (Sofuoglu and Sewell, 2009). Perhaps 
cocaine’s most well documented function is the blockade of monoamine 
transporters and therefore monoamine (DA, 5-HT and NA) re-uptake (Uhl et 
al., 2002; Hall et al., 2004; Jones et al., 2009). DA receptors are also heavily 
implicated in the production of cocaine’s psychoactive effects (Montague et 
al., 2004; Hyman et al., 2006). Taking this into account, it is understandable 
that in the present thesis there were a number of different responses to some 
of the paradigms used. The establishment of preference as measured by the 
CPP test design followed a typical acquisition pattern in response to both 
alcohol and cocaine in WT mice (Fig 3.9A and Fig 4.1). As initially 
hypothesised, cocaine-induced CPP was impaired in Mt mice (Fig 4.1). 
However, alcohol-induced CPP was found to develop at an accelerated rate 
(Fig 3.9A). The CPP test also revealed that alcohol produced a conditioned 
sedation effect in Mt’s when compared to WT mice, whereas there were no 
cocaine-induced differences between genotype groups in conditioned 
hyperactivity. One might conclude that these conditioned effects may 
contribute towards the manifestation of drug-induced CPP in the present 
thesis in different, drug specific, ways. As discussed in Chapter 3, alcohol is 
an anxiolytic drug and may act as a negative reinforcement mechanism. This 
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is not the case for drugs such as cocaine, and thus would not have the same 
implications for the establishment of cocaine preference.  
 Given cocaine’s more specific molecular targets in the brain one might 
anticipate alcohol to affect the monoaminergic system in a more generalised 
way. Chapter 3 showed that alcohol administration induced changes in 
dopaminergic, serotonergic and noradrenergic functioning at an acute level, 
whereas the acute effects of cocaine appeared to be limited to the 
dopaminergic system (Chapter 4). The response of these systems suggests a 
differential role for αCaMKII autophosphorylation in the mesolimbic reward 
system dependent on the type of drug used The vital differences between the 
central effects of alcohol and cocaine allow for separation of the data in a 
more straightforward manner. An attempt to fully characterise the underlying 
action of αCaMKII in the development of addictive behaviours cannot be fully 
determined using current data and requires further investigation. The data 
presented in this thesis suggests that αCaMKII autophosphorylation may play 
a role in the behaviours of specific drugs of abuse as opposed to being 
universally significant for addictive behaviours. In the current example, it 
appears as though αCaMKII autophosphorylation may play a greater role in 

















3. αCaMKII vs. Ras-GRF2 
The thesis aimed to further dissect the relationship between addiction and two 
separate genes that encode proteins which influence LTP and are involved in 
synaptic plasticity. Both αCaMKII (Colbran and Brown, 2004; Irvine et al., 
2006; Wayman et al., 2008) and Ras-GRF2 have a role to play in the plasticity 
of the glutamatergic system (Thomas and Huganir, 2004; Tian et al., 2004; Li 
et al., 2006; Tian and Feig, 2006). They act by influencing LTP, which is 
thought to underlie normal learning and memory formation as well as being 
one of the key mediators of alcohol drinking and dependence (Spanagel, 
2009). While these genes have different downstream functions, there is some 
crossover between the gene products and their impact on molecular 
pathways. When a cell receives an intracellular signal the Ca²⁺ channel 
becomes active and allows for large Ca²⁺ influx. This results in depolarization 
of the cell. Ca2+ influx through AMPA and NMDA receptors, as well as L-type 
Ca2+ channels, activates Ca2+ mediated second messengers such as 
calmodulin. Following influx, Ca²⁺ binds to calmodulin forming a CaM complex 
which can in turn bind to and activate both αCaMKII and Ras-GRF2.  
Once active, CaMKII is able to directly, or indirectly through the Ras-MAPK 
pathway, influence a number of intracellular targets including TH, and cAMP 
response element-binding (CREB) mediated transcription (Xing et al., 1996). 
The intracellular targets of CaMKII include tyrosine hydroxylase (TH ; Griffith 
and Schulman, 1988) and tryptophan hydroxylase (TPH). TH is the rate 
limiting enzyme in DA synthesis, which in turn is a precursor for NA. TH 
activity and DA synthesis are thought to be regulated by Ca2+/CaM/CaMKII in 
the NAcc and other areas (Sutoo et al., 2002). Tryptophan hydroxylase (TPH) 
is the rate limiting enzyme in the biosynthesis of 5-HT (Kuhn et al., 2007). The 
isoform TPH2 is activated by CaMKII phosphorylation and expressed in the 
CNS (Hamon et al., 1977; 1978; 1981; Kuhn et al., 1980; Kuhn and 
Lovenberg, 1982; Yamauchi and Fujisawa, 1981; Ehret et al., 1989). Evidence 
implicates CaMKII in the regulation of DA, 5-HT and NA synthesis in the CNS. 
This ultimately suggests that CaMKII may act as a mediator for resting levels 
of transmitter available for release into the extracellular space. Although less 
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extensively studied, there is also evidence for the involvement of Ras-GRF2 
at the synapse. The RAS-MAPK/ERK pathway has been linked to DRD1 (Tian 
et al., 2004; Girault et al., 2007), and to DAT (Maiya et al., 2007). Previous 
studies and current data also suggest a role for Ras-GRF2 in the regulation of 
extracellular transmitter levels and in neurotransmitter release (Bloch-
Shilderman et al., 2001). This could have implications for transmitter 
synthesis, re-uptake and overall transmission.  
Further studies should therefore investigate the involvement of αCaMKII 
and Ras-GRF2 at the synapse. Experiments designed to determine various 
monoamine receptor and transporter expression levels in the brain may help 
determine a molecular mechanism of how these genes impact on the reward 
system. The dopaminergic system may be the initial point of interest since 
αCaMKII and Ras-GRF2 deficiency have been shown (Fig 3.13A and Fig 5.4) 






















4. Strengths and Limitations 
Availability of the mutant mice was a major drawback in the current thesis, it 
was therefore necessary to use both male and female mice for experiments. 
Since there were no major sex differences detected in experiments, sexes 
were combined and the data generated were collapsed for analysis. However, 
a minor sex specific role for αCaMKII autophosphorylation in threat induced 
hyperactivity, alcohol and cocaine related behaviours cannot be ruled out. The 
present study also retrospectively used the ‘Resource Equation’ method 
(Mead, 1988) to evaluate whether experiments were sufficiently powered to 
detect biologically important effects. Using this method it was determined that 
all experiments in the present thesis had sufficient animal numbers in order to 
yield good returns and reliable data. 
 
Extracellular levels of glutamate were not measured in microdialysis 
experiments in the present thesis. Given that the glutamatergic system is one 
of the main systems affected by αCaMKII and Ras-GRF2, one might have 
reasoned that glutamate is a transmitter of significant interest and importance 
to the current study. Glutamate levels in the NAcc are altered upon acute 
alcohol administration and can affect the function of the reward system 
(Szumlinski et al., 2005). The activation of AMPA receptors in the NAcc 
reinstates cocaine seeking (Kalivas et al., 2005; Schmidt et al., 2005), and 
conversely antagonism of AMPA receptors attenuates cocaine reinstatement 
(Cornish et al., 1999; Park et al., 2002; Suto et al., 2004). Data heavily 
implicates glutamatergic influence in drug addiction. The reinforcing actions of 
drugs of abuse are dependent upon the activity of mesolimbic DA neurons in 
the VTA and their projections into the ventral striatum and PFC (Spanagel and 
Weiss, 1999). The DA system is described as being of crucial impotance in 
order to experience the acute reinforcing effects of alcohol (Koob, 1992; 
McBride and Li, 1998; Nestler, 2005), with alcohol typically inducing an 
approximate 20% increase in DA levels in the NAcc (Doyon et al., 2003). 
Calcium/calmodulin dependent protein kinases and the Ras/mitogen-activated 
protein kinases are also involved in DA signalling, especially in relation to 
stimulant drugs (Licata and Pierce, 2003; Licata et al., 2004). Based on what 
  
 199
is known about the reinforcing action of drugs of abuse (Spanagel, 2009), 
measurement of the DA response was chosen over that of glutamate. In 
addition, an HPLC system with UV detection was not available and therefore 
glutamate was not assessed in this thesis but the importance of such studies 
is acknowledged. 
Following microdialysis experiments, Stacey and colleagues (Stacey et 
al., 2012) investigated whether altered synaptic glutamate input into the VTA 
could explain altered extracellular DA levels. The authors recorded excitatory 
postsynaptic currents of mesolimbic DA neurons by activation of AMPA and 
NMDA receptors in the presence of bicuculline, a GABAA receptor blocker. 
They reported no significant difference in AMPA:NMDA ratio between Ras-
GRF2 KO and WT controls. Stacey and colleagues (2012) also recorded DA 
neurons in current-clamp mode and measured action potentials elicited by 
increasing depolarizing current injections. They reported a reduced excitability 
of DA neurons of Ras-GRF2 KO mice compared to WT animals. Data indicate 
that impaired regulation of DA neuron excitability may provide an explanation 
for the deficient release of DA in the NAcc in the current thesis. 
 
The absence of saline injected groups for each genotype in all microdialysis 
experiments is a major limitation in the present thesis. Inclusion of saline 
groups would have determined whether injection stress alone induced 
behavioural and/or neurochemical changes, especially since threatening 
situations and stimuli have been identified as a potential confound (Chapter 2 
and Easton et al., 2011). Thus, injection stress cannot be ruled out as a 
contributing factor, and the specific responses caused by either alcohol or 
cocaine cannot be fully determined. Stress induced changes in catecholamine 
release are relatively common in the mesolimbic system (Abercrombie et al., 
1989; Keller et al., 1983). However, recent data revealed no consistent 
alterations in the NAcc in basal DOPAC and HVA levels between naive rats, 
and rats that had been injected once a day for four days, or twice a day for 
four days (Johnson and Glick, 1994). Findings suggest that handling and/or 
saline injections twice a day increases basal DA metabolism in the striatum, 
but not in the NAcc (Johnson and Glick, 1994). Imperato and colleagues also 
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show no significant differences in basal output of DA and the DA metabolites 
DOPAC and HVA in the NAcc on days 1 and 6 of testing between control rats 
and rats which had been stressed for the 5 days in between samplings 
(Imperato et al., 1993). Taking all this information into account, as well as 
carefully considering the high cost and limited availability of mice, the decision 
was made to replicate the more recent study design adopted by the Spanagel 
(Spanagel et al., 2005b) and Szumlinski research teams (Szumlinski et al., 
2005). This approach subsequently appears to be flawed in its design, 
especially when one considers the underlying behavioural phenotype of the 
αCaMKII mice described earlier (Easton et al., 2011; Chapter 2). 
 
The use of homozygous and heterozygous αCaMKII autophosphorylation 
deficient and WT mice is a major strength of the current thesis, and provides a 
very thorough investigation of the specific role of this mechanism in addiction 
related behaviours. The inclusion of the heterozygous mice has proven to be 
very informative in the present thesis, especially when one considers that a 
knock-out or knock-down model can have its own drawbacks. Knock-out mice 
may implement mechanisms to compensate for the absence of the 
gene/protein in question, and may not therefore be an accurate representation 
of true variation in gene function. This is where the use of heterozygous 
animals can be helpful in determining a more precise portrayal of the 
deficiency of certain genes. Heterozygous mice are sometimes expected to 
produce a response somewhere between that of the wild-type and knock-out 
mice. This is known as an ‘additive’ effect of the given gene/protein being 
investigated, i.e. the more copies one has of a specific gene, the greater the 
response. However, this is not always the case, and heterozygous mice can 
exhibit characteristics in other ways. A response may be considered as either 
‘dominant’ or ‘recessive’ if the heterozygous mouse displays a response 
similar to that of either the wild-type or the knock-out mouse. Heterozygous 
mice may also develop a response termed ‘hybrid vigour’ or ‘heterosis’ and 
describes the superiority of heterozygous genotypes in certain characteristics 
when compared to the corresponding parental homozygotes. Inclusion of 
heterozygous mice in the current thesis makes interpretation of the data more 
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complex. However, it was possible to acquire a more detailed awareness of 
αCaMKII in particular and its role in addiction-related behaviours, especially 
when attempting to disentangle the positive and negative reinforcing effects of 
alcohol in Chapter 3.  
 
The development of gene targeting strategies means that a mutant organism 
can be created that completely lacks the gene product. However, this method 
can also lead to a range of secondary phenotypic changes e.g. 
developmental, physiological or even behavioural (Büeler et al., 1992; Gerlai, 
1996; Wolfer et al., 2002), termed a ‘congenic footprint’ effect. These 
differences may not have anything to do with the gene of interest and may be 
a result of the organisms’ genetic background. Most gene targeting is carried 
out in embryonic stem cells from the 129 mouse strain (Silva et al., 1997). 
Mice will therefore have a set of chromosomes from the 129 strain and the 
C57BL/6 strain, as in the transgenic mouse models used in the present thesis. 
The probability of recombination is inversely related to the distance between 
loci, thus the 129-type alleles, which are closest to the mutant gene, will 
remain together with the mutant gene of interest (Gerlai, 1996). This implies 
that if the mutation is detected in a mouse, then there is a high probability that 
the mouse will also carry the 129-type flanking genes (Gerlai, 1996; Wolfer et 
al., 2002). This is a very important consideration when choosing to work with 
transgenic mouse models and a key issue when discussing the effects of 
gene products. A solution to this problem is to backcross the mice to create a 
congenic strain that carries both the mutation and the desired genetic 
background (Gerlai, 1996). In the present thesis both αCaMKII and Ras-GRF2 
mutant mice were kept on a mixed background, this was largely due to 
reasons of fecundity. This may potentially explain the inconsistency seen in 
the behaviour between mice and the amount of variation sometimes seen 
within specific genotype groups. For example, Figure 4.7 showed 5-HT 
response in the NAcc and PFC in αCaMKII autophosphorylation deficient 
mice after cocaine administration. WT data was considerably more variable 





Data in the present thesis combines an extensive methodological array of 
experiments, the use of elaborate behavioural and neurochemical protocols 
provide evidence for a role of αCaMKII and Ras-GRF2 in addiction pathways. 
An important role of αCaMKII autophosphorylation in the development of 
alcohol and cocaine related behaviours, and for the novel role of Ras-GRF2 in 
the response to alcohol has been suggested by the work in this thesis. Of 
particular note here, and of considerable interest to the addiction field, is firstly 
the role of αCaMKII in mediating the differential reinforcing effects of alcohol, 
predominantly the implications of αCaMKII in the negatively reinforcing 
mechanistic effects of alcohol use. Secondly, the proposal of Ras-GRF2 as a 
novel candidate in the mediation of alcoholism, a mechanism which appears 
to act by modulating monoaminergic system activation in important brain 






















5. Future directions 
 
5.1. αCaMKII autophosphorylation 
While the present thesis revealed several important and novel functions of 
αCaMKII autophosphorylation in spontaneous and addictive behaviours, there 
are many questions which remain unclear, thereby warranting further 
investigation. While the alcohol study has been developed across a series of 
experiments, research into the role of αCaMKII autophosphorylation on the 
behavioural effects of cocaine use remains relatively underrepresented. 
Following up on the current thesis, there are plans in place to repeat c-Fos 
analysis of the VTA using another drug, cocaine. It would also be invaluable to 
look at cocaine self-administration, withdrawal and reinstatement/relapse 
behaviours in αCaMKII mice. Expanding the current battery of tests to more 
closely mimic the alcohol study design as far as possible, would allow for a 
more accurate assessment of the drug specific role of αCaMKII 
autophosphorylation in addiction. Once the functions of this integral molecule 
have been more precisely elucidated, it would be of considerable benefit to 
support this vast amount of evidence in an animal model with an exploration 
of an appropriate human sample to see if the conclusions that have been 




Investigation into the role of Ras-GRF2 in alcohol consumption is relatively 
unexplored territory. It is therefore difficult to speculate concerning the precise 
involvement of Ras-GRF2 at this early stage. There is evidence for 
involvement of Ras-GRF2 at the synapse since the RAS-MAPK/ERK pathway 
has been linked to both DRD1 (Tian et al., 2004; Girault et al., 2007), and to 
DAT (Maiya et al., 2007). Previous studies and current data also suggest a 
role for Ras-GRF2 in the regulation of extracellular transmitter levels and in 
neurotransmitter release (Bloch-Shilderman et al., 2001), but could also have 
implications for synthesis, re-uptake and overall transmission. Ras-GRF2 has 
been implicated pre- and post-synaptically and further studies should involve 
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the inclusion of DA receptor and DAT expression levels in the brain In order to 
determine a molecular mechanism of how Ras-GRF2 might affect basal and 
induced DA activity in the NAcc.  
 
 
5.3. Other approaches 
The current thesis identifies two targets worthy of further in-depth 
investigation. There are several experimental approaches which may be 
utilised in order to look at the degree of involvement of these and other genes 
in the establishment of addictive behaviours. It may be of considerable 
interest to the addiction field to repeat and thereby extend current studies by 
using other drugs of abuse e.g. opiates or nicotine, and by performing 
microdialysis in additional brain areas of interest e.g. the VTA. Data would 
provide a more thorough and specific characterisation of the involvement of 
these genes in reward pathways and thus the establishment of addictive 
behaviours. Targets may also be used to develop specific strategies for the 
rescue of addiction phenotypes. For example, highly sophisticated techniques 
such as intra-cerebral injections using adeno-virus’ or antibodies may be used 
to alter protein and/or gene expression levels (Fernandes et al., 2012). Such 
specialised procedures, along with pharmacological intervention strategies 
may help in identifying the precise mechanisms involved in the development 
of addiction and determine whether the rescue and subsequent treatment of 
addiction is possible through these targets. Although αCaMKII and RasGRF2 
have been shown to play roles in learning and memory, unfortunately current 
data cannot directly support that these alterations in gene function have any 
consequences on the addiction related behaviours described here. In order to 
assess this further, experiments looking explicitly at LTP and learning 
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